name,pdb_id,pubmed_id,resolution,uniprot,PFAM,CATH,receptor_chain,receptor_length,peptide_chain,peptide_length,sequence_alignment,stride,percent_exposed_alignment,cluster_number,binding_mode,size_of_binding_mode,core_ecr_alignment,longest_continuous_core,longest_continuous_ecr,corebinding_aa,exosite_aa,surface_aa,interior_aa,corebinding_ss,exosite_ss,surface_ss,interior_ss,unique_id,COREBINDING_aa,COREBINDING_ss,EXOSITE_aa,EXOSITE_ss,bfact,bs_loc_type,full_peptide_sequece,mean_seq_iden_in_bm,mean_seq_iden_not_bm,min_dist_E_C_diff_bm,occupancy,pep_loc_type,title
1A3E_H_I_3_2.pdb,1A3E,9772168,1.85,P00734,PF00089,2.40.10.10,H,251,I,11,GDFEEIPEE--YL---,CCCCCCCGG--GC---,520230143--11---,3,2,18,eeCCCCCEE--EE---,5,4,E:0;F:0;I:0;K:0;L:0;M:0;Q:0;R:0;S:0;T:0;Y:0,E:0;F:0;I:0;K:0;L:0;M:0;Q:0;R:0;S:0;T:0;Y:0,A:1;D:7;E:5;F:2;G:1;I:1;K:6;N:4;P:6;R:7;S:2;T:1;W:1,A:10;C:7;D:9;E:8;F:6;G:19;H:5;I:14;K:12;L:18;M:6;N:6;P:8;Q:7;R:9;S:11;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:0;E:0;T:0,C:7;E:2;G:2;H:8;T:25,B:10;C:35;E:75;G:11;H:15;T:48,3_2,E:1;F:1;I:1;K:0;L:2;M:0;Q:1;R:2;S:0;T:1;Y:1,C:1;E:5;T:4,E:0;F:0;I:0;K:1;L:0;M:1;Q:0;R:0;S:1;T:0;Y:0,C:0;E:2;T:1,996678999--99---,ARG_68_H_COREBINDING;ARG_70_H_COREBINDING;GLN_24_H_COREBINDING;GLU_25_H_COREBINDING;ILE_78_H_COREBINDING;LEU_26_H_COREBINDING;LEU_60_H_COREBINDING;LYS_21_H_EXOSITE;MET_80_H_EXOSITE;PHE_19_H_COREBINDING;SER_79_H_EXOSITE;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,GGQSHNDGDFEEIPEEYL,0.974365479290756,0.496499446670151,3.99791308059593,999999999--99---,GLY_1_I_e;ASP_2_I_e;PHE_3_I_C;GLU_4_I_C;GLU_5_I_C;ILE_6_I_C;PRO_7_I_C;GLU_8_I_E;GLU_9_I_E;TYR_10_I_E;LEU_11_I_E,"COMPLEX OF HUMAN ALPHATHROMBIN WITH THE BIFUNCTIONAL BORONATE 2 INHIBITOR BOROLOG2"
1A4W_H_I_3_2.pdb,1A4W,8913620,1.80,P00734,PF00089,2.40.10.10,H,248,I,8,-DFEEIPEE-------,-CCCCCCCC-------,-40220144-------,3,2,18,-eCCCCCee-------,5,2,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,A:1;D:6;E:6;F:2;G:2;I:1;K:8;N:4;P:6;Q:2;R:8;S:2;W:1,A:10;C:7;D:10;E:7;F:5;G:18;H:5;I:14;K:10;L:18;M:7;N:6;P:8;Q:5;R:7;S:12;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:0;E:0;T:0,C:9;E:2;G:3;H:9;T:26,B:9;C:31;E:78;G:10;H:13;T:47,3_2,E:1;F:1;I:1;L:2;Q:1;R:3;T:1;Y:1,C:1;E:6;T:4,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,C:0;E:0;T:0,-88889999-------,ARG_62_H_COREBINDING;ARG_68_H_COREBINDING;ARG_70_H_COREBINDING;GLN_24_H_COREBINDING;GLU_25_H_COREBINDING;ILE_78_H_COREBINDING;LEU_26_H_COREBINDING;LEU_60_H_COREBINDING;PHE_19_H_COREBINDING;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,NGDFEEIPEEL,0.98534406437876,0.500684001898502,3.69595048668134,-99999999-------,ASP_1_I_e;PHE_2_I_C;GLU_3_I_C;GLU_4_I_C;ILE_5_I_C;PRO_6_I_C;GLU_7_I_e;GLU_8_I_e,"CRYSTAL STRUCTURES OF THROMBIN WITH THIAZOLECONTAINING INHIBITORS 2 PROBES OF THE S1 BINDING SITE"
1BB0_B_C_3_2.pdb,1BB0,9724521,2.10,P00734,PF00089,2.40.10.10,B,249,C,7,--FEEIPEE-------,--CCCCCCC-------,--1220144-------,3,2,18,--CCCCCee-------,5,2,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,D:6;E:5;F:2;G:2;I:1;K:7;N:4;P:4;Q:2;R:7;S:1;W:1,A:11;C:7;D:10;E:8;F:6;G:19;H:5;I:14;K:11;L:18;M:7;N:6;P:10;Q:5;R:8;S:12;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:0;E:0;T:0,C:7;E:1;G:2;H:9;T:23,B:10;C:37;E:75;G:11;H:14;T:49,3_2,E:1;F:1;I:1;L:2;Q:1;R:3;T:1;Y:1,C:1;E:6;T:4,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,C:0;E:0;T:0,--8888899-------,ARG_62_B_COREBINDING;ARG_68_B_COREBINDING;ARG_70_B_COREBINDING;GLN_24_B_COREBINDING;GLU_25_B_COREBINDING;ILE_78_B_COREBINDING;LEU_26_B_COREBINDING;LEU_60_B_COREBINDING;PHE_19_B_COREBINDING;THR_69_B_COREBINDING;TYR_71_B_COREBINDING,DGDFEEIPEEL,0.986506510497523,0.499960152639339,5.8003365419603,--9999999-------,PHE_1_C_C;GLU_2_C_C;GLU_3_C_C;ILE_4_C_C;PRO_5_C_C;GLU_6_C_e;GLU_7_C_e,"THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES"
1BBR_N_I_3_4.pdb,1BBR,1560020,2.30,P00735,PF00089,2.40.10.10,N,259,I,10,DFLAEGGGVR,CGGGGCCEEC,1023120100,3,4,5,CCCCCCCCCd,9,1,A:0;C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,A:1;C:1;D:2;E:1;G:3;H:0;I:0;K:0;L:0;N:0;P:0;R:0;S:1;V:1;W:0;Y:1,A:3;D:7;E:3;G:3;H:1;K:6;L:1;N:2;P:4;Q:2;R:8;S:3;T:1;V:1;W:1;Y:2,A:8;C:6;D:7;E:7;F:7;G:14;H:4;I:13;K:13;L:22;M:5;N:5;P:9;Q:6;R:11;S:9;T:10;V:18;W:6;Y:6,B:0;C:0;E:0;G:0;T:0,B:1;C:1;E:3;G:0;T:6,C:10;E:3;G:1;H:7;T:27,B:8;C:32;E:73;G:5;H:16;T:52,3_4,A:0;C:0;D:0;E:2;G:1;H:1;I:1;K:1;L:1;N:1;P:1;R:1;S:1;V:0;W:2;Y:1,B:0;C:2;E:4;G:3;T:5,A:0;C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,4344444334,ALA_200_N_exosite;ARG_178_N_COREBINDING;ASN_95_N_COREBINDING;ASP_199_N_exosite;ASP_204_N_exosite;CYS_201_N_exosite;GLU_202_N_exosite;GLU_229_N_COREBINDING;GLU_94_N_COREBINDING;GLY_203_N_exosite;GLY_228_N_COREBINDING;GLY_230_N_exosite;GLY_238_N_exosite;HIS_43_N_COREBINDING;ILE_179_N_COREBINDING;LEU_96_N_COREBINDING;LYS_93_N_COREBINDING;PRO_49_N_COREBINDING;SER_205_N_exosite;SER_226_N_COREBINDING;TRP_227_N_COREBINDING;TRP_50_N_COREBINDING;TYR_240_N_exosite;TYR_47_N_COREBINDING;VAL_225_N_exosite,DFLAEGGGVR,0.706563706563707,0.530087046753713,0.0376696164036744,9999999999,ASP_1_I_C;PHE_2_I_C;LEU_3_I_C;ALA_4_I_C;GLU_5_I_C;GLY_6_I_C;GLY_7_I_C;GLY_8_I_C;VAL_9_I_C;ARG_10_I_e,"THE STRUCTURE OF RESIDUES 716 OF THE A ALPHA CHAIN OF 2 HUMAN FIBRINOGEN BOUND TO BOVINE THROMBIN AT 23 ANGSTROMS 3 RESOLUTION"
1C4U_2_3_3_2.pdb,1C4U,10713516,2.10,P00734,PF00089,2.40.10.10,2,252,3,7,--FEGIPGE-------,--CCCCCCC-------,--2230244-------,3,2,18,--CCCCCee-------,5,2,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,A:1;D:6;E:7;F:2;G:3;I:1;K:7;N:3;P:2;Q:2;R:7;S:3;T:1,A:10;C:7;D:10;E:7;F:6;G:18;H:5;I:14;K:11;L:19;M:7;N:7;P:12;Q:5;R:8;S:11;T:7;V:16;W:8;Y:9,C:0;E:0;T:0,C:0;E:0;T:0,C:9;E:2;G:1;H:8;T:25,B:7;C:39;E:71;G:9;H:16;T:55,3_2,E:1;F:1;I:1;L:1;Q:1;R:3;T:1;Y:1,C:1;E:5;T:4,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,C:0;E:0;T:0,--7777788-------,ARG_62_2_COREBINDING;ARG_68_2_COREBINDING;ARG_70_2_COREBINDING;GLN_24_2_COREBINDING;GLU_25_2_COREBINDING;ILE_78_2_COREBINDING;LEU_26_2_COREBINDING;PHE_19_2_COREBINDING;THR_69_2_COREBINDING;TYR_71_2_COREBINDING,ACENEDFEGIPGE,0.988860020100379,0.499708869764998,5.93564191979267,--9999999-------,PHE_1_3_C;GLU_2_3_C;GLY_3_3_C;ILE_4_3_C;PRO_5_3_C;GLY_6_3_e;GLU_7_3_e,"SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL 2 MOIETIES"
1D3D_B_A_3_3.pdb,1D3D,10739244,2.04,P00734,PF00089,2.40.10.10,B,250,A,28,-E---A--DCGLRPLFEKKSLEDKTERELLESYI-------,-T---T--TTTTTTTTGGGCCCCCHHHHHHHHCC-------,-2---4--10000010023322031021023004-------,3,3,17,-E---E--DDCCCCCEEEEEEEEEEEEEEEEEEE-------,5,19,C:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,A:2;D:7;E:3;F:2;G:2;K:5;N:3;P:3;Q:2;R:9;S:2;T:2;W:1;Y:1,A:9;C:6;D:7;E:10;F:6;G:15;H:4;I:14;K:11;L:19;M:5;N:5;P:8;Q:6;R:7;S:9;T:7;V:14;W:5;Y:6,B:0;C:0;E:0;H:0;T:0,B:0;C:0;E:0;H:0;T:0,C:9;E:2;G:2;H:10;T:21,B:7;C:29;E:72;G:8;H:11;T:46,3_3,C:1;D:1;E:0;F:0;G:1;H:1;I:1;K:0;L:0;M:1;N:1;P:2;R:2;S:1;V:1;W:2;Y:1,B:2;C:4;E:2;H:0;T:8,C:0;D:1;E:1;F:1;G:2;H:0;I:1;K:2;L:1;M:1;N:1;P:1;R:0;S:2;V:1;W:0;Y:2,B:0;C:1;E:9;H:2;T:5,-8---7--63333333444444444455445568-------,ARG_137_B_COREBINDING;ARG_212_B_COREBINDING;ASN_158_B_EXOSITE;ASN_211_B_COREBINDING;ASP_113_B_COREBINDING;ASP_35_B_EXOSITE;CYS_119_B_COREBINDING;GLU_8_B_EXOSITE;GLY_10_B_COREBINDING;GLY_133_B_EXOSITE;GLY_136_B_EXOSITE;HIS_116_B_COREBINDING;ILE_33_B_EXOSITE;ILE_9_B_COREBINDING;LEU_129_B_EXOSITE;LYS_135_B_EXOSITE;LYS_206_B_EXOSITE;MET_11_B_COREBINDING;MET_205_B_EXOSITE;PHE_209_B_EXOSITE;PRO_117_B_COREBINDING;PRO_13_B_COREBINDING;PRO_208_B_EXOSITE;SER_112_B_COREBINDING;SER_128_B_EXOSITE;SER_34_B_EXOSITE;TRP_14_B_COREBINDING;TRP_213_B_COREBINDING;TYR_114_B_COREBINDING;TYR_134_B_EXOSITE;TYR_184_B_EXOSITE;VAL_118_B_COREBINDING;VAL_204_B_EXOSITE,EADCGLRPLFEKKSLEDKTERELLESYI,0.723539356114292,0.570691178750066,0.206668817193114,-9---9--99999999999999999999999999-------,GLU_1_A_E;ALA_2_A_E;ASP_3_A_E;CYS_4_A_E;GLY_5_A_C;LEU_6_A_C;ARG_7_A_C;PRO_8_A_C;LEU_9_A_C;PHE_10_A_E;GLU_11_A_E;LYS_12_A_E;LYS_13_A_E;SER_14_A_E;LEU_15_A_E;GLU_16_A_E;ASP_17_A_E;LYS_18_A_E;THR_19_A_E;GLU_20_A_E;ARG_21_A_E;GLU_22_A_E;LEU_23_A_E;LEU_24_A_E;GLU_25_A_E;SER_26_A_E;TYR_27_A_E;ILE_28_A_E,"CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH 2 BENZOTHIOPHENE INHIBITOR 4"
1DE7_K_B_3_4.pdb,1DE7,10956659,2.00,P00734,PF00089,2.40.10.10,K,251,B,9,TVELQGVVP-,TTTTTTTBC-,202312020-,3,4,5,CCCCCCCCC-,9,0,E:0;G:0;H:0;I:0;L:0;P:0;R:0;S:0;T:0;W:0;Y:0,E:0;G:0;H:0;I:0;L:0;P:0;R:0;S:0;T:0;W:0;Y:0,A:2;D:6;E:4;F:2;G:2;I:1;K:6;N:4;P:4;Q:3;R:6;S:2;T:2;Y:1,A:9;C:7;D:10;E:8;F:7;G:18;H:4;I:14;K:12;L:19;M:7;N:6;P:9;Q:5;R:10;S:10;T:6;V:16;W:5;Y:8,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:6;E:2;H:8;T:29,B:7;C:27;E:77;G:7;H:15;T:57,3_4,E:2;G:1;H:1;I:1;L:1;P:1;R:2;S:2;T:1;W:3;Y:1,B:1;C:3;E:3;G:3;T:6,E:0;G:0;H:0;I:0;L:0;P:0;R:0;S:0;T:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,999999875-,ARG_172_K_COREBINDING;ARG_93_K_COREBINDING;GLU_223_K_COREBINDING;GLU_94_K_COREBINDING;GLY_222_K_COREBINDING;HIS_43_K_COREBINDING;ILE_173_K_COREBINDING;LEU_96_K_COREBINDING;PRO_49_K_COREBINDING;SER_199_K_COREBINDING;SER_220_K_COREBINDING;THR_171_K_COREBINDING;TRP_221_K_COREBINDING;TRP_50_K_COREBINDING;TRP_92_K_COREBINDING;TYR_47_K_COREBINDING,TVELQGVVP,0.766455627511404,0.590567864272566,,999999999-,THR_1_B_C;VAL_2_B_C;GLU_3_B_C;LEU_4_B_C;GLN_5_B_C;GLY_6_B_C;VAL_7_B_C;VAL_8_B_C;PRO_9_B_C,"INTERACTION OF FACTOR XIII ACTIVATION PEPTIDE WITH ALPHATHROMBIN 2 CRYSTAL STRUCTURE OF THE ENZYMESUBSTRATE COMPLEX"
1DM4_B_C_3_4.pdb,1DM4,10739913,2.50,P00734,PF00089,2.40.10.10,B,252,C,10,DFLAEGGGVR,CCGGGCCEEC,2022110000,3,4,5,CCCCCCCCCd,9,1,A:0;C:0;D:0;E:0;G:0;H:0;I:0;L:0;P:0;R:0;S:0;V:0;W:0;Y:0,A:2;C:2;D:2;E:0;G:3;H:0;I:0;L:0;P:0;R:0;S:0;V:1;W:0;Y:0,A:2;D:7;E:4;F:2;G:2;I:1;K:7;N:3;P:4;Q:1;R:6;S:2;T:2;Y:1,A:8;C:5;D:7;E:8;F:7;G:15;H:4;I:14;K:11;L:19;M:7;N:7;P:9;Q:7;R:10;S:10;T:7;V:15;W:5;Y:8,B:0;C:0;E:0;G:0;T:0,B:1;C:1;E:2;G:0;T:6,C:6;E:2;H:8;T:28,B:6;C:28;E:76;G:6;H:17;T:50,3_4,A:0;C:0;D:0;E:3;G:1;H:1;I:1;L:1;P:1;R:2;S:1;V:0;W:3;Y:1,B:0;C:2;E:4;G:3;T:6,A:0;C:0;D:0;E:0;G:0;H:0;I:0;L:0;P:0;R:0;S:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,5555443333,ALA_194_B_exosite;ALA_199_B_exosite;ARG_172_B_COREBINDING;ARG_93_B_COREBINDING;ASP_193_B_exosite;ASP_198_B_exosite;CYS_195_B_exosite;CYS_225_B_exosite;GLU_196_B_COREBINDING;GLU_223_B_COREBINDING;GLU_94_B_COREBINDING;GLY_197_B_exosite;GLY_222_B_COREBINDING;GLY_224_B_exosite;GLY_232_B_exosite;HIS_43_B_COREBINDING;ILE_173_B_COREBINDING;LEU_96_B_COREBINDING;PRO_49_B_COREBINDING;SER_220_B_COREBINDING;TRP_221_B_COREBINDING;TRP_50_B_COREBINDING;TRP_92_B_COREBINDING;TYR_47_B_COREBINDING;VAL_219_B_exosite,DFLAEGGGVR,0.764237451737452,0.585346807071305,0.28217902119045,9999999999,ASP_1_C_C;PHE_2_C_C;LEU_3_C_C;ALA_4_C_C;GLU_5_C_C;GLY_6_C_C;GLY_7_C_C;GLY_8_C_C;VAL_9_C_C;ARG_10_C_e,"SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A 7 2 16"
1EB1_H_A_3_2.pdb,1EB1,11884127,1.80,P00734,PF00089,2.40.10.10,H,257,A,10,-DYEPIPE-EAF----,-CCCCCTT-TTC----,-3022013-412----,3,2,18,-eCCCCCE-EEE----,5,4,E:0;F:0;I:0;L:0;M:0;Q:0;R:0;T:0;Y:0,E:0;F:0;I:0;L:0;M:0;Q:1;R:0;T:0;Y:0,A:1;D:7;E:3;F:1;G:1;I:1;K:6;N:5;P:4;R:7;S:2;T:1;V:1;W:2,A:11;C:7;D:9;E:10;F:7;G:20;H:5;I:14;K:13;L:18;M:6;N:6;P:10;Q:6;R:8;S:12;T:8;V:16;W:7;Y:9,C:0;E:0;T:0,C:1;E:0;T:0,C:7;E:1;G:3;H:8;T:23,B:9;C:39;E:77;G:10;H:15;T:52,3_2,E:1;F:1;I:1;L:1;M:0;Q:1;R:3;T:1;Y:1,C:1;E:5;T:4,E:0;F:0;I:0;L:1;M:1;Q:0;R:0;T:0;Y:0,C:0;E:2;T:0,-8777789-999----,ARG_62_H_COREBINDING;ARG_68_H_COREBINDING;ARG_70_H_COREBINDING;GLN_156_H_exosite;GLN_24_H_COREBINDING;GLU_25_H_COREBINDING;ILE_78_H_COREBINDING;LEU_26_H_COREBINDING;LEU_60_H_EXOSITE;MET_80_H_EXOSITE;PHE_19_H_COREBINDING;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,DYEPIPEEAF,0.971847104600595,0.491610540363115,3.95580914605343,-9999999-999----,ASP_1_A_e;TYR_2_A_C;GLU_3_A_C;PRO_4_A_C;ILE_5_A_C;PRO_6_A_C;GLU_7_A_E;GLU_8_A_E;ALA_9_A_E;PHE_10_A_E,"COMPLEX STRUCTURE OF HUMAN THROMBIN WITH NMETHYLARGININE INHIBITOR"
1EKB_B_A_3_3.pdb,1EKB,10493881,2.30,P98072,PF00089,2.40.10.10,B,235,A,7,---------CGKKLV-------------------T------,---------CCCCCC-------------------C------,---------202111-------------------5------,3,3,17,---------dCCCCC-------------------e------,5,1,A:0;C:0;D:0;E:0;G:0;I:0;N:0;P:0;Q:0;R:0;T:0;W:0;Y:0,A:0;C:0;D:0;E:0;G:0;I:0;N:0;P:0;Q:0;R:0;T:0;W:0;Y:0,A:1;D:2;E:6;G:3;H:2;I:2;K:1;M:2;N:4;P:3;Q:4;R:3;S:4;T:1;V:1,A:15;C:8;D:8;E:6;F:5;G:15;H:3;I:10;K:5;L:18;M:6;N:9;P:9;Q:10;R:7;S:11;T:5;V:17;W:4;Y:9,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:5;E:2;G:3;H:3;T:26,B:9;C:22;E:77;G:10;H:12;T:50,3_3,A:1;C:1;D:1;E:1;G:1;I:1;N:1;P:2;Q:1;R:1;T:1;W:3;Y:1,B:2;C:2;E:2;T:10,A:0;C:0;D:0;E:0;G:0;I:0;N:0;P:0;Q:0;R:0;T:0;W:0;Y:0,B:0;C:0;E:0;T:0,---------545568-------------------8------,ALA_11_B_COREBINDING;ARG_198_B_COREBINDING;ASN_197_B_COREBINDING;ASP_106_B_COREBINDING;CYS_112_B_COREBINDING;GLN_109_B_COREBINDING;GLU_9_B_COREBINDING;GLY_10_B_COREBINDING;ILE_111_B_COREBINDING;PRO_110_B_COREBINDING;PRO_13_B_COREBINDING;THR_105_B_COREBINDING;TRP_12_B_COREBINDING;TRP_14_B_COREBINDING;TRP_199_B_COREBINDING;TYR_107_B_COREBINDING,CGKKLVTQEVSPK,0.332894665682551,0.332880809985629,0.549495222909171,---------999999-------------------9------,CYS_1_A_e;GLY_2_A_C;LYS_3_A_C;LYS_4_A_C;LEU_5_A_C;VAL_6_A_C;THR_7_A_e,"THE SERINE PROTEASE DOMAIN OF ENTEROPEPTIDASE BOUND TO INHIBITOR VAL 2 ASPASPASPASPLYSCHLOROMETHANE"
1F2S_E_I_3_1.pdb,1F2S,10524768,1.79,P00760,PF00089,2.40.10.10,E,223,I,28,R------------------------------------------------I--------------------------CPRIWM-ECKRDSDC-MAECICVM-GHCG----------------,C------------------------------------------------C--------------------------EECCCC-BCCCGGGC-TTTTCEET-TEEC----------------,1------------------------------------------------0--------------------------000001-20422210-12201024-1100----------------,3,1,29,d------------------------------------------------d--------------------------CCCCCC-EEEEDEDD-DEDDEEEE-EEED----------------,6,20,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;L:0;N:1;Q:1;S:1;V:0;W:0;Y:0,A:1;D:1;E:1;G:7;K:5;N:1;P:2;Q:1;S:13;T:1;V:1;Y:2,A:13;C:8;D:3;E:3;F:2;G:14;H:1;I:15;K:9;L:13;M:2;N:14;P:6;Q:7;R:2;S:17;T:9;V:15;W:3;Y:6,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:3,C:5;E:2;H:8;T:21,B:6;C:26;E:65;G:4;H:9;T:52,3_1,C:4;D:2;F:1;G:4;H:2;L:1;N:0;Q:1;S:3;V:1;W:1;Y:2,B:1;C:3;E:7;G:2;T:9,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,6------------------------------------------------5--------------------------433345-54554544-56544368-5543----------------,ASN_79_E_exosite;ASP_175_E_COREBINDING;ASP_180_E_COREBINDING;CYS_177_E_COREBINDING;CYS_201_E_COREBINDING;CYS_25_E_COREBINDING;CYS_41_E_COREBINDING;GLN_155_E_exosite;GLN_178_E_COREBINDING;GLY_179_E_COREBINDING;GLY_198_E_COREBINDING;GLY_200_E_COREBINDING;GLY_210_E_COREBINDING;HIS_23_E_COREBINDING;HIS_40_E_COREBINDING;LEU_81_E_COREBINDING;PHE_24_E_COREBINDING;SER_176_E_COREBINDING;SER_181_E_COREBINDING;SER_196_E_COREBINDING;SER_199_E_exosite;TRP_197_E_COREBINDING;TYR_131_E_COREBINDING;TYR_22_E_COREBINDING;VAL_195_E_COREBINDING,RICPRIWMECKRDSDCMAECICVMGHCG,0.679816146697421,0.361672637295171,0.855739446326976,9------------------------------------------------9--------------------------999999-99999999-99999999-9999----------------,ARG_1_I_e;ILE_2_I_e;CYS_3_I_C;PRO_4_I_C;ARG_5_I_C;ILE_6_I_C;TRP_7_I_C;MET_8_I_C;GLU_9_I_E;CYS_10_I_E;LYS_11_I_E;ARG_12_I_E;ASP_13_I_E;SER_14_I_E;ASP_15_I_E;CYS_16_I_E;MET_17_I_E;ALA_18_I_E;GLU_19_I_E;CYS_20_I_E;ILE_21_I_E;CYS_22_I_E;VAL_23_I_E;MET_24_I_E;GLY_25_I_E;HIS_26_I_E;CYS_27_I_E;GLY_28_I_E,"CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE BETA 2 TRYPSIN AND MCTIA A TRYPSIN INHIBITOR OF SQUASH FAMILY 3 AT 18 A RESOLUTION"
1FIW_A_L_3_6.pdb,1FIW,11080640,2.10,Q9GL10,PF00089,2.40.10.10,A,260,L,14,T--TCDG------PCGVRFRQN----------------------,T--TTTC------TTTTTTTCC----------------------,4--2021------300101224----------------------,3,6,3,E--EEED------CCCCCDDEE----------------------,5,5,A:0;C:0;E:0;F:0;G:0;H:0;I:0;L:0;M:0;N:0;P:0;Q:0;S:0;T:0;V:0;W:0;Y:0,A:0;C:0;E:0;F:0;G:0;H:0;I:0;L:0;M:0;N:0;P:0;Q:0;S:0;T:0;V:0;W:0;Y:0,A:1;E:3;G:3;H:2;I:1;K:6;N:3;P:4;Q:1;R:6;S:5;T:4;Y:2,A:16;C:8;D:8;E:6;F:5;G:19;H:3;I:16;K:7;L:16;M:4;N:6;P:10;Q:8;R:9;S:10;T:11;V:16;W:9;Y:6,B:0;C:0;E:0;H:0;T:0,B:0;C:0;E:0;H:0;T:0,B:1;C:7;E:2;G:1;H:6;T:24,B:7;C:18;E:82;G:10;H:12;T:64,3_6,A:1;C:1;E:1;F:0;G:2;H:0;I:1;L:1;M:0;N:1;P:2;Q:1;S:1;T:0;V:0;W:2;Y:1,B:1;C:7;E:2;H:0;T:5,A:1;C:1;E:0;F:1;G:1;H:2;I:0;L:0;M:1;N:1;P:0;Q:0;S:1;T:1;V:1;W:0;Y:0,B:1;C:3;E:1;H:1;T:5,9--8788------755656789----------------------,ALA_11_A_COREBINDING;ALA_8_A_EXOSITE;ASN_211_A_COREBINDING;ASN_38_A_EXOSITE;CYS_113_A_EXOSITE;CYS_121_A_COREBINDING;GLN_257_A_COREBINDING;GLU_157_A_COREBINDING;GLY_10_A_COREBINDING;GLY_114_A_EXOSITE;GLY_120_A_COREBINDING;HIS_115_A_EXOSITE;HIS_9_A_EXOSITE;ILE_256_A_COREBINDING;LEU_258_A_COREBINDING;MET_255_A_EXOSITE;PHE_116_A_EXOSITE;PRO_119_A_COREBINDING;PRO_13_A_COREBINDING;SER_212_A_COREBINDING;SER_39_A_EXOSITE;THR_112_A_EXOSITE;TRP_12_A_COREBINDING;TRP_14_A_COREBINDING;TYR_213_A_COREBINDING;VAL_111_A_EXOSITE,DNTTCDGPCGVRFRQNRQGGVR,0.307692307692308,0.307321594068582,0.802254947008743,9--9999------999999999----------------------,THR_1_L_E;THR_2_L_E;CYS_3_L_E;ASP_4_L_E;GLY_5_L_E;PRO_6_L_C;CYS_7_L_C;GLY_8_L_C;VAL_9_L_C;ARG_10_L_C;PHE_11_L_E;ARG_12_L_E;GLN_13_L_E;ASN_14_L_E,"THREEDIMENSIONAL STRUCTURE OF BETAACROSIN FROM RAM SPERMATOZOA"
1FPH_H_F_3_4.pdb,1FPH,1587268,2.50,P00734,PF00089,2.40.10.10,H,259,F,9,DFLAEGGGV-,CCGGGCCBC-,202212010-,3,4,5,CCCCCCCCC-,9,0,E:0;G:0;H:0;I:0;L:0;P:0;R:0;S:0;W:0;Y:0,E:0;G:0;H:0;I:0;L:0;P:0;R:0;S:0;W:0;Y:0,A:2;D:6;E:3;F:2;G:4;K:7;N:5;P:3;Q:2;R:5;S:2;T:3;V:1;Y:1,A:10;C:7;D:10;E:9;F:7;G:17;H:4;I:15;K:12;L:19;M:7;N:6;P:10;Q:6;R:11;S:11;T:7;V:16;W:7;Y:8,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:9;E:2;H:5;T:30,B:7;C:35;E:77;G:7;H:16;T:57,3_4,E:3;G:1;H:1;I:1;L:1;P:1;R:2;S:1;W:2;Y:1,B:1;C:2;E:3;G:3;T:5,E:0;G:0;H:0;I:0;L:0;P:0;R:0;S:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,856647643-,ARG_178_H_COREBINDING;ARG_93_H_COREBINDING;GLU_204_H_COREBINDING;GLU_231_H_COREBINDING;GLU_94_H_COREBINDING;GLY_230_H_COREBINDING;HIS_43_H_COREBINDING;ILE_179_H_COREBINDING;LEU_96_H_COREBINDING;PRO_49_H_COREBINDING;SER_228_H_COREBINDING;TRP_229_H_COREBINDING;TRP_50_H_COREBINDING;TYR_47_H_COREBINDING,DFLAEGGGV,0.755791505791506,0.569555086221753,,999999999-,ASP_1_F_C;PHE_2_F_C;LEU_3_F_C;ALA_4_F_C;GLU_5_F_C;GLY_6_F_C;GLY_7_F_C;GLY_8_F_C;VAL_9_F_C,"THE INTERACTION OF THROMBIN WITH FIBRINOGEN A STRUCTURAL BASIS FOR 2 ITS SPECIFICITY"
1G9I_E_I_3_1.pdb,1G9I,11257512,2.20,P00760,PF00089,2.40.10.10,E,223,I,22,-----------E-PCC--D----------------------S------CR--------------------------CTKSIP---------PQ--C---------HC--ANI---------,-----------C-TTT--T----------------------T------TC--------------------------EBCTTT---------TB--T---------TC--CCC---------,-----------5-322--2----------------------1------00--------------------------000003---------11--1---------10--123---------,3,1,29,-----------E-EEE--E----------------------D------DD--------------------------CCCCCC---------DD--D---------DD--DEE---------,6,8,C:0;D:0;F:0;G:0;H:0;K:0;L:0;M:0;N:0;Q:0;S:0;T:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;K:0;L:0;M:0;N:0;Q:0;S:0;T:0;V:0;W:0;Y:0,A:1;D:1;E:2;G:3;K:5;N:1;P:2;Q:1;S:11;T:2;V:1;Y:2,A:13;C:10;D:3;E:2;F:2;G:19;H:1;I:15;K:8;L:13;M:1;N:14;P:6;Q:7;R:2;S:18;T:7;V:15;W:3;Y:6,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:5;E:2;H:8;T:17,B:7;C:25;E:66;G:5;H:10;T:52,3_1,C:2;D:2;F:1;G:3;H:2;K:0;L:1;M:0;N:0;Q:1;S:3;T:0;V:1;W:1;Y:2,C:3;E:6;G:1;T:9,C:0;D:0;F:0;G:0;H:0;K:1;L:0;M:1;N:1;Q:1;S:2;T:1;V:0;W:0;Y:0,C:1;E:1;G:0;T:5,-----------9-999--9----------------------9------98--------------------------777777---------88--8---------99--999---------,ASN_79_E_EXOSITE;ASP_175_E_COREBINDING;ASP_180_E_COREBINDING;CYS_177_E_COREBINDING;CYS_201_E_COREBINDING;GLN_155_E_EXOSITE;GLN_178_E_COREBINDING;GLY_179_E_COREBINDING;GLY_198_E_COREBINDING;GLY_200_E_COREBINDING;HIS_23_E_COREBINDING;HIS_40_E_COREBINDING;LEU_81_E_COREBINDING;LYS_208_E_EXOSITE;MET_160_E_EXOSITE;PHE_24_E_COREBINDING;SER_176_E_COREBINDING;SER_181_E_COREBINDING;SER_196_E_COREBINDING;SER_199_E_EXOSITE;SER_78_E_EXOSITE;THR_80_E_EXOSITE;TRP_197_E_COREBINDING;TYR_131_E_COREBINDING;TYR_22_E_COREBINDING;VAL_195_E_COREBINDING,EPCCDSCRCTKSIPPQCHCANI,0.679519134846586,0.361032487032473,0.165948787280896,-----------9-999--9----------------------9------99--------------------------999999---------99--9---------99--999---------,GLU_1_I_E;PRO_2_I_E;CYS_3_I_E;CYS_4_I_E;ASP_5_I_E;SER_6_I_E;CYS_7_I_E;ARG_8_I_E;CYS_9_I_C;THR_10_I_C;LYS_11_I_C;SER_12_I_C;ILE_13_I_C;PRO_14_I_C;PRO_15_I_E;GLN_16_I_E;CYS_17_I_E;HIS_18_I_E;CYS_19_I_E;ALA_20_I_E;ASN_21_I_E;ILE_22_I_E,"CRYSTAL STRUCTURE OF BETATRYSIN COMPLEX IN CYCLOHEXANE"
1GI9_B_A_3_3.pdb,1GI9,11292354,1.80,P00749,PF00089,2.40.10.10,B,245,A,9,----L-KFQCGQK--T-------------------------,----C-CCTTTTC--C-------------------------,----4-3220021--4-------------------------,3,3,17,----E-EEDDccc--e-------------------------,3,5,C:1;E:2;I:1;M:1;N:1;P:1;Q:2;R:0;T:1;W:1,C:0;E:0;I:0;M:0;N:0;P:0;Q:0;R:0;T:0;W:0,D:2;E:2;F:2;G:3;H:1;K:5;L:1;M:1;N:2;P:3;Q:4;R:4;S:3;T:3;Y:3,A:11;C:10;D:9;E:8;F:5;G:18;H:8;I:15;K:8;L:17;M:4;N:3;P:6;Q:5;R:8;S:17;T:15;V:12;W:4;Y:9,B:1;C:3;E:2;G:2;T:3,B:0;C:0;E:0;G:0;T:0,C:5;E:2;H:3;T:29,B:8;C:22;E:94;G:10;H:10;T:48,3_3,C:0;E:0;I:0;M:0;N:0;P:0;Q:0;R:0;T:0;W:0,B:0;C:0;E:0;G:0;T:0,C:0;E:0;I:0;M:0;N:0;P:2;Q:0;R:1;T:0;W:0,B:0;C:1;E:1;G:0;T:1,----9-8554569--9-------------------------,ARG_209_B_EXOSITE;ASN_11_B_corebinding;CYS_121_B_corebinding;GLN_118_B_corebinding;GLN_12_B_corebinding;GLU_10_B_corebinding;GLU_136_B_corebinding;ILE_120_B_corebinding;MET_210_B_corebinding;PRO_113_B_EXOSITE;PRO_13_B_corebinding;PRO_38_B_EXOSITE;THR_119_B_corebinding;TRP_14_B_corebinding,KPSSPPEELKFQCGQKTLRPRFK,0.42072189615848,0.40129452743938,0.0872009174263668,----5-9999999--4-------------------------,LEU_1_A_E;LYS_2_A_E;PHE_3_A_E;GLN_4_A_E;CYS_5_A_E;GLY_6_A_c;GLN_7_A_c;LYS_8_A_c;THR_9_A_e,"A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTICENTERED 2 SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE"
1GJ9_B_A_3_3.pdb,1GJ9,11731301,1.80,P00749,PF00089,2.40.10.10,B,246,A,10,----L-KFQCGQKT--------------------L------,----C-CCTTTTCC--------------------C------,----4-31210212--------------------4------,3,3,17,----E-EEDDCCCC--------------------e------,4,5,A:0;C:0;E:0;I:0;L:0;M:0;N:0;P:0;Q:0;R:0;T:0;W:0,A:0;C:0;E:0;I:0;L:0;M:0;N:0;P:0;Q:0;R:0;T:0;W:0,D:2;E:3;F:2;G:4;H:1;K:6;L:1;M:1;N:2;P:1;Q:4;R:3;S:2;T:3;Y:2,A:10;C:10;D:9;E:7;F:5;G:17;H:8;I:14;K:8;L:16;M:4;N:3;P:8;Q:4;R:8;S:18;T:15;V:12;W:4;Y:10,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:7;E:2;G:1;H:2;T:25,B:4;C:21;E:93;G:9;H:11;T:52,3_3,A:0;C:1;E:2;I:1;L:0;M:1;N:1;P:1;Q:2;R:1;T:1;W:1,B:1;C:3;E:2;G:2;T:4,A:1;C:0;E:0;I:1;L:1;M:0;N:0;P:2;Q:1;R:1;T:0;W:0,B:0;C:3;E:2;G:0;T:2,----9-85655778--------------------8------,ALA_111_B_EXOSITE;ARG_115_B_COREBINDING;ARG_209_B_EXOSITE;ASN_11_B_COREBINDING;CYS_121_B_COREBINDING;GLN_112_B_EXOSITE;GLN_118_B_COREBINDING;GLN_12_B_COREBINDING;GLU_10_B_COREBINDING;GLU_136_B_COREBINDING;ILE_117_B_EXOSITE;ILE_120_B_COREBINDING;LEU_35_B_EXOSITE;MET_210_B_COREBINDING;PRO_113_B_EXOSITE;PRO_13_B_COREBINDING;PRO_38_B_EXOSITE;THR_119_B_COREBINDING;TRP_14_B_COREBINDING,KPSSPPEELKFQCGQKTLRPRFK,0.421059983301284,0.401047096023625,0.111022520238013,----3-99999995--------------------0------,LEU_1_A_E;LYS_2_A_E;PHE_3_A_E;GLN_4_A_E;CYS_5_A_E;GLY_6_A_C;GLN_7_A_C;LYS_8_A_C;THR_9_A_C;LEU_10_A_e,"ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 2 TRYPSINLIKE SERINE PROTEASE DRUG TARGETS"
1H9I_E_I_3_1.pdb,1H9I,16131759,1.9,P00761,PF00089,2.40.10.10,E,223,I,30,G---------------------------------------------------------------------------CPRILI-RCKQDSDC-LAGCVCTNNKFCG-------SP-------,C---------------------------------------------------------------------------EECCCC-BCCCGGGC-TTTTEEETTTEEE-------CC-------,2---------------------------------------------------------------------------000000-20322320-1220101412000-------03-------,3,1,29,d---------------------------------------------------------------------------CCCCCC-DEEEDEDD-DEDEDEEEEEEED-------DE-------,6,23,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;V:0;W:0;Y:0,A:4;D:2;E:1;G:6;K:3;L:1;N:3;P:2;Q:1;R:2;S:7;T:1;Y:1,A:11;C:8;D:2;E:4;F:3;G:14;H:2;I:16;K:7;L:14;M:2;N:14;P:7;Q:10;R:2;S:15;T:9;V:15;W:3;Y:5,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:3;E:2;H:8;T:21,B:6;C:29;E:66;G:4;H:10;T:48,3_1,C:4;D:2;F:1;G:4;H:2;L:1;N:0;Q:1;S:3;V:1;W:1;Y:1,B:1;C:2;E:8;G:2;T:8,C:0;D:0;F:0;G:1;H:0;L:0;N:1;Q:0;S:2;V:0;W:0;Y:1,B:0;C:1;E:0;G:0;T:4,8---------------------------------------------------------------------------554445-87988976-6876679987656-------69-------,ASN_79_E_EXOSITE;ASP_171_E_COREBINDING;ASP_176_E_COREBINDING;CYS_173_E_COREBINDING;CYS_197_E_COREBINDING;CYS_25_E_COREBINDING;CYS_41_E_COREBINDING;GLN_174_E_COREBINDING;GLY_128_E_EXOSITE;GLY_175_E_COREBINDING;GLY_194_E_COREBINDING;GLY_196_E_COREBINDING;GLY_204_E_COREBINDING;HIS_23_E_COREBINDING;HIS_40_E_COREBINDING;LEU_81_E_COREBINDING;PHE_24_E_COREBINDING;SER_129_E_EXOSITE;SER_172_E_COREBINDING;SER_177_E_COREBINDING;SER_192_E_COREBINDING;SER_22_E_EXOSITE;TRP_193_E_COREBINDING;TYR_131_E_COREBINDING;TYR_195_E_EXOSITE;VAL_191_E_COREBINDING,GCPRILIRCKQDSDCLAGCVCTNNKFCGSPHHHHHH,0.60709557456849,0.361134989645074,0.508198780006406,9---------------------------------------------------------------------------999999-99999999-9999999999999-------99-------,GLY_1_I_e;CYS_2_I_C;PRO_3_I_C;ARG_4_I_C;ILE_5_I_C;LEU_6_I_C;ILE_7_I_C;ARG_8_I_E;CYS_9_I_E;LYS_10_I_E;GLN_11_I_E;ASP_12_I_E;SER_13_I_E;ASP_14_I_E;CYS_15_I_E;LEU_16_I_E;ALA_17_I_E;GLY_18_I_E;CYS_19_I_E;VAL_20_I_E;CYS_21_I_E;THR_22_I_E;ASN_23_I_E;ASN_24_I_E;LYS_25_I_E;PHE_26_I_E;CYS_27_I_E;GLY_28_I_E;SER_29_I_E;PRO_30_I_E,"COMPLEX OF EETIII MUTANT WITH PORCINE TRYPSIN"
1HXF_H_I_3_2.pdb,1HXF,9108691,2.10,P00734,PF00089,2.40.10.10,H,248,I,10,-DFEEIPGE--YL---,-CCCCCCGG--GC---,-40230123--11---,3,2,18,-eCCCCCEE--EE---,5,4,E:0;F:0;I:0;K:0;L:0;M:0;Q:0;R:0;T:0;Y:0,E:0;F:0;I:0;K:0;L:0;M:0;Q:1;R:0;T:0;Y:0,A:1;D:6;E:7;F:2;G:3;I:1;K:5;N:4;P:4;Q:1;R:7;S:2;W:1,A:10;C:7;D:10;E:6;F:5;G:17;H:5;I:14;K:12;L:18;M:6;N:6;P:10;Q:5;R:8;S:12;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:1;E:0;T:0,C:8;E:1;G:3;H:4;T:28,B:9;C:27;E:77;G:10;H:18;T:49,3_2,E:1;F:1;I:1;K:0;L:2;M:0;Q:1;R:3;T:1;Y:1,C:1;E:6;T:4,E:0;F:0;I:0;K:1;L:0;M:1;Q:0;R:0;T:0;Y:0,C:0;E:1;T:1,-88888888--89---,ARG_62_H_COREBINDING;ARG_68_H_COREBINDING;ARG_70_H_COREBINDING;GLN_149_H_exosite;GLN_24_H_COREBINDING;GLU_25_H_COREBINDING;ILE_78_H_COREBINDING;LEU_26_H_COREBINDING;LEU_60_H_COREBINDING;LYS_21_H_EXOSITE;MET_80_H_EXOSITE;PHE_19_H_COREBINDING;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,DFEEIPGEYL,0.98534406437876,0.500802597723929,3.6917673274463,-99999999--99---,ASP_1_I_e;PHE_2_I_C;GLU_3_I_C;GLU_4_I_C;ILE_5_I_C;PRO_6_I_C;GLY_7_I_E;GLU_8_I_E;TYR_9_I_E;LEU_10_I_E,"HUMAN THROMBIN COMPLEX WITH HIRUDIN VARIANT"
1LHG_H_I_3_2.pdb,1LHG,7893672,2.25,P00734,PF00089,2.40.10.10,H,249,I,7,GDFEEIP---------,CCCCCCC---------,3302314---------,3,2,18,eeCCCCC---------,5,2,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,E:0;F:0;I:0;L:0;Q:1;R:0;T:0;Y:0,A:2;D:7;E:5;F:2;G:3;I:1;K:8;N:4;P:3;Q:1;R:8;S:2;W:1,A:9;C:7;D:9;E:8;F:6;G:17;H:5;I:14;K:10;L:18;M:7;N:6;P:11;Q:5;R:7;S:12;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:1;E:0;T:0,C:7;E:2;G:3;H:10;T:25,B:7;C:30;E:76;G:10;H:13;T:54,3_2,E:1;F:1;I:1;L:2;Q:1;R:3;T:1;Y:1,C:1;E:6;T:4,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,C:0;E:0;T:0,9998999---------,ARG_62_H_COREBINDING;ARG_68_H_COREBINDING;ARG_70_H_COREBINDING;GLN_149_H_exosite;GLN_24_H_COREBINDING;GLU_25_H_COREBINDING;ILE_78_H_COREBINDING;LEU_26_H_COREBINDING;LEU_60_H_COREBINDING;PHE_19_H_COREBINDING;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,GDFEEIPEEYLQ,0.988613237420077,0.500605218878219,3.81626440383787,9999999---------,GLY_1_I_e;ASP_2_I_e;PHE_3_I_C;GLU_4_I_C;GLU_5_I_C;ILE_6_I_C;PRO_7_I_C,"HUMAN ALPHATHROMBIN COMPLEXED WITH ACDPHEPRO 2 BOROORNITHINEOH"
1LMW_D_C_3_3.pdb,1LMW,8591045,2.50,P00749,PF00089,2.40.10.10,D,248,C,8,---C------GQKTL-------------------RP-----,---C------TTTCC-------------------CC-----,---2------02122-------------------34-----,3,3,17,---d------CCCCC-------------------ee-----,5,2,C:0;E:0;I:0;M:0;N:0;P:0;Q:0;R:0;T:0,C:0;E:0;I:0;M:0;N:0;P:0;Q:0;R:0;T:0,D:2;E:5;F:1;G:3;H:2;K:6;L:1;M:1;N:2;P:4;Q:4;R:3;S:3;T:3;Y:3,A:10;C:10;D:9;E:7;F:6;G:18;H:7;I:15;K:8;L:17;M:4;N:4;P:7;Q:5;R:9;S:17;T:15;V:12;W:5;Y:9,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:9;E:3;G:2;H:2;T:27,B:9;C:29;E:79;G:8;H:6;T:63,3_3,C:1;E:2;I:1;M:1;N:1;P:1;Q:2;R:1;T:1,B:1;C:3;E:2;T:5,C:0;E:0;I:0;M:0;N:0;P:0;Q:0;R:0;T:0,B:0;C:0;E:0;T:0,---6------66689-------------------99-----,ARG_118_D_COREBINDING;ASN_11_D_COREBINDING;CYS_124_D_COREBINDING;GLN_12_D_COREBINDING;GLN_121_D_COREBINDING;GLU_10_D_COREBINDING;GLU_139_D_COREBINDING;ILE_123_D_COREBINDING;MET_213_D_COREBINDING;PRO_13_D_COREBINDING;THR_122_D_COREBINDING,KPSSPPEELKFQCGQKTLRPRFK,0.418892525140888,0.398465810252559,0.380043418572142,---9------99999-------------------99-----,CYS_1_C_e;GLY_2_C_C;GLN_3_C_C;LYS_4_C_C;THR_5_C_C;LEU_6_C_C;ARG_7_C_e;PRO_8_C_e,"LMW UPA STRUCTURE COMPLEXED WITH EGRCMK GLUGLYARG CHLOROMETHYL 2 KETONE"
1MCT_A_I_3_1.pdb,1MCT,8445634,1.60,P00761,PF00089,2.40.10.10,A,223,I,28,R------------------------------------------------I--------------------------CPRIWM-ECTRDSDC-MAKCICVA-GHCG----------------,C------------------------------------------------E--------------------------EECCCC-BCCCGGGC-TTTTCEET-TEEC----------------,2------------------------------------------------0--------------------------000001-20332310-12201024-1101----------------,3,1,29,d------------------------------------------------d--------------------------CCCCCC-EEEEDEDD-DEDDEEEE-EEED----------------,6,20,C:0;D:0;F:0;G:0;H:0;L:0;P:0;Q:0;S:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;L:0;P:0;Q:1;S:0;V:0;W:0;Y:1,A:6;D:1;G:5;K:3;L:1;N:5;P:2;Q:2;R:2;S:7;T:1;W:1;Y:1,A:9;C:9;D:2;E:4;F:3;G:17;H:2;I:16;K:7;L:14;M:2;N:14;P:6;Q:9;R:2;S:16;T:9;V:14;W:2;Y:5,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:1;G:0;T:1,C:3;E:3;H:8;T:23,B:4;C:28;E:63;G:4;H:10;T:53,3_1,C:3;D:2;F:1;G:3;H:2;L:1;P:1;Q:1;S:4;V:2;W:1;Y:1,B:1;C:4;E:8;G:2;T:7,C:0;D:0;F:0;G:0;H:0;L:0;P:0;Q:0;S:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,9------------------------------------------------6--------------------------344444-65855865-56556459-7644----------------,ASP_175_A_COREBINDING;ASP_180_A_COREBINDING;CYS_177_A_COREBINDING;CYS_25_A_COREBINDING;CYS_41_A_COREBINDING;GLN_155_A_exosite;GLN_178_A_COREBINDING;GLY_179_A_COREBINDING;GLY_198_A_COREBINDING;GLY_210_A_COREBINDING;HIS_23_A_COREBINDING;HIS_40_A_COREBINDING;LEU_81_A_COREBINDING;PHE_24_A_COREBINDING;PRO_209_A_COREBINDING;SER_176_A_COREBINDING;SER_181_A_COREBINDING;SER_196_A_COREBINDING;SER_22_A_COREBINDING;TRP_197_A_COREBINDING;TYR_131_A_COREBINDING;TYR_199_A_exosite;VAL_195_A_COREBINDING;VAL_211_A_COREBINDING,RICPRIWMECTRDSDCMAKCICVAGHCG,0.603242646639378,0.361507095198897,0.305532322349044,9------------------------------------------------9--------------------------999999-99999999-99999999-9999----------------,ARG_1_I_e;ILE_2_I_e;CYS_3_I_C;PRO_4_I_C;ARG_5_I_C;ILE_6_I_C;TRP_7_I_C;MET_8_I_C;GLU_9_I_E;CYS_10_I_E;THR_11_I_E;ARG_12_I_E;ASP_13_I_E;SER_14_I_E;ASP_15_I_E;CYS_16_I_E;MET_17_I_E;ALA_18_I_E;LYS_19_I_E;CYS_20_I_E;ILE_21_I_E;CYS_22_I_E;VAL_23_I_E;ALA_24_I_E;GLY_25_I_E;HIS_26_I_E;CYS_27_I_E;GLY_28_I_E,"THE REFINED 16 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF 2 THE COMPLEX FORMED BETWEEN PORCINE BETATRYPSIN AND MCTIA 3 A TRYPSIN INHIBITOR OF SQUASH FAMILY"
1NRR_H_R_3_8.pdb,1NRR,8136362,2.40,P00734,PF00089,2.40.10.10,H,249,R,5,K-------YEPF----,C-------CCCC----,4-------0123----,3,8,2,d-------CCCC----,4,1,F:0;I:0;Q:0;R:0;T:0;Y:0,F:0;I:0;Q:0;R:0;T:0;Y:0,A:2;D:6;E:6;F:1;G:2;I:1;K:5;N:4;P:3;Q:1;R:8;S:2;W:1,A:9;C:7;D:10;E:8;F:7;G:18;H:5;I:14;K:13;L:20;M:7;N:6;P:11;Q:6;R:7;S:12;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:0;E:0;T:0,C:7;E:1;G:4;H:9;T:21,B:9;C:35;E:81;G:12;H:14;T:48,3_8,F:1;I:1;Q:1;R:3;T:1;Y:1,C:1;E:3;T:4,F:0;I:0;Q:0;R:0;T:0;Y:0,C:0;E:0;T:0,9-------9999----,ARG_62_H_COREBINDING;ARG_70_H_COREBINDING;ARG_73_H_COREBINDING;GLN_24_H_COREBINDING;ILE_78_H_COREBINDING;PHE_19_H_COREBINDING;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,FLLRNPNDKYEPFWEDEE,0.968871595330739,0.593937577586911,1.13356120258237,9-------9999----,LYS_1_R_e;TYR_2_R_C;GLU_3_R_C;PRO_4_R_C;PHE_5_R_C,"CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN 2 RECEPTOR PEPTIDES EXISTENCE OF EXPECTED AND NOVEL BINDING MODES"
1O3P_B_A_3_6.pdb,1O3P,12742021,1.81,P00749,PF00089,2.40.10.10,B,246,A,8,--L----KF----QCGQK--------------------------,--C----CC----TTTTC--------------------------,--4----30----21022--------------------------,3,6,3,--e----ee----CCCCC--------------------------,5,3,A:0;C:0;E:0;I:0;L:0;M:0;N:0;P:0;Q:0;R:0;T:0;W:0,A:1;C:0;E:0;I:1;L:1;M:0;N:0;P:2;Q:1;R:0;T:0;W:0,A:1;D:2;E:3;F:2;G:3;H:1;K:5;L:1;M:1;N:2;P:2;Q:5;R:4;S:2;T:3;Y:1,A:9;C:10;D:9;E:7;F:5;G:18;H:8;I:14;K:9;L:16;M:4;N:3;P:7;Q:3;R:8;S:18;T:15;V:12;W:4;Y:11,B:0;C:0;E:0;G:0;T:0,B:0;C:3;E:1;G:0;T:2,B:1;C:5;E:4;H:2;T:26,B:5;C:23;E:90;G:10;H:11;T:51,3_6,A:0;C:1;E:2;I:1;L:0;M:1;N:1;P:1;Q:2;R:1;T:1;W:1,B:1;C:3;E:3;G:2;T:3,A:0;C:0;E:0;I:0;L:0;M:0;N:0;P:0;Q:0;R:0;T:0;W:0,B:0;C:0;E:0;G:0;T:0,--8----75----64466--------------------------,ALA_111_B_exosite;ARG_209_B_COREBINDING;ASN_11_B_COREBINDING;CYS_121_B_COREBINDING;GLN_112_B_exosite;GLN_118_B_COREBINDING;GLN_12_B_COREBINDING;GLU_10_B_COREBINDING;GLU_136_B_COREBINDING;ILE_117_B_exosite;ILE_120_B_COREBINDING;LEU_35_B_exosite;MET_210_B_COREBINDING;PRO_113_B_exosite;PRO_13_B_COREBINDING;PRO_38_B_exosite;THR_119_B_COREBINDING;TRP_14_B_COREBINDING,KPSSPPEELKFQCGQKTLRPRFK,0.295846153846154,0.407293035286833,3.73337139861547,--2----99----99996--------------------------,LEU_1_A_e;LYS_2_A_e;PHE_3_A_e;GLN_4_A_C;CYS_5_A_C;GLY_6_A_C;GLN_7_A_C;LYS_8_A_C,"ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING 2 BINDING OF ACTIVE SITEDIRECTED SERINE PROTEASE INHIBITORS"
1OX1_A_B_3_1.pdb,1OX1,,2.00,P00760,PF00089,2.40.10.10,A,223,B,10,S---------------------------------------------------------------------------CTRSIP---------PQ-C--------------------------,C---------------------------------------------------------------------------EBCTTT---------TB-C--------------------------,2---------------------------------------------------------------------------100003---------12-3--------------------------,3,1,29,d---------------------------------------------------------------------------CCCCCC---------dd-d--------------------------,6,3,C:0;D:0;F:0;G:0;H:0;L:0;P:0;Q:0;S:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;L:0;P:0;Q:0;S:1;V:0;W:0;Y:0,A:1;E:2;G:6;K:4;N:3;P:2;Q:2;S:13;T:2;V:1,A:13;C:10;D:4;E:2;F:2;G:15;H:1;I:15;K:10;L:13;M:2;N:13;P:5;Q:7;R:2;S:17;T:8;V:14;W:3;Y:8,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:1,C:4;E:1;H:8;T:23,B:7;C:26;E:66;G:4;H:10;T:51,3_1,C:2;D:2;F:1;G:4;H:2;L:1;P:1;Q:1;S:3;V:2;W:1;Y:2,C:5;E:7;G:2;T:8,C:0;D:0;F:0;G:0;H:0;L:0;P:0;Q:0;S:0;V:0;W:0;Y:0,C:0;E:0;G:0;T:0,9---------------------------------------------------------------------------866678---------89-9--------------------------,ASP_175_A_COREBINDING;ASP_180_A_COREBINDING;CYS_177_A_COREBINDING;CYS_41_A_COREBINDING;GLN_178_A_COREBINDING;GLY_179_A_COREBINDING;GLY_198_A_COREBINDING;GLY_200_A_COREBINDING;GLY_210_A_COREBINDING;HIS_23_A_COREBINDING;HIS_40_A_COREBINDING;LEU_81_A_COREBINDING;PHE_24_A_COREBINDING;PRO_209_A_COREBINDING;SER_176_A_COREBINDING;SER_181_A_COREBINDING;SER_196_A_COREBINDING;SER_199_A_exosite;TRP_197_A_COREBINDING;TYR_131_A_COREBINDING;TYR_22_A_COREBINDING;VAL_195_A_COREBINDING;VAL_211_A_COREBINDING,SCTRSIPPQCY,0.679668567004386,0.361315135733278,0.0935093578204875,9---------------------------------------------------------------------------999999---------99-9--------------------------,SER_1_B_e;CYS_2_B_C;THR_3_B_C;ARG_4_B_C;SER_5_B_C;ILE_6_B_C;PRO_7_B_C;PRO_8_B_e;GLN_9_B_e;CYS_10_B_e,"CRYSTAL STRUCTURE OF THE BOVINE TRYPSIN COMPLEX WITH A 2 SYNTHETIC 11 PEPTIDE INHIBITOR"
1OYT_H_I_3_2.pdb,1OYT,12800172,1.67,P00734,PF00089,2.40.10.10,H,250,I,5,--FEEIP---------,--CCCCC---------,--12303---------,3,2,18,--CCCCC---------,5,0,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,A:2;D:8;E:4;F:2;G:2;I:1;K:5;N:4;P:5;Q:1;R:8;S:2;T:1;W:1,A:9;C:7;D:8;E:9;F:6;G:18;H:5;I:14;K:13;L:18;M:7;N:6;P:9;Q:6;R:7;S:12;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:0;E:0;T:0,C:5;E:3;G:4;H:10;T:24,B:9;C:32;E:78;G:9;H:13;T:52,3_2,E:1;F:1;I:1;L:2;Q:1;R:3;T:1;Y:1,C:1;E:6;T:4,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,C:0;E:0;T:0,--99999---------,ARG_62_H_COREBINDING;ARG_68_H_COREBINDING;ARG_70_H_COREBINDING;GLN_24_H_COREBINDING;GLU_25_H_COREBINDING;ILE_78_H_COREBINDING;LEU_26_H_COREBINDING;LEU_60_H_COREBINDING;PHE_19_H_COREBINDING;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,FEEIPEEYLQ,0.990472535668102,0.501533645959199,,--99999---------,PHE_1_I_C;GLU_2_I_C;GLU_3_I_C;ILE_4_I_C;PRO_5_I_C,"COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A DESIGNED FLUORINATED 2 INHIBITOR"
1PPE_E_I_3_1.pdb,1PPE,2914611,2.00,P00760,PF00089,2.40.10.10,E,223,I,29,R------------------------------------------------V--------------------------CPRILM-ECKKDSDC-LAECVCLEHGYCG----------------,C------------------------------------------------C--------------------------EECCCC-BCCCGGGC-TTTTCEETTTEEC----------------,1------------------------------------------------0--------------------------000000-20432320-1220101421100----------------,3,1,29,d------------------------------------------------d--------------------------CCCCCC-DEEEDEDD-DEDEDEEEEEEED----------------,6,21,C:0;D:0;F:0;G:0;H:0;K:0;L:0;Q:0;S:0;T:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;K:0;L:0;Q:2;S:1;T:0;V:0;W:0;Y:0,A:1;D:1;E:1;G:6;K:4;N:2;P:2;Q:2;S:13;T:1;V:1,A:13;C:8;D:3;E:3;F:2;G:15;H:1;I:15;K:9;L:13;M:2;N:14;P:6;Q:5;R:2;S:17;T:8;V:15;W:3;Y:8,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:3,C:3;E:1;H:9;T:21,B:6;C:28;E:66;G:4;H:9;T:49,3_1,C:4;D:2;F:1;G:4;H:2;K:1;L:1;Q:1;S:3;T:0;V:1;W:1;Y:2,B:1;C:3;E:7;G:2;T:10,C:0;D:0;F:0;G:0;H:0;K:0;L:0;Q:0;S:0;T:1;V:0;W:0;Y:0,B:0;C:1;E:0;G:0;T:0,8------------------------------------------------5--------------------------435333-74554453-4436435743333----------------,ASP_175_E_COREBINDING;ASP_180_E_COREBINDING;CYS_177_E_COREBINDING;CYS_201_E_COREBINDING;CYS_25_E_COREBINDING;CYS_41_E_COREBINDING;GLN_155_E_exosite;GLN_178_E_COREBINDING;GLN_203_E_exosite;GLY_179_E_COREBINDING;GLY_198_E_COREBINDING;GLY_200_E_COREBINDING;GLY_210_E_COREBINDING;HIS_23_E_COREBINDING;HIS_40_E_COREBINDING;LEU_81_E_COREBINDING;LYS_43_E_COREBINDING;PHE_24_E_COREBINDING;SER_176_E_COREBINDING;SER_181_E_COREBINDING;SER_196_E_COREBINDING;SER_199_E_exosite;THR_129_E_EXOSITE;TRP_197_E_COREBINDING;TYR_131_E_COREBINDING;TYR_22_E_COREBINDING;VAL_195_E_COREBINDING,RVCPRILMECKKDSDCLAECVCLEHGYCG,0.679358981098988,0.36138587710283,0.723419656907386,9------------------------------------------------9--------------------------999999-99999999-9999999999999----------------,ARG_1_I_e;VAL_2_I_e;CYS_3_I_C;PRO_4_I_C;ARG_5_I_C;ILE_6_I_C;LEU_7_I_C;MET_8_I_C;GLU_9_I_E;CYS_10_I_E;LYS_11_I_E;LYS_12_I_E;ASP_13_I_E;SER_14_I_E;ASP_15_I_E;CYS_16_I_E;LEU_17_I_E;ALA_18_I_E;GLU_19_I_E;CYS_20_I_E;VAL_21_I_E;CYS_22_I_E;LEU_23_I_E;GLU_24_I_E;HIS_25_I_E;GLY_26_I_E;TYR_27_I_E;CYS_28_I_E;GLY_29_I_E,"THE REFINED 20 ANGSTROMS XRAY CRYSTAL STRUCTURE OF THE 2 COMPLEX FORMED BETWEEN BOVINE BETATRYPSIN AND CMTII A 3 TRYPSIN INHIBITOR FROM SQUASH SEEDS CUCURBITA MAXIMA 4 TOPOLOGICAL SIMILARITY OF THE SQUASH SEED INHIBITORS WITH 5 THE CARBOXYPEPTIDASE A INHIBITOR FROM POTATOES"
1QUR_H_I_3_8.pdb,1QUR,10504391,2.00,P00734,PF00089,2.40.10.10,H,257,I,15,-GGGGNGDYEPIPEEA,-CCCCCCCCCCCCCCC,-522013102202442,3,8,2,-EEDEEEDCCCCDEEE,4,7,E:0;F:0;I:0;K:0;L:0;N:0;P:0;Q:0;R:0;T:0;Y:0,E:0;F:0;I:0;K:0;L:0;N:0;P:0;Q:0;R:0;T:0;Y:0,A:3;D:6;E:3;F:3;G:3;I:1;K:5;N:5;P:4;Q:1;R:7;S:2;T:2;W:2,A:9;C:7;D:10;E:9;F:5;G:18;H:5;I:14;K:13;L:19;M:7;N:5;P:9;Q:5;R:8;S:12;T:7;V:17;W:7;Y:9,C:0;E:0;T:0,C:0;E:0;T:0,C:12;E:2;G:1;H:7;T:25,B:9;C:32;E:79;G:9;H:14;T:52,3_8,E:1;F:1;I:1;K:0;L:1;N:0;P:0;Q:1;R:3;T:1;Y:1,C:1;E:5;T:4,E:1;F:0;I:0;K:1;L:0;N:1;P:1;Q:1;R:0;T:0;Y:0,C:3;E:0;T:2,-345667888888887,ARG_62_H_COREBINDING;ARG_68_H_COREBINDING;ARG_70_H_COREBINDING;ASN_143_H_EXOSITE;GLN_156_H_EXOSITE;GLN_24_H_COREBINDING;GLU_202_H_EXOSITE;GLU_25_H_COREBINDING;ILE_78_H_COREBINDING;LEU_26_H_COREBINDING;LYS_154_H_EXOSITE;PHE_19_H_COREBINDING;PRO_23_H_EXOSITE;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,GGGGNGDYEPIPEEA,0.968871595330739,0.58242476391448,0.638537391230929,-000000999990009,GLY_1_I_E;GLY_2_I_E;GLY_3_I_E;GLY_4_I_E;ASN_5_I_E;GLY_6_I_E;ASP_7_I_E;TYR_8_I_C;GLU_9_I_C;PRO_10_I_C;ILE_11_I_C;PRO_12_I_E;GLU_13_I_E;GLU_14_I_E;ALA_15_I_E,"HUMAN ALPHATHROMBIN IN COMPLEX WITH BIVALENT BENZAMIDINEBASED 2 SYNTHETIC INHIBITOR"
1SBW_A_I_3_1.pdb,1SBW,10447205,1.80,P00760,PF00089,2.40.10.10,A,223,I,14,----------S-------------------------------------CR--------------------------CTKSIP---------PQ-C----------HC--------------,----------C-------------------------------------CE--------------------------EECTTT---------TE-E----------EC--------------,----------2-------------------------------------20--------------------------000003---------12-2----------13--------------,3,1,29,----------d-------------------------------------dd--------------------------CCCCCC---------DD-D----------DD--------------,6,5,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;T:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:1;S:1;T:1;V:0;W:0;Y:0,A:1;E:2;G:4;K:6;N:1;P:2;Q:1;S:12;T:1;V:1;Y:2,A:13;C:10;D:4;E:2;F:2;G:18;H:1;I:15;K:8;L:13;M:2;N:14;P:6;Q:7;R:2;S:17;T:8;V:15;W:3;Y:5,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:3,C:4;E:3;H:8;T:18,B:6;C:27;E:64;G:4;H:10;T:54,3_1,C:2;D:2;F:1;G:3;H:2;L:1;N:0;Q:1;S:3;T:0;V:1;W:1;Y:3,B:1;C:3;E:7;G:2;T:7,C:0;D:0;F:0;G:0;H:0;L:0;N:1;Q:0;S:1;T:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:2,----------9-------------------------------------98--------------------------544455---------56-6----------89--------------,ASN_79_A_EXOSITE;ASP_175_A_COREBINDING;ASP_180_A_COREBINDING;CYS_177_A_COREBINDING;CYS_41_A_COREBINDING;GLN_155_A_exosite;GLN_178_A_COREBINDING;GLY_179_A_COREBINDING;GLY_198_A_COREBINDING;GLY_210_A_COREBINDING;HIS_23_A_COREBINDING;HIS_40_A_COREBINDING;LEU_81_A_COREBINDING;PHE_24_A_COREBINDING;SER_176_A_COREBINDING;SER_181_A_COREBINDING;SER_196_A_COREBINDING;SER_199_A_exosite;SER_78_A_EXOSITE;THR_80_A_exosite;TRP_197_A_COREBINDING;TYR_131_A_COREBINDING;TYR_212_A_COREBINDING;TYR_22_A_COREBINDING;VAL_195_A_COREBINDING,SSEPCCDSCRCTKSIPPQCHCANIRLFCYKPCESM,0.679519134846586,0.36138587710283,0.0834925146345473,----------9-------------------------------------99--------------------------999999---------99-9----------99--------------,SER_1_I_e;CYS_2_I_e;ARG_3_I_e;CYS_4_I_C;THR_5_I_C;LYS_6_I_C;SER_7_I_C;ILE_8_I_C;PRO_9_I_C;PRO_10_I_E;GLN_11_I_E;CYS_12_I_E;HIS_13_I_E;CYS_14_I_E,"CRYSTAL STRUCTURE OF MUNG BEAN INHIBITOR LYSINE ACTIVE 2 FRAGMENT COMPLEX WITH BOVINE BETATRYPSIN AT 18A 3 RESOLUTION"
1SFI_A_I_3_1.pdb,1SFI,10390350,1.65,P00760,PF00089,2.40.10.10,A,223,I,14,G------------------------------------------------R--------------------------CTKSIP---------PI-C----------FP--D-----------,C------------------------------------------------E--------------------------EECTTT---------TE-E----------CC--C-----------,1------------------------------------------------0--------------------------000003---------11-2----------04--2-----------,3,1,29,d------------------------------------------------d--------------------------CCCCCC---------DD-D----------DD--D-----------,6,6,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:1;S:1;V:0;W:0;Y:0,A:1;E:1;G:7;K:5;N:1;P:2;Q:1;S:13;T:1;V:1;Y:1,A:13;C:10;D:4;E:3;F:2;G:15;H:1;I:15;K:9;L:13;M:2;N:14;P:6;Q:7;R:2;S:16;T:9;V:15;W:3;Y:7,C:0;E:0;G:0;T:0,C:0;E:1;G:0;T:1,C:4;E:2;H:8;T:20,B:4;C:29;E:66;G:5;H:10;T:52,3_1,C:2;D:2;F:1;G:3;H:2;L:1;N:0;Q:1;S:3;V:1;W:1;Y:2,C:3;E:6;G:1;T:9,C:0;D:0;F:0;G:0;H:0;L:0;N:1;Q:0;S:1;V:0;W:0;Y:0,C:0;E:0;G:0;T:2,9------------------------------------------------8--------------------------765556---------66-7----------89--9-----------,ASN_79_A_EXOSITE;ASP_175_A_COREBINDING;ASP_180_A_COREBINDING;CYS_177_A_COREBINDING;CYS_201_A_COREBINDING;GLN_155_A_exosite;GLN_178_A_COREBINDING;GLY_179_A_COREBINDING;GLY_198_A_COREBINDING;GLY_200_A_COREBINDING;HIS_23_A_COREBINDING;HIS_40_A_COREBINDING;LEU_81_A_COREBINDING;PHE_24_A_COREBINDING;SER_176_A_COREBINDING;SER_181_A_COREBINDING;SER_196_A_COREBINDING;SER_199_A_exosite;SER_78_A_EXOSITE;TRP_197_A_COREBINDING;TYR_131_A_COREBINDING;TYR_22_A_COREBINDING;VAL_195_A_COREBINDING,GRCTKSIPPICFPD,0.679519134846586,0.361391083177646,0.0903825204339865,9------------------------------------------------9--------------------------999999---------99-9----------99--9-----------,GLY_1_I_e;ARG_2_I_e;CYS_3_I_C;THR_4_I_C;LYS_5_I_C;SER_6_I_C;ILE_7_I_C;PRO_8_I_C;PRO_9_I_E;ILE_10_I_E;CYS_11_I_E;PHE_12_I_E;PRO_13_I_E;ASP_14_I_E,"HIGH RESOLUTION STRUCTURE OF A POTENT CYCLIC PROTEASE INHIBITOR FROM 2 SUNFLOWER SEEDS"
1SMF_E_I_3_7.pdb,1SMF,7798176,2.10,P00760,PF00089,2.40.10.10,E,223,I,9,C-TKS---------------IPPEC-------------,C-BCT---------------TTTBC-------------,1-000---------------03124-------------,3,7,3,D-DDD---------------CCCCd-------------,4,4,C:0;D:0;F:0;G:0;H:0;L:0;Q:0;S:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;L:0;Q:0;S:0;V:0;W:0;Y:0,A:1;D:1;E:2;G:5;K:5;N:2;P:2;Q:1;S:12;T:2;V:1;Y:1,A:13;C:10;D:4;E:2;F:2;G:17;H:1;I:15;K:9;L:13;M:2;N:14;P:6;Q:8;R:2;S:19;T:8;V:15;W:3;Y:7,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:4;E:2;H:9;T:20,B:3;C:29;E:66;G:5;H:9;T:58,3_7,C:0;D:0;F:1;G:1;H:2;L:0;Q:1;S:0;V:0;W:0;Y:2,B:0;C:1;E:2;G:1;T:3,C:2;D:1;F:0;G:2;H:0;L:1;Q:0;S:3;V:1;W:1;Y:0,B:1;C:1;E:2;G:0;T:7,5-554---------------56678-------------,ASP_180_E_EXOSITE;CYS_177_E_EXOSITE;CYS_201_E_EXOSITE;GLN_178_E_COREBINDING;GLY_179_E_COREBINDING;GLY_198_E_EXOSITE;GLY_200_E_EXOSITE;HIS_23_E_COREBINDING;HIS_40_E_COREBINDING;LEU_81_E_EXOSITE;PHE_24_E_COREBINDING;SER_176_E_EXOSITE;SER_181_E_EXOSITE;SER_196_E_EXOSITE;TRP_197_E_EXOSITE;TYR_131_E_COREBINDING;TYR_22_E_COREBINDING;VAL_195_E_EXOSITE,EPCCDSCRCTKSIPPECHCANI,0.347043807641634,0.469054736489433,0.0460217339960154,9-999---------------99999-------------,CYS_1_I_E;THR_2_I_E;LYS_3_I_E;SER_4_I_E;ILE_5_I_C;PRO_6_I_C;PRO_7_I_C;GLU_8_I_C;CYS_9_I_e,"STUDIES ON AN ARTIFICIAL TRYPSIN INHIBITOR PEPTIDE DERIVED FROM THE 2 MUNG BEAN INHIBITOR"
1TBZ_H_L_3_3.pdb,1TBZ,8913620,2.30,P00734,PF00089,2.40.10.10,H,251,L,25,---C------GLRPLFEKKSLEDKTERELLESYI-------,---C------CCTTTTGGGCCCCCHHHHHHHHCC-------,---2------010010022322021021013004-------,3,3,17,---d------CCCCCEEEEEEEEEEEEEEEEEEE-------,5,19,C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,D:5;E:7;F:2;G:2;K:4;N:3;P:2;Q:1;R:7;S:2;T:1;W:1;Y:1,A:11;C:6;D:9;E:7;F:7;G:16;H:4;I:15;K:12;L:19;M:5;N:5;P:9;Q:7;R:9;S:9;T:7;V:15;W:5;Y:7,B:0;C:0;E:0;H:0;T:0,B:0;C:0;E:0;H:0;T:0,C:7;E:1;G:3;H:5;T:22,B:7;C:32;E:74;G:10;H:17;T:44,3_3,C:1;D:1;E:0;G:1;H:1;I:1;K:0;L:0;M:1;N:1;P:2;R:2;S:2;V:1;W:2;Y:0,B:2;C:4;E:2;H:0;T:8,C:0;D:1;E:1;G:2;H:0;I:0;K:2;L:1;M:1;N:1;P:1;R:0;S:1;V:0;W:0;Y:2,B:0;C:1;E:8;H:1;T:3,---4------333344444444344454444567-------,ARG_137_H_COREBINDING;ARG_211_H_COREBINDING;ASN_157_H_EXOSITE;ASN_210_H_COREBINDING;ASP_113_H_COREBINDING;ASP_6_H_EXOSITE;CYS_119_H_COREBINDING;GLU_8_H_EXOSITE;GLY_10_H_COREBINDING;GLY_133_H_EXOSITE;GLY_136_H_EXOSITE;HIS_116_H_COREBINDING;ILE_9_H_COREBINDING;LEU_129_H_EXOSITE;LYS_135_H_EXOSITE;LYS_205_H_EXOSITE;MET_11_H_COREBINDING;MET_204_H_EXOSITE;PRO_117_H_COREBINDING;PRO_13_H_COREBINDING;PRO_207_H_EXOSITE;SER_112_H_COREBINDING;SER_12_H_COREBINDING;SER_5_H_EXOSITE;TRP_14_H_COREBINDING;TRP_212_H_COREBINDING;TYR_134_H_EXOSITE;TYR_183_H_EXOSITE;VAL_118_H_COREBINDING,TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR,0.721879161691237,0.568242674541853,0.13468852957843,---9------999999999999999999999999-------,CYS_1_L_e;GLY_2_L_C;LEU_3_L_C;ARG_4_L_C;PRO_5_L_C;LEU_6_L_C;PHE_7_L_E;GLU_8_L_E;LYS_9_L_E;LYS_10_L_E;SER_11_L_E;LEU_12_L_E;GLU_13_L_E;ASP_14_L_E;LYS_15_L_E;THR_16_L_E;GLU_17_L_E;ARG_18_L_E;GLU_19_L_E;LEU_20_L_E;LEU_21_L_E;GLU_22_L_E;SER_23_L_E;TYR_24_L_E;ILE_25_L_E,"HUMAN THROMBIN WITH ACTIVE SITE NMETHYLD PHENYLALANYLN5 2 AMINOIMINOMETHYLAMINO1BENZOTHIAZOLYLCARBONYL BUTYLL 3 PROLINAMIDE TRIFLUROACETATE AND EXOSITEHIRUGEN"
1THR_H_I_3_2.pdb,1THR,8376390,2.30,P00734,PF00089,2.40.10.10,H,252,I,13,SDFEEFSL-DDI-EQ-,TTTTCCTT-TTT-CC-,32022012-311-11-,3,2,18,eeCCCCCE-EEE-EE-,5,6,A:0;E:0;F:0;I:0;K:0;L:0;M:0;P:0;Q:0;R:0;S:0;T:0;V:0;Y:0,A:0;E:0;F:0;I:0;K:0;L:0;M:0;P:0;Q:1;R:0;S:0;T:0;V:0;Y:0,A:1;D:7;E:6;F:2;G:3;I:1;K:5;N:4;P:3;R:8;S:2;T:1;W:1,A:9;C:7;D:9;E:8;F:6;G:18;H:5;I:14;K:10;L:18;M:5;N:6;P:10;Q:6;R:7;S:11;T:7;V:15;W:7;Y:9,C:0;E:0;T:0,C:1;E:0;T:0,C:8;E:2;G:4;H:7;T:23,B:9;C:33;E:73;G:12;H:17;T:43,3_2,A:0;E:1;F:1;I:1;K:0;L:2;M:1;P:0;Q:1;R:3;S:0;T:1;V:0;Y:1,C:1;E:7;T:4,A:1;E:0;F:0;I:0;K:3;L:0;M:1;P:1;Q:0;R:0;S:1;T:0;V:1;Y:0,C:2;E:3;T:3,88888888-888-88-,ALA_110_H_EXOSITE;ARG_62_H_COREBINDING;ARG_68_H_COREBINDING;ARG_70_H_COREBINDING;GLN_150_H_exosite;GLN_24_H_COREBINDING;GLU_25_H_COREBINDING;ILE_78_H_COREBINDING;LEU_26_H_COREBINDING;LEU_60_H_COREBINDING;LYS_106_H_EXOSITE;LYS_107_H_EXOSITE;LYS_77_H_EXOSITE;MET_17_H_COREBINDING;MET_80_H_EXOSITE;PHE_19_H_COREBINDING;PRO_108_H_EXOSITE;SER_79_H_EXOSITE;THR_69_H_COREBINDING;TYR_71_H_COREBINDING;VAL_109_H_EXOSITE,SDFEEFSLDDIEQ,0.988860020100379,0.499709556314127,3.68798061274731,99999999-599-69-,SER_1_I_e;ASP_2_I_e;PHE_3_I_C;GLU_4_I_C;GLU_5_I_C;PHE_6_I_C;SER_7_I_C;LEU_8_I_E;ASP_9_I_E;ASP_10_I_E;ILE_11_I_E;GLU_12_I_E;GLN_13_I_E,"STRUCTURES OF THROMBIN COMPLEXES WITH A DESIGNED AND A 2 NATURAL EXOSITE INHIBITOR"
1THS_H_I_3_2.pdb,1THS,8376390,2.20,P00734,PF00089,2.40.10.10,H,252,I,8,--YEPIPE-EA-----,--CCCCCC-CC-----,--123014-42-----,3,2,18,--CCCCCe-ee-----,5,3,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,A:1;D:8;E:7;F:2;G:3;I:1;K:5;N:4;P:3;R:7;S:3;T:1;W:1,A:10;C:7;D:8;E:7;F:6;G:18;H:5;I:14;K:13;L:19;M:7;N:6;P:11;Q:7;R:8;S:11;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:0;E:0;T:0,C:9;E:2;G:3;H:9;T:23,B:9;C:36;E:80;G:13;H:15;T:43,3_2,E:1;F:1;I:1;L:1;Q:1;R:3;T:1;Y:1,C:1;E:5;T:4,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,C:0;E:0;T:0,--878899-99-----,ARG_62_H_COREBINDING;ARG_68_H_COREBINDING;ARG_70_H_COREBINDING;GLN_24_H_COREBINDING;GLU_25_H_COREBINDING;ILE_78_H_COREBINDING;LEU_26_H_COREBINDING;PHE_19_H_COREBINDING;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,YEPIPEEAE,0.988860020100379,0.499708869764998,5.90617397305565,--999999-99-----,TYR_1_I_C;GLU_2_I_C;PRO_3_I_C;ILE_4_I_C;PRO_5_I_C;GLU_6_I_e;GLU_7_I_e;ALA_8_I_e,"STRUCTURES OF THROMBIN COMPLEXES WITH A DESIGNED AND A NATURAL EXOSITE 2 INHIBITOR"
1UVT_H_L_3_3.pdb,1UVT,8939759,2.50,P00735,PF00089,2.40.10.10,H,247,L,25,---C------GLRPLFEKKQVQDQTEKELFESYI-------,---C------CCTTTTGGGCCCCCHHHHHHHHHC-------,---1------000010022322030021022003-------,3,3,17,---d------CCCCCEEEEEEEEEEEEEEEEEEE-------,5,19,C:0;D:0;E:0;F:0;G:0;H:0;K:0;L:0;M:0;N:0;P:0;Q:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:0;E:0;F:0;G:0;H:0;K:0;L:0;M:0;N:0;P:0;Q:0;R:0;S:0;V:0;W:0;Y:0,A:1;D:4;E:4;G:2;K:9;N:1;P:3;Q:2;R:9;S:2;T:2;Y:2,A:10;C:6;D:11;E:7;F:6;G:16;H:5;I:14;K:9;L:21;M:4;N:4;P:8;Q:4;R:8;S:9;T:7;V:17;W:6;Y:7,B:0;C:0;E:0;H:0;T:0,B:0;C:0;E:0;H:0;T:0,C:7;E:2;G:2;H:6;T:24,B:6;C:28;E:75;G:12;H:7;T:51,3_3,C:1;D:1;E:0;F:0;G:1;H:1;K:0;L:1;M:0;N:2;P:2;Q:0;R:2;S:1;V:2;W:2;Y:1,B:1;C:3;E:3;H:0;T:10,C:0;D:0;E:1;F:1;G:1;H:0;K:2;L:1;M:1;N:1;P:1;Q:1;R:0;S:0;V:0;W:0;Y:0,B:0;C:0;E:6;H:1;T:3,---4------444534667665554464444446-------,ARG_137_H_COREBINDING;ARG_214_H_COREBINDING;ASN_158_H_EXOSITE;ASN_212_H_COREBINDING;ASN_213_H_COREBINDING;ASP_113_H_COREBINDING;CYS_119_H_COREBINDING;GLN_5_H_EXOSITE;GLU_8_H_EXOSITE;GLY_10_H_COREBINDING;GLY_133_H_EXOSITE;HIS_116_H_COREBINDING;LEU_11_H_COREBINDING;LEU_129_H_EXOSITE;LYS_135_H_EXOSITE;LYS_208_H_EXOSITE;MET_207_H_EXOSITE;PHE_134_H_EXOSITE;PRO_117_H_COREBINDING;PRO_13_H_COREBINDING;PRO_210_H_EXOSITE;SER_112_H_COREBINDING;TRP_14_H_COREBINDING;TRP_215_H_COREBINDING;TYR_114_H_COREBINDING;VAL_118_H_COREBINDING;VAL_9_H_COREBINDING,TSEDHFQPFFNEKTFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR,0.649541167769307,0.525523481067985,0.527412551993218,---9------999999999999999999999999-------,CYS_1_L_e;GLY_2_L_C;LEU_3_L_C;ARG_4_L_C;PRO_5_L_C;LEU_6_L_C;PHE_7_L_E;GLU_8_L_E;LYS_9_L_E;LYS_10_L_E;GLN_11_L_E;VAL_12_L_E;GLN_13_L_E;ASP_14_L_E;GLN_15_L_E;THR_16_L_E;GLU_17_L_E;LYS_18_L_E;GLU_19_L_E;LEU_20_L_E;PHE_21_L_E;GLU_22_L_E;SER_23_L_E;TYR_24_L_E;ILE_25_L_E,"BOVINE THROMBINBM141248 COMPLEX"
1VZQ_H_I_3_2.pdb,1VZQ,,1.54,P00734,,2.40.10.10,H,250,I,6,-DFEEIP---------,-CCCCCC---------,-302313---------,3,2,18,-eCCCCC---------,5,1,A:0;E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,A:0;E:0;F:0;I:0;L:0;Q:1;R:0;T:0;Y:0,A:1;D:7;E:4;F:2;G:2;I:1;K:5;N:4;P:5;Q:1;R:8;S:2;T:1;W:1,A:10;C:7;D:9;E:9;F:6;G:18;H:5;I:14;K:13;L:18;M:7;N:6;P:9;Q:5;R:7;S:12;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:1;E:0;T:0,C:6;E:1;G:2;H:9;T:26,B:9;C:32;E:77;G:8;H:14;T:54,3_2,A:1;E:1;F:1;I:1;L:2;Q:1;R:2;T:1;Y:1,C:1;E:6;T:4,A:0;E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,C:0;E:0;T:0,-988999---------,ALA_70_H_COREBINDING;ARG_62_H_COREBINDING;ARG_68_H_COREBINDING;GLN_150_H_exosite;GLN_24_H_COREBINDING;GLU_25_H_COREBINDING;ILE_78_H_COREBINDING;LEU_26_H_COREBINDING;LEU_60_H_COREBINDING;PHE_19_H_COREBINDING;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,DFEEIPEEYLQ,0.986733719347788,0.500484469153836,3.72838477091622,-999999---------,ASP_1_I_e;PHE_2_I_C;GLU_3_I_C;GLU_4_I_C;ILE_5_I_C;PRO_6_I_C,"COMPLEX OF THROMBIN WITH DESIGNED INHIBITOR 7165"
1W7G_H_I_3_2.pdb,1W7G,16294249,1.65,P00734,PF00089,2.40.10.10,H,252,I,8,-DFEEIP-E--Y----,-CCCCCC-C--C----,-402302-4--1----,3,2,18,-eCCCCC-e--e----,5,2,E:0;F:0;I:0;K:0;L:0;M:0;Q:0;R:0;S:0;T:0;Y:0,E:0;F:0;I:0;K:1;L:0;M:1;Q:0;R:0;S:1;T:0;Y:0,A:2;D:7;E:3;F:2;G:1;I:1;K:4;N:4;P:5;Q:2;R:7;S:2;T:1;W:2,A:9;C:7;D:9;E:10;F:6;G:20;H:5;I:14;K:13;L:18;M:6;N:6;P:9;Q:5;R:8;S:11;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:0;E:3;T:0,C:8;E:1;G:2;H:8;T:24,B:9;C:30;E:76;G:8;H:14;T:58,3_2,E:1;F:1;I:1;K:0;L:2;M:0;Q:1;R:3;S:0;T:1;Y:1,C:1;E:6;T:4,E:0;F:0;I:0;K:0;L:0;M:0;Q:0;R:0;S:0;T:0;Y:0,C:0;E:0;T:0,-976678-9--8----,ARG_62_H_COREBINDING;ARG_68_H_COREBINDING;ARG_70_H_COREBINDING;GLN_24_H_COREBINDING;GLU_25_H_COREBINDING;ILE_78_H_COREBINDING;LEU_26_H_COREBINDING;LEU_60_H_COREBINDING;LYS_77_H_exosite;MET_80_H_exosite;PHE_19_H_COREBINDING;SER_79_H_exosite;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,NEDFEEIPEEYL,0.988850937349251,0.49900837151699,3.72279223164549,-999999-9--9----,ASP_1_I_e;PHE_2_I_C;GLU_3_I_C;GLU_4_I_C;ILE_5_I_C;PRO_6_I_C;GLU_7_I_e;TYR_8_I_e,"ALPHATHROMBIN COMPLEX WITH SULFATED HIRUDIN RESIDUES 5465 AND L 2 ARGININE TEMPLATE INHIBITOR CS107"
1YF4_A_B_3_11.pdb,1YF4,15854654,1.98,P00761,PF00089,2.40.10.10,A,223,B,9,CYFQNCPRG,TTTTEEECC,113220102,3,11,1,CCCCCCCCC,9,0,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;V:0;W:0;Y:0,A:6;D:2;E:1;G:5;K:2;L:1;N:4;P:2;Q:1;R:2;S:7;T:1;Y:2,A:9;C:10;D:2;E:4;F:3;G:15;H:3;I:16;K:8;L:14;M:2;N:13;P:7;Q:10;R:2;S:14;T:9;V:15;W:3;Y:4,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:4;E:3;H:7;T:22,B:8;C:25;E:66;G:5;H:11;T:48,3_11,C:2;D:2;F:1;G:5;H:1;L:1;N:1;Q:1;S:6;V:1;W:1;Y:2,C:5;E:6;G:1;T:12,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;V:0;W:0;Y:0,C:0;E:0;G:0;T:0,655654458,ASN_123_A_COREBINDING;ASP_175_A_COREBINDING;ASP_180_A_COREBINDING;CYS_177_A_COREBINDING;CYS_201_A_COREBINDING;GLN_178_A_COREBINDING;GLY_128_A_COREBINDING;GLY_179_A_COREBINDING;GLY_198_A_COREBINDING;GLY_200_A_COREBINDING;GLY_210_A_COREBINDING;HIS_40_A_COREBINDING;LEU_81_A_COREBINDING;PHE_24_A_COREBINDING;SER_126_A_COREBINDING;SER_127_A_COREBINDING;SER_129_A_COREBINDING;SER_176_A_COREBINDING;SER_181_A_COREBINDING;SER_196_A_COREBINDING;TRP_197_A_COREBINDING;TYR_152_A_COREBINDING;TYR_199_A_COREBINDING;VAL_195_A_COREBINDING,CYFQNCPRG,-1,0.445596448041406,,999999999,CYS_1_B_C;TYR_2_B_C;PHE_3_B_C;GLN_4_B_C;ASN_5_B_C;CYS_6_B_C;PRO_7_B_C;ARG_8_B_C;GLY_9_B_C,"CRYSTAL STRUCTURE OF TRYPSINVASOPRESSIN COMPLEX"
2ANM_H_L_3_6.pdb,2ANM,16460939,2.40,P00734,PF00089,2.40.10.10,H,250,L,34,-G-------SGEADCGLR-PL-FEKKSLEDKTERELLESYIDGR,-T-------TTTTTTTTT-TT-TGGGCCCCCHHHHHHHTTTTCC,-5-------202220000-00-0022322020021012002313,3,6,3,-E-------DEEECCCCC-DD-DEEEEEEEEEEEEEEEEEEEEE,5,24,C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,A:2;D:5;E:3;F:2;G:2;K:5;N:3;P:3;Q:2;R:9;S:2;T:1;W:1;Y:1,A:9;C:6;D:8;E:9;F:7;G:15;H:4;I:15;K:10;L:18;M:5;N:5;P:8;Q:6;R:7;S:9;T:8;V:15;W:5;Y:7,B:0;C:0;E:0;H:0;T:0,B:0;C:0;E:0;H:0;T:0,C:9;E:1;G:2;H:10;T:19,B:7;C:32;E:71;G:8;H:11;T:47,3_6,C:1;D:0;E:0;G:1;H:1;I:0;K:0;L:0;M:1;N:1;P:2;R:2;S:0;V:1;W:2;Y:0,B:1;C:4;E:2;H:0;T:5,C:0;D:3;E:2;G:2;H:0;I:1;K:3;L:2;M:1;N:1;P:1;R:0;S:3;V:0;W:0;Y:2,B:1;C:2;E:8;H:2;T:8,-9-------999964444-44-4444555454454444579499,ARG_137_H_COREBINDING;ARG_212_H_COREBINDING;ASN_158_H_EXOSITE;ASN_211_H_COREBINDING;ASP_113_H_EXOSITE;ASP_122_H_EXOSITE;ASP_6_H_EXOSITE;CYS_119_H_COREBINDING;GLU_188_H_EXOSITE;GLU_8_H_EXOSITE;GLY_10_H_COREBINDING;GLY_133_H_EXOSITE;GLY_136_H_EXOSITE;HIS_116_H_COREBINDING;ILE_9_H_EXOSITE;LEU_120_H_EXOSITE;LEU_129_H_EXOSITE;LYS_135_H_EXOSITE;LYS_206_H_EXOSITE;LYS_241_H_EXOSITE;MET_11_H_COREBINDING;MET_205_H_EXOSITE;PRO_117_H_COREBINDING;PRO_13_H_COREBINDING;PRO_208_H_EXOSITE;SER_112_H_EXOSITE;SER_34_H_EXOSITE;SER_5_H_EXOSITE;TRP_14_H_COREBINDING;TRP_213_H_COREBINDING;TYR_114_H_EXOSITE;TYR_134_H_EXOSITE;VAL_118_H_COREBINDING,TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR,0.295846153846154,0.606633136054438,0.0743572457800853,-9-------999999999-99-9999999999999999999999,GLY_1_L_E;SER_2_L_E;GLY_3_L_E;GLU_4_L_E;ALA_5_L_E;ASP_6_L_C;CYS_7_L_C;GLY_8_L_C;LEU_9_L_C;ARG_10_L_C;PRO_11_L_E;LEU_12_L_E;PHE_13_L_E;GLU_14_L_E;LYS_15_L_E;LYS_16_L_E;SER_17_L_E;LEU_18_L_E;GLU_19_L_E;ASP_20_L_E;LYS_21_L_E;THR_22_L_E;GLU_23_L_E;ARG_24_L_E;GLU_25_L_E;LEU_26_L_E;LEU_27_L_E;GLU_28_L_E;SER_29_L_E;TYR_30_L_E;ILE_31_L_E;ASP_32_L_E;GLY_33_L_E;ARG_34_L_E,"TERNARY COMPLEX OF AN ORALLY ACTIVE THROMBIN INHIBITOR WITH 2 HUMAN THROMBIN AND A CTERMINAL HIRUDIN DERIVED EXOSIT 3 INHIBITOR"
2BTC_E_I_3_1.pdb,2BTC,10089404,1.50,P00760,PF00089,2.40.10.10,E,223,I,29,R------------------------------------------------V--------------------------CPKILM-ECKKDSDC-LAECICLEHGYCG----------------,C------------------------------------------------C--------------------------EECCCC-BCCCGGGC-TTTTCEETTTEEC----------------,1------------------------------------------------0--------------------------000001-20432320-1220101421100----------------,3,1,29,d------------------------------------------------d--------------------------CCCCCC-EEEEDEDD-DEDDEEEEEEEED----------------,6,21,C:0;D:0;F:0;G:0;H:0;L:0;Q:0;S:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;L:0;Q:1;S:1;V:0;W:0;Y:0,A:1;D:1;E:1;G:4;K:5;N:2;P:2;Q:1;S:13;T:1;V:1;Y:2,A:13;C:8;D:3;E:3;F:2;G:18;H:1;I:15;K:9;L:13;M:2;N:14;P:6;Q:7;R:2;S:17;T:9;V:15;W:3;Y:6,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:2,C:4;E:2;H:9;T:19,B:6;C:28;E:65;G:4;H:9;T:54,3_1,C:4;D:2;F:1;G:3;H:2;L:1;Q:1;S:3;V:1;W:1;Y:2,B:1;C:2;E:7;G:2;T:9,C:0;D:0;F:0;G:0;H:0;L:0;Q:0;S:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,6------------------------------------------------5--------------------------333334-44554544-5554435775433----------------,ASP_175_E_COREBINDING;ASP_180_E_COREBINDING;CYS_177_E_COREBINDING;CYS_201_E_COREBINDING;CYS_25_E_COREBINDING;CYS_41_E_COREBINDING;GLN_155_E_exosite;GLN_178_E_COREBINDING;GLY_179_E_COREBINDING;GLY_198_E_COREBINDING;GLY_200_E_COREBINDING;HIS_23_E_COREBINDING;HIS_40_E_COREBINDING;LEU_81_E_COREBINDING;PHE_24_E_COREBINDING;SER_176_E_COREBINDING;SER_181_E_COREBINDING;SER_196_E_COREBINDING;SER_199_E_exosite;TRP_197_E_COREBINDING;TYR_131_E_COREBINDING;TYR_22_E_COREBINDING;VAL_195_E_COREBINDING,RVCPKILMECKKDSDCLAECICLEHGYCG,0.679198827351391,0.361249439577996,0.793076919346415,9------------------------------------------------9--------------------------999999-99999999-9999999999999----------------,ARG_1_I_e;VAL_2_I_e;CYS_3_I_C;PRO_4_I_C;LYS_5_I_C;ILE_6_I_C;LEU_7_I_C;MET_8_I_C;GLU_9_I_E;CYS_10_I_E;LYS_11_I_E;LYS_12_I_E;ASP_13_I_E;SER_14_I_E;ASP_15_I_E;CYS_16_I_E;LEU_17_I_E;ALA_18_I_E;GLU_19_I_E;CYS_20_I_E;ILE_21_I_E;CYS_22_I_E;LEU_23_I_E;GLU_24_I_E;HIS_25_I_E;GLY_26_I_E;TYR_27_I_E;CYS_28_I_E;GLY_29_I_E,"BOVINE TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR 2 CUCURBITA PEPO TRYPSIN INHIBITOR II"
2CV3_A_B_3_7.pdb,2CV3,16511165,1.90,P00772,PF00089,2.40.10.10,A,240,B,11,T-TLK---------------FPSD-WDD----------,C-BCT---------------TTTT-TTC----------,1-000---------------1100-320----------,3,7,3,D-DDD---------------CCCC-ddd----------,4,4,C:0;D:0;F:0;G:0;H:0;L:0;Q:0;R:0;S:0;T:0;V:0;Y:0,C:0;D:0;F:0;G:0;H:0;L:1;Q:0;R:1;S:0;T:0;V:0;Y:0,A:4;D:1;E:1;G:4;I:1;L:1;N:6;P:1;Q:5;R:3;S:5;T:3;Y:2,A:13;C:5;D:5;E:3;F:2;G:19;H:4;I:9;K:3;L:14;M:2;N:10;P:6;Q:9;R:7;S:14;T:13;V:25;W:7;Y:8,B:0;C:0;E:0;G:0;T:0,B:0;C:2;E:0;G:0;T:0,C:5;E:4;H:5;T:23,B:8;C:20;E:75;G:6;H:11;T:58,3_7,C:0;D:1;F:0;G:1;H:2;L:2;Q:1;R:0;S:0;T:1;V:0;Y:1,B:2;C:1;E:3;G:1;T:2,C:3;D:1;F:1;G:1;H:0;L:0;Q:0;R:1;S:3;T:2;V:2;Y:0,B:1;C:2;E:4;G:2;T:5,5-322---------------3556-987----------,ARG_211_A_EXOSITE;ARG_49_A_exosite;ASP_187_A_EXOSITE;ASP_48_A_COREBINDING;CYS_184_A_EXOSITE;CYS_30_A_EXOSITE;CYS_46_A_EXOSITE;GLN_185_A_COREBINDING;GLY_183_A_EXOSITE;GLY_186_A_COREBINDING;HIS_28_A_COREBINDING;HIS_45_A_COREBINDING;LEU_134_A_COREBINDING;LEU_141_A_COREBINDING;LEU_51_A_exosite;PHE_208_A_EXOSITE;SER_188_A_EXOSITE;SER_207_A_EXOSITE;SER_210_A_EXOSITE;THR_206_A_EXOSITE;THR_221_A_EXOSITE;THR_29_A_COREBINDING;TYR_20_A_COREBINDING;VAL_209_A_EXOSITE;VAL_88_A_EXOSITE,TTLKFPSDWDD,0.31937582345191,0.307047885647552,0.125323581180877,9-999---------------9999-999----------,THR_1_B_E;THR_2_B_E;LEU_3_B_E;LYS_4_B_E;PHE_5_B_C;PRO_6_B_C;SER_7_B_C;ASP_8_B_C;TRP_9_B_e;ASP_10_B_e;ASP_11_B_e,"CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH A 2 MACROCLYCLIC PEPTIDE INHIBITOR"
2F91_A_B_3_1.pdb,2F91,16475800,1.20,Q52V24,PF00089,2.40.10.10,A,236,B,32,---------Q--------EC--TPGQTKKQDCNTCNCTPTGV------WA--------------------------CTRKGC-P-------------------------------------,---------C--------CC--TTTEEEEETTEEEEETTTTC------EE--------------------------EECCCC-C-------------------------------------,---------4--------20--22321131310000002100------00--------------------------000001-3-------------------------------------,3,1,29,---------E--------EE--EEEEEEDDDEDDDDDEEEEE------DD--------------------------CCCCCC-d-------------------------------------,6,25,A:0;C:0;D:0;E:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;V:0;W:0;Y:0,A:0;C:0;D:0;E:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;V:0;W:0;Y:0,A:1;D:5;E:5;G:7;I:1;K:1;N:3;P:2;S:4;T:3,A:15;C:3;D:11;E:8;F:6;G:18;H:4;I:15;K:4;L:15;M:2;N:7;P:8;Q:6;R:2;S:12;T:13;V:16;W:2;Y:8,B:0;C:0;E:0;G:0;H:0;T:0,B:0;C:0;E:0;G:0;H:0;T:0,C:6;E:1;H:5;T:20,B:5;C:29;E:75;G:4;H:8;T:54,3_1,A:0;C:3;D:2;E:0;F:2;G:4;H:1;L:1;N:0;Q:1;S:3;V:1;W:1;Y:0,B:1;C:1;E:7;G:2;H:0;T:8,A:1;C:0;D:1;E:1;F:0;G:1;H:0;L:1;N:1;Q:0;S:0;V:0;W:0;Y:4,B:0;C:0;E:0;G:0;H:3;T:7,---------9--------98--76555567874554445555------54--------------------------444457-9-------------------------------------,ALA_161_A_EXOSITE;ASN_91_A_EXOSITE;ASP_162_A_EXOSITE;ASP_183_A_COREBINDING;ASP_188_A_COREBINDING;CYS_185_A_COREBINDING;CYS_213_A_COREBINDING;CYS_46_A_COREBINDING;GLN_186_A_COREBINDING;GLU_167_A_EXOSITE;GLY_164_A_EXOSITE;GLY_187_A_COREBINDING;GLY_210_A_COREBINDING;GLY_212_A_COREBINDING;GLY_220_A_COREBINDING;HIS_45_A_COREBINDING;LEU_92_A_EXOSITE;LEU_93_A_COREBINDING;PHE_27_A_COREBINDING;PHE_29_A_COREBINDING;SER_184_A_COREBINDING;SER_189_A_COREBINDING;SER_208_A_COREBINDING;TRP_209_A_COREBINDING;TYR_163_A_EXOSITE;TYR_211_A_EXOSITE;TYR_218_A_EXOSITE;TYR_90_A_EXOSITE;VAL_207_A_COREBINDING,EQECTPGQTKKQDCNTCNCTPTGVWACTRKGCPPH,0.380506702766303,0.323696757223226,0.153440542230533,---------9--------99--99999999999999999999------99--------------------------999999-9-------------------------------------,GLN_1_B_E;GLU_2_B_E;CYS_3_B_E;THR_4_B_E;PRO_5_B_E;GLY_6_B_E;GLN_7_B_E;THR_8_B_E;LYS_9_B_E;LYS_10_B_E;GLN_11_B_E;ASP_12_B_E;CYS_13_B_E;ASN_14_B_E;THR_15_B_E;CYS_16_B_E;ASN_17_B_E;CYS_18_B_E;THR_19_B_E;PRO_20_B_E;THR_21_B_E;GLY_22_B_E;VAL_23_B_E;TRP_24_B_E;ALA_25_B_E;CYS_26_B_C;THR_27_B_C;ARG_28_B_C;LYS_29_B_C;GLY_30_B_C;CYS_31_B_C;PRO_32_B_e,"12A RESOLUTION STRUCTURE OF A CRAYFISH TRYPSIN COMPLEXED 2 WITH A PEPTIDE INHIBITOR SGTI"
2HGT_H_J_3_2.pdb,2HGT,1942057,2.20,P00734,PF00089,2.40.10.10,H,253,J,5,-DFEEI----------,-CCCCC----------,-30241----------,3,2,18,-eCCCC----------,4,1,E:0;F:0;L:0;Q:0;R:0;T:0;Y:0,E:0;F:0;L:0;Q:0;R:0;T:0;Y:0,A:1;D:7;E:6;F:2;G:2;I:1;K:6;M:1;N:4;P:4;Q:1;R:8;S:2;T:1;W:2,A:10;C:7;D:9;E:8;F:6;G:19;H:5;I:15;K:12;L:18;M:6;N:6;P:10;Q:6;R:8;S:12;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:0;E:0;T:0,C:6;E:4;G:2;H:9;T:27,B:9;C:32;E:79;G:11;H:15;T:50,3_2,E:1;F:1;L:2;Q:1;R:2;T:1;Y:1,C:1;E:4;T:4,E:0;F:0;L:0;Q:0;R:0;T:0;Y:0,C:0;E:0;T:0,-99999----------,ARG_68_H_COREBINDING;ARG_70_H_COREBINDING;GLN_24_H_COREBINDING;GLU_25_H_COREBINDING;LEU_26_H_COREBINDING;LEU_60_H_COREBINDING;PHE_19_H_COREBINDING;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,PGGGGNGDFEEIPEEYL,0.986325684823998,0.497677974399019,4.20566451348654,-99999----------,ASP_1_J_e;PHE_2_J_C;GLU_3_J_C;GLU_4_J_C;ILE_5_J_C,"STRUCTURE OF THE HIRUGEN AND HIRULOG 1 COMPLEXES OF ALPHATHROMBIN"
2NWN_A_B_3_5.pdb,2NWN,17692534,2.15,P00749,PF00089,2.40.10.10,A,240,B,12,C-SW---RGLENHRMC-,C-CT---TTTTTTCCC-,1-21---000000342-,3,5,4,d-dd---CCCCCCCCd-,8,3,C:0;D:0;F:0;G:0;H:0;I:0;K:0;L:0;P:0;Q:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:1;H:0;I:0;K:1;L:1;P:0;Q:0;R:0;S:0;V:0;W:0;Y:0,A:1;E:4;F:2;G:2;H:1;K:6;L:1;M:1;N:2;P:4;Q:5;R:5;S:3;T:2;V:1;Y:2,A:10;C:7;D:8;E:8;F:4;G:13;H:5;I:16;K:7;L:16;M:4;N:4;P:7;Q:6;R:6;S:14;T:16;V:8;W:4;Y:7,C:0;E:0;G:0;T:0,C:0;E:1;G:0;T:2,B:1;C:7;E:4;G:2;H:3;T:25,B:10;C:23;E:75;G:8;H:10;T:44,3_5,C:3;D:2;F:1;G:3;H:2;I:1;K:0;L:0;P:1;Q:1;R:1;S:3;V:3;W:1;Y:3,C:2;E:11;G:2;T:10,C:0;D:0;F:0;G:0;H:0;I:0;K:0;L:0;P:0;Q:0;R:0;S:0;V:0;W:0;Y:0,C:0;E:0;G:0;T:0,7-76---555566899-,ARG_20_A_COREBINDING;ASP_195_A_COREBINDING;ASP_47_A_COREBINDING;CYS_192_A_COREBINDING;CYS_28_A_COREBINDING;CYS_44_A_COREBINDING;GLN_193_A_COREBINDING;GLY_194_A_COREBINDING;GLY_217_A_COREBINDING;GLY_219_A_exosite;GLY_227_A_COREBINDING;HIS_43_A_COREBINDING;HIS_92_A_COREBINDING;ILE_46_A_COREBINDING;LEU_89_A_exosite;LYS_140_A_exosite;PHE_45_A_COREBINDING;PRO_226_A_COREBINDING;SER_191_A_COREBINDING;SER_196_A_COREBINDING;SER_215_A_COREBINDING;TRP_216_A_COREBINDING;TYR_148_A_COREBINDING;TYR_48_A_COREBINDING;TYR_54_A_COREBINDING;VAL_214_A_COREBINDING;VAL_228_A_COREBINDING;VAL_27_A_COREBINDING,CSWRGLENHRMC,0.972904946185709,0.38581105916366,0.397256843868045,9-99---999999999-,CYS_1_B_e;SER_2_B_e;TRP_3_B_e;ARG_4_B_C;GLY_5_B_C;LEU_6_B_C;GLU_7_B_C;ASN_8_B_C;HIS_9_B_C;ARG_10_B_C;MET_11_B_C;CYS_12_B_e,"NEW PHARMACOPHORE FOR SERINE PROTEASE INHIBITION REVEALED 2 BY CRYSTAL STRUCTURE OF HUMAN UROKINASETYPE PLASMINOGEN 3 ACTIVATOR COMPLEXED WITH A CYCLIC PEPTIDYL INHIBITOR 4 UPAIN1"
2O9Q_A_C_3_1.pdb,2O9Q,,1.70,P00760,PF00089,2.40.10.10,A,223,C,14,G------------------------------------------------C--------------------------WTKSIP---------PKP-------------CFG-----------,C------------------------------------------------E--------------------------EECTTT---------TEE-------------CCC-----------,3------------------------------------------------0--------------------------200002---------122-------------032-----------,3,1,29,d------------------------------------------------d--------------------------CCCCCC---------DDE-------------DDD-----------,6,6,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:1;H:0;L:0;N:0;Q:0;S:1;V:0;W:0;Y:0,A:1;D:1;E:2;G:7;K:5;N:1;P:2;Q:1;S:12;T:2;V:1,A:13;C:10;D:3;E:2;F:2;G:14;H:1;I:15;K:9;L:13;M:2;N:14;P:6;Q:7;R:2;S:17;T:8;V:15;W:3;Y:6,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:1;G:0;T:1,C:5;E:1;H:9;T:20,B:5;C:28;E:66;G:5;H:9;T:49,3_1,C:2;D:2;F:1;G:3;H:2;L:1;N:0;Q:1;S:3;V:1;W:1;Y:3,B:1;C:2;E:9;G:1;T:7,C:0;D:0;F:0;G:0;H:0;L:0;N:1;Q:1;S:1;V:0;W:0;Y:1,B:0;C:1;E:0;G:0;T:3,8------------------------------------------------6--------------------------644345---------556-------------689-----------,ASN_79_A_EXOSITE;ASP_171_A_COREBINDING;ASP_176_A_COREBINDING;CYS_173_A_COREBINDING;CYS_25_A_COREBINDING;GLN_155_A_EXOSITE;GLN_174_A_COREBINDING;GLY_175_A_COREBINDING;GLY_194_A_COREBINDING;GLY_196_A_exosite;GLY_204_A_COREBINDING;HIS_23_A_COREBINDING;HIS_40_A_COREBINDING;LEU_81_A_COREBINDING;PHE_24_A_COREBINDING;SER_172_A_COREBINDING;SER_177_A_COREBINDING;SER_192_A_COREBINDING;SER_195_A_exosite;SER_78_A_EXOSITE;TRP_193_A_COREBINDING;TYR_131_A_COREBINDING;TYR_206_A_COREBINDING;TYR_22_A_COREBINDING;TYR_42_A_EXOSITE;VAL_191_A_COREBINDING,LKGCWTKSIPPKPCFGK,0.679145548819822,0.359093424086377,0.236148258515704,9------------------------------------------------9--------------------------999999---------999-------------999-----------,GLY_1_C_e;CYS_2_C_e;TRP_3_C_C;THR_4_C_C;LYS_5_C_C;SER_6_C_C;ILE_7_C_C;PRO_8_C_C;PRO_9_C_E;LYS_10_C_E;PRO_11_C_E;CYS_12_C_E;PHE_13_C_E;GLY_14_C_E,"THE CRYSTAL STRUCTURE OF BOVINE TRYPSIN COMPLEXED WITH A 2 SMALL INHIBITION PEPTIDE ORB2K"
2STA_E_I_3_1.pdb,2STA,10089404,1.80,P35031,PF00089,2.40.10.10,E,222,I,29,R------------------------------------------------V--------------------------CPRILM-ECKKDSDC-LAECVCLEHGYCG----------------,C------------------------------------------------C--------------------------EECCCC-BCCCGGGC-TTTTCEETTTEEC----------------,2------------------------------------------------0--------------------------000001-20432320-1220101431100----------------,3,1,29,d------------------------------------------------d--------------------------CCCCCC-EEEEDEDD-DEDDDEEEEEEED----------------,6,21,C:0;D:0;F:0;G:0;H:0;I:0;M:0;P:0;Q:0;S:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;I:0;M:1;P:0;Q:0;S:0;V:0;W:0;Y:1,A:1;D:1;E:1;G:4;K:3;M:1;N:4;P:5;R:1;S:6;T:5;Y:4,A:11;C:9;D:4;E:8;F:3;G:16;H:3;I:10;K:5;L:13;M:4;N:13;P:6;Q:6;R:3;S:17;T:6;V:16;W:3;Y:7,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:2,C:7;E:1;H:5;T:23,B:8;C:22;E:65;G:4;H:11;T:53,3_1,C:3;D:2;F:1;G:3;H:2;I:1;M:0;P:1;Q:1;S:3;V:2;W:1;Y:1,B:1;C:3;E:8;G:2;T:7,C:0;D:0;F:0;G:0;H:0;I:0;M:0;P:0;Q:0;S:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,9------------------------------------------------8--------------------------543456-88999997-7777778998766----------------,ASP_174_E_COREBINDING;ASP_179_E_COREBINDING;CYS_176_E_COREBINDING;CYS_25_E_COREBINDING;CYS_41_E_COREBINDING;GLN_177_E_COREBINDING;GLY_178_E_COREBINDING;GLY_197_E_COREBINDING;GLY_209_E_COREBINDING;HIS_23_E_COREBINDING;HIS_40_E_COREBINDING;ILE_81_E_COREBINDING;MET_154_E_exosite;PHE_24_E_COREBINDING;PRO_208_E_COREBINDING;SER_175_E_COREBINDING;SER_180_E_COREBINDING;SER_195_E_COREBINDING;TRP_196_E_COREBINDING;TYR_198_E_exosite;TYR_22_E_COREBINDING;VAL_194_E_COREBINDING;VAL_210_E_COREBINDING,RVCPRILMECKKDSDCLAECVCLEHGYCG,0.526025604883851,0.339085377458125,0.349757058542069,9------------------------------------------------9--------------------------999999-99999999-9999999099999----------------,ARG_1_I_e;VAL_2_I_e;CYS_3_I_C;PRO_4_I_C;ARG_5_I_C;ILE_6_I_C;LEU_7_I_C;MET_8_I_C;GLU_9_I_E;CYS_10_I_E;LYS_11_I_E;LYS_12_I_E;ASP_13_I_E;SER_14_I_E;ASP_15_I_E;CYS_16_I_E;LEU_17_I_E;ALA_18_I_E;GLU_19_I_E;CYS_20_I_E;VAL_21_I_E;CYS_22_I_E;LEU_23_I_E;GLU_24_I_E;HIS_25_I_E;GLY_26_I_E;TYR_27_I_E;CYS_28_I_E;GLY_29_I_E,"ANIONIC SALMON TRYPSIN IN COMPLEX WITH SQUASH SEED 2 INHIBITOR CUCURBITA MAXIMA TRYPSIN INHIBITOR I"
2STB_E_I_3_1.pdb,2STB,10089404,1.80,P35031,PF00089,2.40.10.10,E,222,I,29,R------------------------------------------------V--------------------------CPKILM-ECKKDSDC-LAECICLEHGYCG----------------,C------------------------------------------------C--------------------------EECCCC-BCCCGGGC-TTTTCEETTTEEC----------------,3------------------------------------------------0--------------------------000001-20432310-1220101431100----------------,3,1,29,d------------------------------------------------d--------------------------CCCCCC-EEEEDEDD-DEDDDEEEEEEED----------------,6,21,C:0;D:0;F:0;G:0;H:0;I:0;Q:0;S:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;I:0;Q:0;S:0;V:0;W:0;Y:1,A:1;D:1;E:1;G:4;K:3;M:1;N:4;P:5;R:1;S:5;T:5;Y:4,A:11;C:8;D:4;E:8;F:3;G:16;H:3;I:10;K:5;L:13;M:5;N:13;P:7;Q:6;R:3;S:18;T:6;V:17;W:3;Y:7,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:1,C:6;E:1;H:4;T:24,B:8;C:25;E:66;G:4;H:12;T:51,3_1,C:4;D:2;F:1;G:3;H:2;I:1;Q:1;S:3;V:1;W:1;Y:1,B:1;C:1;E:7;G:2;T:9,C:0;D:0;F:0;G:0;H:0;I:0;Q:0;S:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,8------------------------------------------------6--------------------------543445-78999997-6677789998766----------------,ASP_174_E_COREBINDING;ASP_179_E_COREBINDING;CYS_176_E_COREBINDING;CYS_200_E_COREBINDING;CYS_25_E_COREBINDING;CYS_41_E_COREBINDING;GLN_177_E_COREBINDING;GLY_178_E_COREBINDING;GLY_197_E_COREBINDING;GLY_199_E_COREBINDING;HIS_23_E_COREBINDING;HIS_40_E_COREBINDING;ILE_81_E_COREBINDING;PHE_24_E_COREBINDING;SER_175_E_COREBINDING;SER_180_E_COREBINDING;SER_195_E_COREBINDING;TRP_196_E_COREBINDING;TYR_198_E_exosite;TYR_22_E_COREBINDING;VAL_194_E_COREBINDING,RVCPKILMECKKDSDCLAECICLEHGYCG,0.525865451136253,0.339361697259131,0.410768791414343,9------------------------------------------------9--------------------------999999-99999999-9999999099999----------------,ARG_1_I_e;VAL_2_I_e;CYS_3_I_C;PRO_4_I_C;LYS_5_I_C;ILE_6_I_C;LEU_7_I_C;MET_8_I_C;GLU_9_I_E;CYS_10_I_E;LYS_11_I_E;LYS_12_I_E;ASP_13_I_E;SER_14_I_E;ASP_15_I_E;CYS_16_I_E;LEU_17_I_E;ALA_18_I_E;GLU_19_I_E;CYS_20_I_E;ILE_21_I_E;CYS_22_I_E;LEU_23_I_E;GLU_24_I_E;HIS_25_I_E;GLY_26_I_E;TYR_27_I_E;CYS_28_I_E;GLY_29_I_E,"ANIONIC SALMON TRYPSIN IN COMPLEX WITH SQUASH SEED 2 INHIBITOR CUCURBITA PEPO TRYPSIN INHIBITOR II"
2ZC9_H_I_3_2.pdb,2ZC9,19520086,1.58,P00734,PF00089,2.40.10.10,H,251,I,9,GDFEEIPEE-------,CCCCCCCCC-------,530130144-------,3,2,18,eeCCCCCee-------,5,2,E:0;F:0;I:0;L:0;M:0;Q:0;R:0;T:0;Y:0,E:0;F:0;I:0;L:0;M:1;Q:1;R:0;T:0;Y:0,A:2;D:8;E:4;F:2;G:2;I:1;K:7;N:4;P:4;Q:1;R:7;S:2;T:1;W:1,A:9;C:7;D:8;E:9;F:6;G:19;H:5;I:14;K:11;L:18;M:6;N:6;P:10;Q:5;R:9;S:12;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:1;E:1;T:0,C:6;E:3;G:3;H:9;T:25,B:9;C:33;E:78;G:10;H:15;T:48,3_2,E:1;F:1;I:1;L:2;M:0;Q:1;R:2;T:1;Y:1,C:1;E:5;T:4,E:0;F:0;I:0;L:0;M:0;Q:0;R:0;T:0;Y:0,C:0;E:0;T:0,997676997-------,ARG_68_H_COREBINDING;ARG_70_H_COREBINDING;GLN_150_H_exosite;GLN_24_H_COREBINDING;GLU_25_H_COREBINDING;ILE_78_H_COREBINDING;LEU_26_H_COREBINDING;LEU_60_H_COREBINDING;MET_80_H_exosite;PHE_19_H_COREBINDING;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,GDFEEIPEEL,0.990475399939438,0.500820141024456,3.75665675834245,999999999-------,GLY_1_I_e;ASP_2_I_e;PHE_3_I_C;GLU_4_I_C;GLU_5_I_C;ILE_6_I_C;PRO_7_I_C;GLU_8_I_e;GLU_9_I_e,"THROMBIN IN COMPLEX WITH INHIBITOR"
2ZGH_A_B_3_4.pdb,2ZGH,19542453,2.17,P51124,PF00089,2.40.10.10,A,231,B,6,----SGKVPL,----CCCEEC,----510110,3,4,5,----CCCCCd,5,1,C:0;D:0;F:0;G:0;H:0;K:0;L:0;P:0;R:0;S:0;V:0;W:0,C:1;D:1;F:0;G:1;H:0;K:1;L:0;P:1;R:0;S:1;V:0;W:0,A:3;D:3;G:3;H:2;I:1;K:7;M:1;N:2;P:5;R:11;S:3;V:1,A:17;C:7;D:5;E:3;F:3;G:17;H:5;I:7;K:2;L:28;M:4;N:3;P:9;Q:9;R:7;S:11;T:10;V:18;W:3;Y:3,C:0;E:0;G:0;T:0,C:1;E:0;G:0;T:5,C:12;E:2;G:2;H:3;T:23,B:8;C:22;E:73;G:6;H:10;T:52,3_4,C:0;D:0;F:1;G:0;H:1;K:1;L:1;P:1;R:1;S:4;V:1;W:1,C:0;E:3;G:1;T:8,C:0;D:0;F:0;G:0;H:0;K:0;L:0;P:0;R:0;S:0;V:0;W:0,C:0;E:0;G:0;T:0,----976444,ARG_203_A_COREBINDING;ASP_181_A_exosite;CYS_178_A_exosite;GLY_180_A_exosite;HIS_41_A_COREBINDING;LEU_83_A_COREBINDING;LYS_179_A_exosite;LYS_210_A_COREBINDING;PHE_200_A_COREBINDING;PRO_177_A_exosite;PRO_81_A_COREBINDING;SER_160_A_COREBINDING;SER_182_A_exosite;SER_199_A_COREBINDING;SER_201_A_COREBINDING;SER_202_A_COREBINDING;TRP_157_A_COREBINDING;VAL_80_A_COREBINDING,SSGKVPL,0.259564808120585,0.299480191224624,0.189602215176934,----999999,SER_1_B_C;GLY_2_B_C;LYS_3_B_C;VAL_4_B_C;PRO_5_B_C;LEU_6_B_e,"CRYSTAL STRUCTURE OF ACTIVE GRANZYME M BOUND TO ITS PRODUCT"
2ZGJ_A_B_3_1.pdb,2ZGJ,19542453,2.30,P51124,PF00089,2.40.10.10,A,231,B,7,--------S---------------------------------------GK--------------------------VPLS-----------------------------------------,--------C---------------------------------------CC--------------------------EECC-----------------------------------------,--------5---------------------------------------10--------------------------1001-----------------------------------------,3,1,29,--------d---------------------------------------dd--------------------------CCCC-----------------------------------------,4,3,A:0;C:0;D:0;F:0;G:0;H:0;K:0;L:0;M:0;P:0;R:0;S:0;V:0;W:0,A:1;C:0;D:0;F:0;G:0;H:0;K:0;L:0;M:1;P:1;R:0;S:1;V:1;W:1,A:3;D:3;G:4;H:2;I:1;K:6;M:1;N:2;P:6;R:11;S:3;V:1,A:16;C:6;D:4;E:3;F:3;G:16;H:5;I:7;K:4;L:26;M:3;N:4;P:8;Q:9;R:7;S:11;T:10;V:18;W:3;Y:3,C:0;E:0;G:0;T:0,C:0;E:1;G:0;T:5,C:14;E:2;G:2;H:4;T:21,B:8;C:23;E:70;G:7;H:9;T:49,3_1,A:0;C:2;D:1;F:1;G:1;H:1;K:1;L:3;M:0;P:1;R:1;S:4;V:0;W:0,C:1;E:6;G:1;T:8,A:0;C:0;D:0;F:0;G:0;H:0;K:0;L:0;M:0;P:0;R:0;S:0;V:0;W:0,C:0;E:0;G:0;T:0,--------5---------------------------------------44--------------------------3445-----------------------------------------,ALA_82_A_exosite;ARG_203_A_COREBINDING;ASP_181_A_COREBINDING;CYS_178_A_COREBINDING;CYS_26_A_COREBINDING;GLY_180_A_COREBINDING;HIS_41_A_COREBINDING;LEU_198_A_COREBINDING;LEU_25_A_COREBINDING;LEU_83_A_COREBINDING;LYS_179_A_COREBINDING;MET_165_A_exosite;PHE_200_A_COREBINDING;PRO_177_A_COREBINDING;PRO_81_A_exosite;SER_160_A_exosite;SER_182_A_COREBINDING;SER_199_A_COREBINDING;SER_201_A_COREBINDING;SER_202_A_COREBINDING;TRP_157_A_exosite;VAL_80_A_exosite,SSGKVPLS,0.312495683739844,0.284357977226701,0.0231948270094861,--------9---------------------------------------99--------------------------9999-----------------------------------------,SER_1_B_e;GLY_2_B_e;LYS_3_B_e;VAL_4_B_C;PRO_5_B_C;LEU_6_B_C;SER_7_B_C,"CRYSTAL STRUCTURE OF D86NGZMM COMPLEXED WITH ITS OPTIMAL SYNTHESIZED 2 SUBSTRATE"
3C27_B_A_3_3.pdb,3C27,,2.18,P00734,PF00089,2.40.10.10,B,249,A,26,-A------DCGLRPLFEKKSLEDKTERELLESY--------,-C------TTTTTTTTGGGCCCCCHHHHHHHHC--------,-5------1000001002332303102101201--------,3,3,17,-e------ddCCCCCEEEEEEEEEEEEEEEEEE--------,5,18,C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,A:2;D:7;E:3;F:2;G:2;K:5;N:3;P:3;Q:2;R:8;S:2;T:1;W:1;Y:1,A:9;C:6;D:8;E:10;F:7;G:15;H:4;I:15;K:11;L:19;M:5;N:5;P:8;Q:6;R:8;S:10;T:7;V:15;W:5;Y:6,B:0;C:0;E:0;H:0;T:0,B:0;C:0;E:0;H:0;T:0,C:8;E:2;G:2;H:9;T:21,B:7;C:27;E:75;G:8;H:13;T:49,3_3,C:1;D:1;E:0;G:1;H:1;I:1;K:0;L:0;M:1;N:1;P:2;R:2;S:2;V:1;W:2;Y:1,B:2;C:4;E:2;H:0;T:9,C:0;D:0;E:1;G:2;H:0;I:0;K:2;L:1;M:1;N:1;P:1;R:0;S:0;V:0;W:0;Y:2,B:0;C:1;E:6;H:1;T:3,-8------7433334344544535445544545--------,ARG_137_B_COREBINDING;ARG_211_B_COREBINDING;ASN_157_B_EXOSITE;ASN_210_B_COREBINDING;ASP_113_B_COREBINDING;CYS_119_B_COREBINDING;GLU_8_B_EXOSITE;GLY_10_B_COREBINDING;GLY_133_B_EXOSITE;GLY_136_B_EXOSITE;HIS_116_B_COREBINDING;ILE_9_B_COREBINDING;LEU_129_B_EXOSITE;LYS_135_B_EXOSITE;LYS_205_B_EXOSITE;MET_11_B_COREBINDING;MET_204_B_EXOSITE;PRO_117_B_COREBINDING;PRO_13_B_COREBINDING;PRO_207_B_EXOSITE;SER_112_B_COREBINDING;SER_12_B_COREBINDING;TRP_14_B_COREBINDING;TRP_212_B_COREBINDING;TYR_114_B_COREBINDING;TYR_134_B_EXOSITE;TYR_183_B_EXOSITE;VAL_118_B_COREBINDING,ADCGLRPLFEKKSLEDKTERELLESY,0.722450962795237,0.563300423120066,0.241900806116888,-9------9999999999999999999999999--------,ALA_1_A_e;ASP_2_A_e;CYS_3_A_e;GLY_4_A_C;LEU_5_A_C;ARG_6_A_C;PRO_7_A_C;LEU_8_A_C;PHE_9_A_E;GLU_10_A_E;LYS_11_A_E;LYS_12_A_E;SER_13_A_E;LEU_14_A_E;GLU_15_A_E;ASP_16_A_E;LYS_17_A_E;THR_18_A_E;GLU_19_A_E;ARG_20_A_E;GLU_21_A_E;LEU_22_A_E;LEU_23_A_E;GLU_24_A_E;SER_25_A_E;TYR_26_A_E,"CYANOFLUOROPHENYLACETAMIDES AS ORALLY EFFICACIOUS THROMBIN INHIBITORS"
3C27_B_H_3_2.pdb,3C27,,2.18,P00734,PF00089,2.40.10.10,B,249,H,11,-DFEEIPEE--YL--Q,-CCCCCTTT--TT--C,-30220133--01--3,3,2,18,-eCCCCCEE--EE--E,5,5,E:0;F:0;I:0;K:0;L:0;Q:0;R:0;T:0;Y:0,E:0;F:0;I:0;K:0;L:0;Q:0;R:0;T:0;Y:0,A:2;D:8;E:4;F:2;G:3;I:1;K:5;N:4;P:4;R:8;S:3;W:1,A:9;C:7;D:8;E:9;F:6;G:17;H:5;I:14;K:12;L:18;M:7;N:6;P:10;Q:7;R:7;S:11;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:0;E:0;T:0,C:7;E:3;G:2;H:9;T:24,B:9;C:32;E:76;G:8;H:14;T:53,3_2,E:1;F:1;I:1;K:0;L:2;Q:1;R:3;T:1;Y:1,C:1;E:6;T:4,E:0;F:0;I:0;K:1;L:0;Q:0;R:0;T:0;Y:0,C:0;E:0;T:1,-86667999--99--9,ARG_62_B_COREBINDING;ARG_68_B_COREBINDING;ARG_70_B_COREBINDING;GLN_24_B_COREBINDING;GLU_25_B_COREBINDING;ILE_78_B_COREBINDING;LEU_26_B_COREBINDING;LEU_60_B_COREBINDING;LYS_21_B_EXOSITE;PHE_19_B_COREBINDING;THR_69_B_COREBINDING;TYR_71_B_COREBINDING,DFEEIPEEYLQ,0.988613237420077,0.49339133045891,3.95086484203143,-99999999--99--9,ASP_1_H_e;PHE_2_H_C;GLU_3_H_C;GLU_4_H_C;ILE_5_H_C;PRO_6_H_C;GLU_7_H_E;GLU_8_H_E;TYR_9_H_E;LEU_10_H_E;GLN_11_H_E,"CYANOFLUOROPHENYLACETAMIDES AS ORALLY EFFICACIOUS THROMBIN INHIBITORS"
3DA9_B_D_3_2.pdb,3DA9,19371038,1.80,P00734,PF00089,2.40.10.10,B,251,D,8,-DFEEIPGE-------,-CCCCCCCC-------,-30230244-------,3,2,18,-eCCCCCee-------,5,2,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,E:0;F:0;I:0;L:0;Q:1;R:0;T:0;Y:0,A:1;D:7;E:5;F:2;G:3;I:1;K:6;N:4;P:5;R:8;S:2;T:1;W:1,A:10;C:7;D:9;E:8;F:6;G:18;H:5;I:14;K:12;L:18;M:7;N:6;P:9;Q:6;R:7;S:12;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:1;E:0;T:0,C:6;E:1;G:4;H:10;T:25,B:9;C:32;E:78;G:12;H:14;T:48,3_2,E:1;F:1;I:1;L:2;Q:1;R:3;T:1;Y:1,C:1;E:6;T:4,E:0;F:0;I:0;L:0;Q:0;R:0;T:0;Y:0,C:0;E:0;T:0,-98889999-------,ARG_62_B_COREBINDING;ARG_68_B_COREBINDING;ARG_70_B_COREBINDING;GLN_150_B_exosite;GLN_24_B_COREBINDING;GLU_25_B_COREBINDING;ILE_78_B_COREBINDING;LEU_26_B_COREBINDING;LEU_60_B_COREBINDING;PHE_19_B_COREBINDING;THR_69_B_COREBINDING;TYR_71_B_COREBINDING,DFEEIPGE,0.990475399939438,0.500820141024456,3.74698318651152,-99999999-------,ASP_1_D_e;PHE_2_D_C;GLU_3_D_C;GLU_4_D_C;ILE_5_D_C;PRO_6_D_C;GLY_7_D_e;GLU_8_D_e,"CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH INHIBITOR"
3IG6_D_C_3_3.pdb,3IG6,19703768,1.83,P00749,PF00089,2.40.10.10,D,243,C,9,------KFQCGQK-T-------------------L------,------CCTTTTC-C-------------------C------,------4021021-1-------------------3------,3,3,17,------EEDDCCC-C-------------------e------,4,4,A:0;C:0;E:0;I:0;L:0;M:0;N:0;P:0;Q:0;R:0;T:0;W:0,A:0;C:0;E:0;I:0;L:0;M:0;N:0;P:0;Q:0;R:0;T:0;W:0,D:2;E:3;F:1;G:2;H:2;K:6;L:1;N:2;P:2;Q:5;R:3;S:4;T:3;Y:3,A:9;C:10;D:9;E:8;F:6;G:17;H:7;I:15;K:8;L:16;M:4;N:4;P:7;Q:4;R:7;S:16;T:15;V:12;W:4;Y:9,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:7;E:1;G:1;H:2;T:28,B:7;C:27;E:85;G:9;H:12;T:47,3_3,A:0;C:1;E:1;I:1;L:0;M:1;N:1;P:1;Q:1;R:1;T:1;W:1,B:1;C:3;E:1;G:2;T:3,A:1;C:0;E:0;I:1;L:1;M:0;N:0;P:2;Q:1;R:1;T:0;W:0,B:1;C:3;E:2;G:0;T:1,------7655567-9-------------------9------,ALA_110_D_EXOSITE;ARG_114_D_COREBINDING;ARG_208_D_EXOSITE;ASN_11_D_COREBINDING;CYS_120_D_COREBINDING;GLN_111_D_EXOSITE;GLN_117_D_COREBINDING;GLU_10_D_COREBINDING;ILE_116_D_EXOSITE;ILE_119_D_COREBINDING;LEU_34_D_EXOSITE;MET_209_D_COREBINDING;PRO_112_D_EXOSITE;PRO_13_D_COREBINDING;PRO_37_D_EXOSITE;THR_118_D_COREBINDING;TRP_14_D_COREBINDING,KPSSPPEELKFQCGQKTLRPRFK,0.421534551062932,0.403259703351233,0.256193286406965,------9999999-9-------------------9------,LYS_1_C_E;PHE_2_C_E;GLN_3_C_E;CYS_4_C_E;GLY_5_C_C;GLN_6_C_C;LYS_7_C_C;THR_8_C_C;LEU_9_C_e,"LOW MOLECULAR WEIGTH HUMAN UROKINASE TYPE PLASMINOGEN ACTIVATOR 26 2 3AMINOMETHYLBIPHENYL3YLOXY43DIMETHYLAMINOPYRROLIDIN1 3 YL35DIFLUOROPYRIDIN2YLOXY4DIMETHYLAMINOBENZOIC ACID 4 COMPLEX"
3K2U_A_B_3_3.pdb,3K2U,20004165,2.35,Q04756,PF00089,2.40.10.10,A,233,B,5,-A-C------GRR----------------------------,-C-C------CCC----------------------------,-3-1------033----------------------------,3,3,17,-d-d------ccc----------------------------,3,2,A:1;C:1;G:2;I:1;P:2;Q:1;R:0;S:1;V:1;W:1,A:0;C:0;G:0;I:0;P:0;Q:0;R:1;S:0;V:0;W:0,A:2;C:1;D:7;E:3;F:1;G:5;H:3;K:2;L:3;N:2;P:5;Q:2;R:1;S:5;T:3;V:2;W:1,A:13;C:10;D:7;E:2;F:8;G:15;H:7;I:13;K:7;L:14;M:1;N:4;P:8;Q:3;R:7;S:19;T:6;V:15;W:3;Y:11,B:1;C:3;E:2;T:5,B:0;C:1;E:0;T:0,C:12;E:5;G:3;H:2;T:26,B:6;C:28;E:71;G:9;H:12;T:47,3_3,A:0;C:0;G:0;I:0;P:0;Q:0;R:0;S:0;V:0;W:0,B:0;C:0;E:0;T:0,A:0;C:0;G:0;I:0;P:0;Q:0;R:0;S:0;V:0;W:0,B:0;C:0;E:0;T:0,-6-5------666----------------------------,ALA_208_A_corebinding;ARG_108_A_exosite;CYS_116_A_corebinding;GLN_113_A_corebinding;GLY_10_A_corebinding;GLY_206_A_corebinding;ILE_115_A_corebinding;PRO_114_A_corebinding;PRO_13_A_corebinding;SER_11_A_corebinding;TRP_14_A_corebinding;VAL_207_A_corebinding,VQLSPDLLATLPEPASPGRQACGRRHKKRTFLRPR,0.319893346534036,0.331014797865687,0.642686548793424,-9-9------999----------------------------,ALA_1_B_e;CYS_2_B_e;GLY_3_B_c;ARG_4_B_c;ARG_5_B_c,"CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC INHIBITORY 2 ANTIBODY FAB40"
3M61_U_P_3_5.pdb,3M61,,1.68,P00749,PF00089,2.40.10.10,U,247,P,12,C-SA---RGLENHRMC-,C-CT---TTTTTTCCC-,2-20---000000342-,3,5,4,d-dd---CCCCCCCCd-,8,3,C:0;D:0;F:0;G:0;H:0;I:0;K:0;L:0;P:0;Q:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:1;H:0;I:0;K:1;L:0;P:0;Q:0;R:0;S:0;V:0;W:0;Y:0,A:1;D:1;E:3;F:2;G:3;K:6;L:1;N:2;P:3;Q:5;R:6;S:3;T:3;Y:2,A:10;C:7;D:7;E:10;F:4;G:14;H:7;I:16;K:7;L:16;M:5;N:4;P:8;Q:6;R:6;S:14;T:16;V:9;W:4;Y:7,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:2,B:1;C:9;E:5;G:1;H:2;T:23,B:9;C:23;E:77;G:9;H:12;T:47,3_5,C:3;D:3;F:1;G:3;H:2;I:1;K:0;L:1;P:1;Q:1;R:1;S:3;V:3;W:1;Y:3,B:1;C:2;E:11;G:2;T:11,C:0;D:0;F:0;G:0;H:0;I:0;K:0;L:0;P:0;Q:0;R:0;S:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,9-99---988788999-,ARG_20_U_COREBINDING;ASP_192_U_COREBINDING;ASP_197_U_COREBINDING;ASP_50_U_COREBINDING;CYS_194_U_COREBINDING;CYS_31_U_COREBINDING;CYS_47_U_COREBINDING;GLN_195_U_COREBINDING;GLY_196_U_COREBINDING;GLY_219_U_COREBINDING;GLY_221_U_exosite;GLY_229_U_COREBINDING;HIS_46_U_COREBINDING;HIS_94_U_COREBINDING;ILE_49_U_COREBINDING;LEU_92_U_COREBINDING;LYS_142_U_exosite;PHE_48_U_COREBINDING;PRO_228_U_COREBINDING;SER_193_U_COREBINDING;SER_198_U_COREBINDING;SER_217_U_COREBINDING;TRP_218_U_COREBINDING;TYR_231_U_COREBINDING;TYR_51_U_COREBINDING;TYR_57_U_COREBINDING;VAL_216_U_COREBINDING;VAL_230_U_COREBINDING;VAL_30_U_COREBINDING,CSARGLENHRMC,0.985155195681512,0.384630511803683,0.715029370026155,9-99---999599999-,CYS_1_P_e;SER_2_P_e;ALA_3_P_e;ARG_4_P_C;GLY_5_P_C;LEU_6_P_C;GLU_7_P_C;ASN_8_P_C;HIS_9_P_C;ARG_10_P_C;MET_11_P_C;CYS_12_P_e,"CRYSTAL STRUCTURE OF COMPLEX OF UROKINASE AND A UPAIN1 2 VARIANTW3A IN PH46 CONDITION"
3P6Z_B_A_3_3.pdb,3P6Z,21555742,1.70,P00734,PF00089,2.40.10.10,B,255,A,30,-E---A--DCGLRPLFEKKSLEDKTERELLESYI--DG---,-T---T--TTTTTTTTGGGCCCCCHHHHHHHHHH--CC---,-3---4--10000000022422021031012012--26---,3,3,17,-E---E--DDCCCCCEEEEEEEEEEEEEEEEEEE--EE---,5,21,C:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,A:3;D:6;E:4;F:1;G:2;K:7;N:3;P:3;Q:2;R:8;S:2;T:1;W:2;Y:1,A:9;C:6;D:8;E:10;F:7;G:16;H:4;I:14;K:8;L:19;M:6;N:4;P:8;Q:6;R:8;S:8;T:9;V:15;W:5;Y:6,B:0;C:0;E:0;H:0;T:0,B:0;C:0;E:0;H:0;T:0,C:7;E:1;G:4;H:11;T:22,B:7;C:28;E:72;G:11;H:12;T:46,3_3,C:1;D:1;E:0;F:0;G:1;H:1;I:1;K:0;L:0;M:1;N:2;P:2;R:2;S:1;V:1;W:2;Y:1,B:2;C:4;E:2;H:0;T:9,C:0;D:1;E:1;F:1;G:2;H:0;I:1;K:3;L:1;M:0;N:1;P:1;R:0;S:3;V:0;W:0;Y:2,B:0;C:1;E:9;H:2;T:5,-9---9--74343444456655455444334434--78---,ARG_137_B_COREBINDING;ARG_215_B_COREBINDING;ASN_161_B_EXOSITE;ASN_213_B_COREBINDING;ASN_214_B_COREBINDING;ASP_113_B_COREBINDING;ASP_6_B_EXOSITE;CYS_119_B_COREBINDING;GLU_8_B_EXOSITE;GLY_10_B_COREBINDING;GLY_133_B_EXOSITE;GLY_136_B_EXOSITE;HIS_116_B_COREBINDING;ILE_33_B_EXOSITE;ILE_9_B_COREBINDING;LEU_129_B_EXOSITE;LYS_135_B_EXOSITE;LYS_193_B_EXOSITE;LYS_209_B_EXOSITE;MET_11_B_COREBINDING;PHE_212_B_EXOSITE;PRO_117_B_COREBINDING;PRO_13_B_COREBINDING;PRO_211_B_EXOSITE;SER_112_B_COREBINDING;SER_128_B_EXOSITE;SER_34_B_EXOSITE;SER_5_B_EXOSITE;TRP_14_B_COREBINDING;TRP_216_B_COREBINDING;TYR_114_B_COREBINDING;TYR_134_B_EXOSITE;TYR_187_B_EXOSITE;VAL_118_B_COREBINDING,TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR,0.713235294117647,0.562558625537916,0.291818436703374,-9---9--99999999999999999999999999--99---,GLU_1_A_E;ALA_2_A_E;ASP_3_A_E;CYS_4_A_E;GLY_5_A_C;LEU_6_A_C;ARG_7_A_C;PRO_8_A_C;LEU_9_A_C;PHE_10_A_E;GLU_11_A_E;LYS_12_A_E;LYS_13_A_E;SER_14_A_E;LEU_15_A_E;GLU_16_A_E;ASP_17_A_E;LYS_18_A_E;THR_19_A_E;GLU_20_A_E;ARG_21_A_E;GLU_22_A_E;LEU_23_A_E;LEU_24_A_E;GLU_25_A_E;SER_26_A_E;TYR_27_A_E;ILE_28_A_E;ASP_29_A_E;GLY_30_A_E,"STRUCTURAL BASIS OF THROMBIN MEDIATED FACTOR V ACTIVATION ESSENTIAL 2 ROLE OF THE HIRUDINLIKE SEQUENCE GLU666GLU672 FOR PROCESSING AT THE 3 HEAVY CHAINB DOMAIN JUNCTION"
3QN7_A_B_3_9.pdb,3QN7,22304751,1.90,P00749,PF00089,2.40.10.10,A,245,B,16,ACSRYEVDCRGRGSAC,CCCCCTTTTTTTTTCC,3332310011002142,3,9,1,CCCCCCCCCCCCCCCC,16,0,A:0;C:0;D:0;G:0;H:0;I:0;K:0;Q:0;R:0;S:0;T:0;V:0;Y:0,A:0;C:0;D:0;G:0;H:0;I:0;K:0;Q:0;R:0;S:0;T:0;V:0;Y:0,E:3;F:2;G:3;H:1;K:5;L:1;M:1;N:2;P:2;Q:5;R:5;S:5;T:3;Y:2,A:10;C:8;D:8;E:9;F:5;G:14;H:5;I:16;K:6;L:17;M:4;N:4;P:10;Q:6;R:7;S:13;T:15;V:11;W:5;Y:6,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:7;E:5;G:1;H:3;T:24,B:6;C:28;E:81;G:10;H:10;T:44,3_9,A:1;C:2;D:3;G:4;H:3;I:1;K:2;Q:1;R:1;S:2;T:1;V:1;Y:4,B:1;C:3;E:5;G:1;T:16,A:0;C:0;D:0;G:0;H:0;I:0;K:0;Q:0;R:0;S:0;T:0;V:0;Y:0,B:0;C:0;E:0;G:0;T:0,9998754344456778,ALA_223_A_COREBINDING;ARG_23_A_COREBINDING;ASP_192_A_COREBINDING;ASP_197_A_COREBINDING;ASP_50_A_COREBINDING;CYS_194_A_COREBINDING;CYS_222_A_COREBINDING;GLN_195_A_COREBINDING;GLY_196_A_COREBINDING;GLY_219_A_COREBINDING;GLY_221_A_COREBINDING;GLY_229_A_COREBINDING;HIS_22_A_COREBINDING;HIS_46_A_COREBINDING;HIS_94_A_COREBINDING;ILE_49_A_COREBINDING;LYS_142_A_COREBINDING;LYS_227_A_COREBINDING;SER_193_A_COREBINDING;SER_198_A_COREBINDING;THR_28_A_COREBINDING;TYR_150_A_COREBINDING;TYR_29_A_COREBINDING;TYR_51_A_COREBINDING;TYR_87_A_COREBINDING;VAL_30_A_COREBINDING,ACSRYEVDCRGRGSACG,-1,0.406677797760308,,9999999999999999,ALA_1_B_C;CYS_2_B_C;SER_3_B_C;ARG_4_B_C;TYR_5_B_C;GLU_6_B_C;VAL_7_B_C;ASP_8_B_C;CYS_9_B_C;ARG_10_B_C;GLY_11_B_C;ARG_12_B_C;GLY_13_B_C;SER_14_B_C;ALA_15_B_C;CYS_16_B_C,"POTENT AND SELECTIVE BICYCLIC PEPTIDE INHIBITOR UK18 OF HUMAN 2 UROKINASETYPE PLASMINOGEN ACTIVATORUPA"
3S9C_A_B_3_12.pdb,3S9C,21871889,1.80,P18965,,2.40.10.10,A,234,B,7,IAAWYLR,CTTTTBC,1143000,3,12,1,CCCCCCC,7,0,A:0;C:0;E:0;F:0;G:0;H:0;L:0;N:0;P:0;S:0;W:0;Y:0,A:0;C:0;E:0;F:0;G:0;H:0;L:0;N:0;P:0;S:0;W:0;Y:0,A:3;D:2;E:1;F:1;G:1;I:1;K:4;N:3;P:3;R:4;S:3;T:5;V:1,A:8;C:10;D:8;E:6;F:3;G:18;H:8;I:19;K:7;L:13;M:4;N:9;P:12;Q:3;R:13;S:10;T:10;V:14;W:4;Y:6,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:5;E:4;G:1;H:2;T:20,B:7;C:28;E:74;G:8;H:7;T:61,3_12,A:1;C:2;E:1;F:1;G:3;H:2;L:2;N:1;P:1;S:1;W:1;Y:1,B:1;C:1;E:1;G:1;T:13,A:0;C:0;E:0;F:0;G:0;H:0;L:0;N:0;P:0;S:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,6664333,ALA_195_A_COREBINDING;ASN_83_A_COREBINDING;CYS_176_A_COREBINDING;CYS_201_A_COREBINDING;GLU_199_A_COREBINDING;GLY_178_A_COREBINDING;GLY_196_A_COREBINDING;GLY_197_A_COREBINDING;HIS_177_A_COREBINDING;HIS_43_A_COREBINDING;LEU_153_A_COREBINDING;LEU_85_A_COREBINDING;PHE_81_A_COREBINDING;PRO_155_A_COREBINDING;SER_180_A_COREBINDING;TRP_156_A_COREBINDING;TYR_154_A_COREBINDING,SRDPDNIAAWYLRS,-1,0.309855245368131,,9999999,ILE_1_B_C;ALA_2_B_C;ALA_3_B_C;TRP_4_B_C;TYR_5_B_C;LEU_6_B_C;ARG_7_B_C,"RUSSELLS VIPER VENOM SERINE PROTEINASE RVVV IN COMPLEX WITH THE 2 FRAGMENT RESIDUES 15331546 OF HUMAN FACTOR V"
3TJV_A_B_3_1.pdb,3TJV,22156497,2.40,P20718,PF00089,2.40.10.10,A,225,B,9,-------P--------------------------------------------------------------------TSYAG---------------------------------DDS----,-------C--------------------------------------------------------------------EECCE---------------------------------ECC----,-------2--------------------------------------------------------------------10000---------------------------------203----,3,1,29,-------d--------------------------------------------------------------------CCCCC---------------------------------dee----,5,3,C:0;D:0;F:0;G:0;H:0;K:0;L:0;N:0;Q:0;R:0;S:0;Y:0,C:0;D:0;F:2;G:0;H:0;K:1;L:1;N:1;Q:1;R:0;S:1;Y:1,E:1;F:1;G:2;H:2;K:16;L:1;M:1;P:3;Q:2;R:7;S:5;T:2;W:1,A:13;C:5;D:4;E:7;F:3;G:14;H:4;I:12;K:1;L:15;M:3;N:6;P:12;Q:11;R:4;S:6;T:12;V:16;W:2;Y:4,B:0;C:0;E:0;G:0;H:0;T:0,B:2;C:0;E:3;G:0;H:1;T:2,C:8;E:7;H:5;T:24,B:6;C:22;E:66;G:4;H:12;T:44,3_1,C:2;D:1;F:2;G:3;H:1;K:3;L:1;N:1;Q:0;R:2;S:2;Y:1,B:0;C:1;E:8;G:2;H:0;T:8,C:0;D:0;F:0;G:0;H:0;K:0;L:0;N:0;Q:0;R:0;S:0;Y:0,B:0;C:0;E:0;G:0;H:0;T:0,-------6--------------------------------------------------------------------55556---------------------------------889----,ARG_26_A_COREBINDING;ARG_28_A_COREBINDING;ASN_159_A_exosite;ASN_200_A_COREBINDING;ASP_181_A_COREBINDING;CYS_29_A_COREBINDING;CYS_45_A_COREBINDING;GLN_19_A_exosite;GLY_177_A_COREBINDING;GLY_180_A_COREBINDING;GLY_199_A_COREBINDING;HIS_44_A_COREBINDING;LEU_135_A_exosite;LEU_196_A_COREBINDING;LYS_179_A_COREBINDING;LYS_201_A_COREBINDING;LYS_27_A_COREBINDING;LYS_60_A_exosite;PHE_156_A_exosite;PHE_17_A_exosite;PHE_178_A_COREBINDING;PHE_85_A_COREBINDING;SER_182_A_COREBINDING;SER_197_A_COREBINDING;SER_25_A_exosite;TYR_129_A_exosite;TYR_198_A_COREBINDING,PTSYAGDDSG,0.314418187067559,0.253749214372154,0.631232128459888,-------9--------------------------------------------------------------------99999---------------------------------999----,PRO_1_B_e;THR_2_B_C;SER_3_B_C;TYR_4_B_C;ALA_5_B_C;GLY_6_B_C;ASP_7_B_e;ASP_8_B_e;SER_9_B_e,"CRYSTAL STRUCTURE OF HUMAN GRANZYME H WITH A PEPTIDYL SUBSTRATE"
3TVJ_B_I_3_1.pdb,3TVJ,22511776,1.28,O00187,PF00089,2.40.10.10,B,242,I,35,------E-----VT------CEP-GTTFKDKCNTCRC-----GSDGKSAV--------------------------CTKLWCNQ-------------------------------------,------C-----CC------CTT-TEEEEETTEEEEE-----TTTTTTEE--------------------------EECCEECC-------------------------------------,------4-----03------022-2110312100000-----02102000--------------------------00000013-------------------------------------,3,1,29,------E-----EE------EEE-EEEEDDDDDDEDD-----EEEEEEDD--------------------------CCCCCCde-------------------------------------,6,27,A:0;C:0;D:0;E:0;F:0;G:0;H:0;L:0;M:0;P:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:0;C:0;D:0;E:0;F:0;G:1;H:0;L:1;M:0;P:0;R:1;S:0;T:0;V:0;W:0;Y:0,A:2;D:2;E:6;H:2;I:1;K:6;N:1;P:3;Q:3;R:4;S:5;V:1;Y:1,A:17;C:4;D:10;E:4;F:6;G:18;H:2;I:17;K:5;L:15;M:4;N:10;P:4;Q:4;R:2;S:4;T:12;V:12;W:6;Y:8,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:1;G:0;T:2,C:3;E:3;H:6;T:25,B:6;C:25;E:67;G:8;H:13;T:45,3_1,A:2;C:1;D:2;E:0;F:2;G:5;H:1;L:2;M:1;P:0;R:1;S:3;T:2;V:1;W:1;Y:1,B:3;C:2;E:9;G:2;T:9,A:1;C:0;D:1;E:1;F:0;G:2;H:1;L:0;M:0;P:3;R:1;S:2;T:0;V:0;W:0;Y:1,B:0;C:0;E:1;G:0;T:12,------9-----99------899-9766555555445-----67778654--------------------------44343469-------------------------------------,ALA_24_B_COREBINDING;ALA_40_B_COREBINDING;ALA_84_B_EXOSITE;ARG_166_B_EXOSITE;ARG_187_B_COREBINDING;ARG_60_B_exosite;ASP_184_B_COREBINDING;ASP_189_B_COREBINDING;ASP_83_B_EXOSITE;CYS_186_B_COREBINDING;GLU_43_B_EXOSITE;GLY_136_B_COREBINDING;GLY_167_B_EXOSITE;GLY_188_B_COREBINDING;GLY_20_B_exosite;GLY_21_B_COREBINDING;GLY_213_B_COREBINDING;GLY_224_B_COREBINDING;GLY_85_B_EXOSITE;HIS_39_B_COREBINDING;HIS_82_B_EXOSITE;LEU_132_B_COREBINDING;LEU_138_B_COREBINDING;LEU_19_B_exosite;MET_215_B_COREBINDING;PHE_137_B_COREBINDING;PHE_86_B_COREBINDING;PRO_162_B_EXOSITE;PRO_163_B_EXOSITE;PRO_165_B_EXOSITE;SER_168_B_EXOSITE;SER_185_B_COREBINDING;SER_190_B_COREBINDING;SER_211_B_COREBINDING;SER_214_B_EXOSITE;THR_22_B_COREBINDING;THR_23_B_COREBINDING;TRP_212_B_COREBINDING;TYR_164_B_EXOSITE;TYR_226_B_COREBINDING;VAL_210_B_COREBINDING,GSGEVTCEPGTTFKDKCNTCRCGSDGKSAVCTKLWCNQ,0.312447059106529,0.3190324743567,0.558736073651952,------9-----99------959-9999995999999-----99999999--------------------------99999995-------------------------------------,GLU_1_I_E;VAL_2_I_E;THR_3_I_E;CYS_4_I_E;GLU_5_I_E;PRO_6_I_E;GLY_7_I_E;THR_8_I_E;THR_9_I_E;PHE_10_I_E;LYS_11_I_E;ASP_12_I_E;LYS_13_I_E;CYS_14_I_E;ASN_15_I_E;THR_16_I_E;CYS_17_I_E;ARG_18_I_E;CYS_19_I_E;GLY_20_I_E;SER_21_I_E;ASP_22_I_E;GLY_23_I_E;LYS_24_I_E;SER_25_I_E;ALA_26_I_E;VAL_27_I_E;CYS_28_I_C;THR_29_I_C;LYS_30_I_C;LEU_31_I_C;TRP_32_I_C;CYS_33_I_C;ASN_34_I_e;GLN_35_I_e,"CATALYTIC FRAGMENT OF MASP2 IN COMPLEX WITH ITS SPECIFIC INHIBITOR 2 DEVELOPED BY DIRECTED EVOLUTION ON SGCI SCAFFOLD"
3U8O_H_L_3_3.pdb,3U8O,22457833,1.28,P00734,PF00089,2.40.10.10,H,251,L,30,-A------DCGLRPLFEKKSLEDKTERELLESYI--D-GR-,-C------TTTTTTTTGGGCCCCCHHHHHHHHHH--H-HC-,-4------10000010023322031021012022--3-13-,3,3,17,-e------ddCCCCCEEEEEEEEEEEEEEEEEEE--E-EE-,5,22,A:0;C:0;D:0;E:0;G:0;H:0;I:0;K:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,A:0;C:0;D:0;E:0;G:0;H:0;I:0;K:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,A:1;D:4;E:4;F:2;G:2;K:7;N:3;P:3;Q:2;R:7;S:2;T:1;W:1;Y:1,A:9;C:6;D:11;E:9;F:7;G:16;H:4;I:15;K:9;L:20;M:5;N:5;P:9;Q:6;R:9;S:10;T:7;V:14;W:5;Y:6,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:8;E:1;G:3;H:10;T:18,B:7;C:28;E:75;G:13;H:15;T:44,3_3,A:0;C:1;D:1;E:0;G:1;H:1;I:1;K:0;M:1;N:1;P:2;R:2;S:2;V:1;W:2;Y:1,B:2;C:4;E:2;T:9,A:1;C:0;D:0;E:2;G:2;H:0;I:0;K:2;M:1;N:1;P:0;R:0;S:0;V:1;W:0;Y:2,B:0;C:2;E:7;T:3,-9------94444555567766575454444445--5-58-,ALA_132_H_EXOSITE;ARG_137_H_COREBINDING;ARG_211_H_COREBINDING;ASN_157_H_EXOSITE;ASN_210_H_COREBINDING;ASP_113_H_COREBINDING;CYS_119_H_COREBINDING;GLU_162_H_EXOSITE;GLU_8_H_EXOSITE;GLY_10_H_COREBINDING;GLY_133_H_EXOSITE;GLY_136_H_EXOSITE;HIS_116_H_COREBINDING;ILE_9_H_COREBINDING;LYS_135_H_EXOSITE;LYS_205_H_EXOSITE;MET_11_H_COREBINDING;MET_204_H_EXOSITE;PRO_117_H_COREBINDING;PRO_13_H_COREBINDING;SER_112_H_COREBINDING;SER_12_H_COREBINDING;TRP_14_H_COREBINDING;TRP_212_H_COREBINDING;TYR_114_H_COREBINDING;TYR_134_H_EXOSITE;TYR_183_H_EXOSITE;VAL_118_H_COREBINDING;VAL_203_H_EXOSITE,ADCGLRPLFEKKSLEDKTERELLESYIDGR,0.722128165675301,0.568184934487578,0.247840674627874,-9------99999999999999939999979999--9-99-,ALA_1_L_e;ASP_2_L_e;CYS_3_L_e;GLY_4_L_C;LEU_5_L_C;ARG_6_L_C;PRO_7_L_C;LEU_8_L_C;PHE_9_L_E;GLU_10_L_E;LYS_11_L_E;LYS_12_L_E;SER_13_L_E;LEU_14_L_E;GLU_15_L_E;ASP_16_L_E;LYS_17_L_E;THR_18_L_E;GLU_19_L_E;ARG_20_L_E;GLU_21_L_E;LEU_22_L_E;LEU_23_L_E;GLU_24_L_E;SER_25_L_E;TYR_26_L_E;ILE_27_L_E;ASP_28_L_E;GLY_29_L_E;ARG_30_L_E,"HUMAN THROMBIN COMPLEXED WITH DPHEPRODARGDTHR"
3VXE_H_J_3_2.pdb,3VXE,23712263,1.25,P00734,PF00089,2.40.10.10,H,257,J,9,-DFEEIPEE--Y----,-CCCCCCCC--C----,-30230133--1----,3,2,18,-eCCCCCee--e----,5,3,E:0;F:0;I:0;K:0;L:0;M:0;Q:0;R:0;T:0;Y:0,E:0;F:0;I:0;K:1;L:0;M:1;Q:0;R:0;T:0;Y:0,A:1;D:7;E:3;F:2;G:3;I:1;K:6;N:4;P:6;Q:1;R:7;S:2;T:2;V:1;W:2,A:11;C:7;D:9;E:10;F:6;G:18;H:5;I:14;K:12;L:18;M:6;N:7;P:8;Q:6;R:8;S:12;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:0;E:1;T:1,C:11;E:1;G:4;H:11;T:21,B:9;C:33;E:79;G:12;H:13;T:50,3_2,E:1;F:1;I:1;K:0;L:2;M:0;Q:1;R:3;T:1;Y:1,C:1;E:6;T:4,E:0;F:0;I:0;K:0;L:0;M:0;Q:0;R:0;T:0;Y:0,C:0;E:0;T:0,-96577979--8----,ARG_62_H_COREBINDING;ARG_68_H_COREBINDING;ARG_70_H_COREBINDING;GLN_24_H_COREBINDING;GLU_25_H_COREBINDING;ILE_78_H_COREBINDING;LEU_26_H_COREBINDING;LEU_60_H_COREBINDING;LYS_21_H_exosite;MET_80_H_exosite;PHE_19_H_COREBINDING;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,PGGGGNGDFEEIPEEYL,0.971847104600595,0.491038327041989,3.41950420382838,-99999999--9----,ASP_1_J_e;PHE_2_J_C;GLU_3_J_C;GLU_4_J_C;ILE_5_J_C;PRO_6_J_C;GLU_7_J_e;GLU_8_J_e;TYR_9_J_e,"HUMAN ALPHATHROMBINBIVALIRUDIN COMPLEX AT PD50"
4AOQ_C_F_3_1.pdb,4AOQ,23275169,2.00,P00760,PF00089,2.40.10.10,C,223,F,35,-----K--------------------------------------------CSPSGAICSGAGPPEQCCSGACVPHPILRIFV--CQ-----------------------------------,-----C--------------------------------------------CBTTTEECTTTTCGGGBTTTCEEETTTBCCEE--EC-----------------------------------,-----5--------------------------------------------10222100001012300221101102100000--02-----------------------------------,3,1,29,-----E--------------------------------------------EDDDDDDDDEEEEEEEEEEEEEEEDDCCCCCC--ee-----------------------------------,6,27,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;T:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;T:0;V:0;W:0;Y:0,A:1;D:1;E:1;F:1;G:7;K:3;N:2;P:2;Q:2;S:14;T:1;V:1;W:1,A:13;C:9;D:3;E:3;F:1;G:15;H:1;I:15;K:11;L:13;M:2;N:13;P:6;Q:7;R:2;S:16;T:8;V:15;W:2;Y:7,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:4;E:1;H:9;T:23,B:3;C:28;E:69;G:4;H:9;T:49,3_1,C:3;D:2;F:1;G:3;H:1;L:1;N:1;Q:1;S:4;T:1;V:1;W:1;Y:0,B:2;C:3;E:3;G:2;T:10,C:0;D:0;F:0;G:0;H:1;L:0;N:0;Q:0;S:0;T:0;V:0;W:0;Y:3,B:0;C:2;E:1;G:0;T:1,-----9--------------------------------------------96555545569698966567745544443344--57-----------------------------------,ASN_123_C_COREBINDING;ASP_171_C_COREBINDING;ASP_176_C_COREBINDING;CYS_173_C_COREBINDING;CYS_197_C_COREBINDING;CYS_41_C_COREBINDING;GLN_174_C_COREBINDING;GLY_175_C_COREBINDING;GLY_194_C_COREBINDING;GLY_196_C_COREBINDING;HIS_23_C_EXOSITE;HIS_40_C_COREBINDING;LEU_81_C_COREBINDING;PHE_24_C_COREBINDING;SER_172_C_COREBINDING;SER_177_C_COREBINDING;SER_192_C_COREBINDING;SER_195_C_COREBINDING;THR_129_C_COREBINDING;TRP_193_C_COREBINDING;TYR_131_C_EXOSITE;TYR_22_C_EXOSITE;TYR_42_C_EXOSITE;VAL_191_C_COREBINDING,EDKCSPSGAICSGAGPPEQCCSGACVPHPILRIFVCQ,0.678846684504221,0.358888825679351,0.636353675246714,-----9--------------------------------------------99999999699999999999999999999999--99-----------------------------------,LYS_1_F_E;CYS_2_F_E;SER_3_F_E;PRO_4_F_E;SER_5_F_E;GLY_6_F_E;ALA_7_F_E;ILE_8_F_E;CYS_9_F_E;SER_10_F_E;GLY_11_F_E;ALA_12_F_E;GLY_13_F_E;PRO_14_F_E;PRO_15_F_E;GLU_16_F_E;GLN_17_F_E;CYS_18_F_E;CYS_19_F_E;SER_20_F_E;GLY_21_F_E;ALA_22_F_E;CYS_23_F_E;VAL_24_F_E;PRO_25_F_E;HIS_26_F_E;PRO_27_F_E;ILE_28_F_C;LEU_29_F_C;ARG_30_F_C;ILE_31_F_C;PHE_32_F_C;VAL_33_F_C;CYS_34_F_e;GLN_35_F_e,"CATIONIC TRYPSIN IN COMPLEX WITH MUTATED SPINACIA OLERACEA 2 TRYPSIN INHIBITOR III SOTIIII F14A"
4AOR_C_F_3_1.pdb,4AOR,23275169,1.70,P00760,PF00089,2.40.10.10,C,223,F,34,----C----------------------------------------------SPSGAICSGFGPPEQCCSGACVPHPILRIFV--CQ-----------------------------------,----C----------------------------------------------BTTTEECTTTTCGGGBTTTCEEETTTBCCEE--EC-----------------------------------,----3----------------------------------------------1232100011012300221101102100000--02-----------------------------------,3,1,29,----E----------------------------------------------DDDDDDDDEEEEEEEEEEEEEEEDDCCCCCC--ee-----------------------------------,6,26,C:0;D:0;F:0;G:0;H:0;K:0;L:0;N:0;Q:0;S:0;T:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;K:0;L:0;N:0;Q:0;S:0;T:0;V:0;W:0;Y:0,A:1;E:1;G:6;K:5;N:2;P:2;Q:1;S:13;T:1;V:1;W:1,A:13;C:9;D:3;E:3;F:2;G:15;H:1;I:15;K:8;L:13;M:2;N:13;P:6;Q:8;R:2;S:17;T:8;V:15;W:2;Y:7,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:3;E:1;H:9;T:21,B:4;C:28;E:68;G:4;H:9;T:49,3_1,C:3;D:2;F:1;G:4;H:1;K:0;L:1;N:0;Q:1;S:3;T:0;V:1;W:1;Y:0,B:2;C:1;E:4;G:2;T:9,C:0;D:1;F:0;G:0;H:1;K:1;L:0;N:1;Q:0;S:1;T:1;V:0;W:0;Y:3,B:0;C:4;E:1;G:0;T:4,----9----------------------------------------------7887544465476656675766537444454--58-----------------------------------,ASN_56_C_EXOSITE;ASP_133_C_EXOSITE;ASP_171_C_COREBINDING;ASP_176_C_COREBINDING;CYS_173_C_COREBINDING;CYS_197_C_COREBINDING;CYS_41_C_COREBINDING;GLN_174_C_COREBINDING;GLY_175_C_COREBINDING;GLY_194_C_COREBINDING;GLY_196_C_COREBINDING;GLY_204_C_COREBINDING;HIS_23_C_EXOSITE;HIS_40_C_COREBINDING;LEU_81_C_COREBINDING;LYS_43_C_EXOSITE;PHE_24_C_COREBINDING;SER_172_C_COREBINDING;SER_177_C_COREBINDING;SER_192_C_COREBINDING;SER_195_C_EXOSITE;THR_129_C_EXOSITE;TRP_193_C_COREBINDING;TYR_131_C_EXOSITE;TYR_22_C_EXOSITE;TYR_42_C_EXOSITE;VAL_191_C_COREBINDING,EDKCSPSGAICSGFGPPEQCCSGACVPHPILRIFVCQ,0.678996116662021,0.358961925094556,0.734329626257854,----9----------------------------------------------9999999999999399999979999999999--99-----------------------------------,CYS_1_F_E;SER_2_F_E;PRO_3_F_E;SER_4_F_E;GLY_5_F_E;ALA_6_F_E;ILE_7_F_E;CYS_8_F_E;SER_9_F_E;GLY_10_F_E;PHE_11_F_E;GLY_12_F_E;PRO_13_F_E;PRO_14_F_E;GLU_15_F_E;GLN_16_F_E;CYS_17_F_E;CYS_18_F_E;SER_19_F_E;GLY_20_F_E;ALA_21_F_E;CYS_22_F_E;VAL_23_F_E;PRO_24_F_E;HIS_25_F_E;PRO_26_F_E;ILE_27_F_C;LEU_28_F_C;ARG_29_F_C;ILE_30_F_C;PHE_31_F_C;VAL_32_F_C;CYS_33_F_e;GLN_34_F_e,"CATIONIC TRYPSIN IN COMPLEX WITH THE SPINACIA OLERACEA 2 TRYPSIN INHIBITOR III SOTIIII"
4AX9_H_I_3_2.pdb,4AX9,7966150,1.90,P00734,PF00089,2.40.10.10,H,250,I,10,-DFEEIPEE--YL---,-CCCCCCGG--GC---,-30230133--12---,3,2,18,-eCCCCCEE--EE---,5,4,E:0;F:0;I:0;K:0;L:0;Q:0;R:0;T:0;Y:0,E:0;F:0;I:0;K:0;L:0;Q:1;R:0;T:0;Y:0,A:2;D:7;E:5;F:2;G:2;I:1;K:5;N:4;P:5;R:7;S:2;T:1;W:1,A:9;C:7;D:9;E:8;F:6;G:18;H:5;I:14;K:12;L:18;M:7;N:6;P:9;Q:6;R:8;S:12;T:7;V:16;W:7;Y:9,C:0;E:0;T:0,C:1;E:0;T:0,C:7;E:1;G:2;H:8;T:26,B:9;C:31;E:79;G:8;H:16;T:50,3_2,E:1;F:1;I:1;K:0;L:2;Q:1;R:3;T:1;Y:1,C:1;E:6;T:4,E:0;F:0;I:0;K:1;L:0;Q:0;R:0;T:0;Y:0,C:0;E:0;T:1,-87788999--99---,ARG_62_H_COREBINDING;ARG_68_H_COREBINDING;ARG_70_H_COREBINDING;GLN_150_H_exosite;GLN_24_H_COREBINDING;GLU_25_H_COREBINDING;ILE_78_H_COREBINDING;LEU_26_H_COREBINDING;LEU_60_H_COREBINDING;LYS_21_H_EXOSITE;PHE_19_H_COREBINDING;THR_69_H_COREBINDING;TYR_71_H_COREBINDING,DFEEIPEEYLQ,0.990472535668102,0.501651293018022,3.83829832087085,-99999999--95---,ASP_1_I_e;PHE_2_I_C;GLU_3_I_C;GLU_4_I_C;ILE_5_I_C;PRO_6_I_C;GLU_7_I_E;GLU_8_I_E;TYR_9_I_E;LEU_10_I_E,"HUMAN THROMBIN COMPLEXED WITH NAPSAGATRAN RO0466240"
4BAH_B_A_3_3.pdb,4BAH,23290007,1.94,P00734,PF00089,2.40.10.10,B,251,A,29,-E---A--DCGLRPLFEKKSLEDKTERELLESYI------D,-T---T--TTTTTTTTGGGCCCCCHHHHHHHHCC------C,-2---3--20000010023322031021023003------4,3,3,17,-E---E--DDCCCCCEEEEEEEEEEEEEEEEEEE------E,5,20,C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,A:2;D:7;E:3;F:2;G:3;K:5;N:3;P:4;Q:3;R:8;S:2;T:2;W:1;Y:1,A:9;C:6;D:7;E:10;F:7;G:15;H:4;I:14;K:10;L:19;M:5;N:5;P:7;Q:5;R:8;S:10;T:7;V:15;W:5;Y:6,B:0;C:0;E:0;H:0;T:0,B:0;C:0;E:0;H:0;T:0,C:8;E:2;G:2;H:10;T:24,B:7;C:25;E:73;G:8;H:13;T:48,3_3,C:1;D:1;E:0;G:1;H:1;I:1;K:0;L:0;M:1;N:1;P:2;R:2;S:1;V:1;W:2;Y:1,B:2;C:4;E:2;H:0;T:8,C:0;D:1;E:1;G:2;H:0;I:1;K:3;L:1;M:1;N:1;P:1;R:0;S:1;V:0;W:0;Y:2,B:0;C:3;E:6;H:1;T:5,-9---9--64433333344444344344334347------9,ARG_137_B_COREBINDING;ARG_212_B_COREBINDING;ASN_158_B_EXOSITE;ASN_211_B_COREBINDING;ASP_113_B_COREBINDING;ASP_35_B_EXOSITE;CYS_119_B_COREBINDING;GLU_8_B_EXOSITE;GLY_10_B_COREBINDING;GLY_133_B_EXOSITE;GLY_136_B_EXOSITE;HIS_116_B_COREBINDING;ILE_33_B_EXOSITE;ILE_9_B_COREBINDING;LEU_129_B_EXOSITE;LYS_135_B_EXOSITE;LYS_190_B_EXOSITE;LYS_206_B_EXOSITE;MET_11_B_COREBINDING;MET_205_B_EXOSITE;PRO_117_B_COREBINDING;PRO_13_B_COREBINDING;PRO_208_B_EXOSITE;SER_112_B_COREBINDING;SER_34_B_EXOSITE;TRP_14_B_COREBINDING;TRP_213_B_COREBINDING;TYR_114_B_COREBINDING;TYR_134_B_EXOSITE;TYR_184_B_EXOSITE;VAL_118_B_COREBINDING,TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR,0.723622189579683,0.569680119244471,0.25142394476263,-9---9--99999999999999999999999999------9,GLU_1_A_E;ALA_2_A_E;ASP_3_A_E;CYS_4_A_E;GLY_5_A_C;LEU_6_A_C;ARG_7_A_C;PRO_8_A_C;LEU_9_A_C;PHE_10_A_E;GLU_11_A_E;LYS_12_A_E;LYS_13_A_E;SER_14_A_E;LEU_15_A_E;GLU_16_A_E;ASP_17_A_E;LYS_18_A_E;THR_19_A_E;GLU_20_A_E;ARG_21_A_E;GLU_22_A_E;LEU_23_A_E;LEU_24_A_E;GLU_25_A_E;SER_26_A_E;TYR_27_A_E;ILE_28_A_E;ASP_29_A_E,"THROMBIN IN COMPLEX WITH INHIBITOR"
4BAO_B_A_3_3.pdb,4BAO,23290007,1.87,P00734,PF00089,2.40.10.10,B,249,A,27,-A------DCGLRPLFEKKSLEDKTERELLESYI-------,-C------TTTTTTTTGGGCCCCCHHHHHHHHCC-------,-5------11000010022322021021023004-------,3,3,17,-e------ddCCCCCEEEEEEEEEEEEEEEEEEE-------,5,19,C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,A:2;D:6;E:4;F:2;G:2;K:3;N:3;P:2;Q:2;R:9;S:2;T:2;W:1;Y:1,A:9;C:6;D:8;E:9;F:6;G:15;H:4;I:15;K:12;L:19;M:5;N:5;P:9;Q:6;R:7;S:9;T:7;V:15;W:5;Y:6,B:0;C:0;E:0;H:0;T:0,B:0;C:0;E:0;H:0;T:0,C:8;E:1;G:3;H:8;T:21,B:7;C:26;E:74;G:10;H:13;T:47,3_3,C:1;D:1;E:0;G:1;H:1;I:1;K:0;L:0;M:1;N:1;P:2;R:2;S:2;V:1;W:2;Y:1,B:2;C:4;E:2;H:0;T:9,C:0;D:1;E:1;G:2;H:0;I:0;K:3;L:1;M:1;N:1;P:1;R:0;S:1;V:0;W:0;Y:2,B:0;C:2;E:8;H:1;T:3,-8------74333333344444444354444456-------,ARG_137_B_COREBINDING;ARG_212_B_COREBINDING;ASN_158_B_EXOSITE;ASN_211_B_COREBINDING;ASP_113_B_COREBINDING;ASP_6_B_EXOSITE;CYS_119_B_COREBINDING;GLU_8_B_EXOSITE;GLY_10_B_COREBINDING;GLY_133_B_EXOSITE;GLY_136_B_EXOSITE;HIS_116_B_COREBINDING;ILE_9_B_COREBINDING;LEU_129_B_EXOSITE;LYS_135_B_EXOSITE;LYS_190_B_EXOSITE;LYS_206_B_EXOSITE;MET_11_B_COREBINDING;MET_205_B_EXOSITE;PRO_117_B_COREBINDING;PRO_13_B_COREBINDING;PRO_208_B_EXOSITE;SER_112_B_COREBINDING;SER_12_B_COREBINDING;SER_5_B_EXOSITE;TRP_14_B_COREBINDING;TRP_213_B_COREBINDING;TYR_114_B_COREBINDING;TYR_134_B_EXOSITE;TYR_184_B_EXOSITE;VAL_118_B_COREBINDING,TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR,0.722956970891366,0.569801766732458,0.192153584405808,-9------99999999999999999999999999-------,ALA_1_A_e;ASP_2_A_e;CYS_3_A_e;GLY_4_A_C;LEU_5_A_C;ARG_6_A_C;PRO_7_A_C;LEU_8_A_C;PHE_9_A_E;GLU_10_A_E;LYS_11_A_E;LYS_12_A_E;SER_13_A_E;LEU_14_A_E;GLU_15_A_E;ASP_16_A_E;LYS_17_A_E;THR_18_A_E;GLU_19_A_E;ARG_20_A_E;GLU_21_A_E;LEU_22_A_E;LEU_23_A_E;GLU_24_A_E;SER_25_A_E;TYR_26_A_E;ILE_27_A_E,"THROMBIN IN COMPLEX WITH INHIBITOR"
4CH2_D_C_3_3.pdb,4CH2,24316004,1.60,P00734,PF00089,2.40.10.10,D,251,C,29,-E---A--DCGLRPLFEKKSLEDKTERELLESYI--D----,-T---T--TTTTTTTTGGGCCCCCHHHHHHHHHH--C----,-3---4--10010010023322021020012013--4----,3,3,17,-E---E--DDCCCCCEEEEEEEEEEEEEEEEEEE--E----,5,20,C:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,A:2;D:5;E:3;F:1;G:3;K:5;N:3;P:4;Q:2;R:5;S:1;T:2;W:1;Y:1,A:9;C:6;D:9;E:10;F:7;G:15;H:4;I:14;K:10;L:19;M:5;N:4;P:7;Q:6;R:11;S:7;T:7;V:14;W:5;Y:6,B:0;C:0;E:0;H:0;T:0,B:0;C:0;E:0;H:0;T:0,C:8;E:1;G:2;H:9;T:18,B:7;C:30;E:70;G:10;H:14;T:44,3_3,C:1;D:1;E:0;F:0;G:1;H:1;I:1;K:0;L:0;M:1;N:2;P:2;R:2;S:2;V:1;W:2;Y:1,B:2;C:4;E:2;H:0;T:10,C:0;D:1;E:1;F:1;G:2;H:0;I:1;K:3;L:1;M:1;N:1;P:1;R:0;S:4;V:1;W:0;Y:2,B:0;C:2;E:11;H:2;T:5,-9---7--54333443445555444344445446--8----,ARG_137_D_COREBINDING;ARG_212_D_COREBINDING;ASN_158_D_EXOSITE;ASN_210_D_COREBINDING;ASN_211_D_COREBINDING;ASP_113_D_COREBINDING;ASP_6_D_EXOSITE;CYS_119_D_COREBINDING;GLU_8_D_EXOSITE;GLY_10_D_COREBINDING;GLY_133_D_EXOSITE;GLY_136_D_EXOSITE;HIS_116_D_COREBINDING;ILE_33_D_EXOSITE;ILE_9_D_COREBINDING;LEU_129_D_EXOSITE;LYS_135_D_EXOSITE;LYS_190_D_EXOSITE;LYS_206_D_EXOSITE;MET_11_D_COREBINDING;MET_205_D_EXOSITE;PHE_209_D_EXOSITE;PRO_117_D_COREBINDING;PRO_13_D_COREBINDING;PRO_208_D_EXOSITE;SER_112_D_COREBINDING;SER_12_D_COREBINDING;SER_128_D_EXOSITE;SER_207_D_EXOSITE;SER_34_D_EXOSITE;SER_5_D_EXOSITE;TRP_14_D_COREBINDING;TRP_213_D_COREBINDING;TYR_114_D_COREBINDING;TYR_134_D_EXOSITE;TYR_184_D_EXOSITE;VAL_118_D_COREBINDING;VAL_204_D_EXOSITE,TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR,0.723622189579683,0.569795599353022,0.266625205110096,-9---9--99999999999999999999959999--9----,GLU_1_C_E;ALA_2_C_E;ASP_3_C_E;CYS_4_C_E;GLY_5_C_C;LEU_6_C_C;ARG_7_C_C;PRO_8_C_C;LEU_9_C_C;PHE_10_C_E;GLU_11_C_E;LYS_12_C_E;LYS_13_C_E;SER_14_C_E;LEU_15_C_E;GLU_16_C_E;ASP_17_C_E;LYS_18_C_E;THR_19_C_E;GLU_20_C_E;ARG_21_C_E;GLU_22_C_E;LEU_23_C_E;LEU_24_C_E;GLU_25_C_E;SER_26_C_E;TYR_27_C_E;ILE_28_C_E;ASP_29_C_E,"LOWSALT CRYSTAL STRUCTURE OF A THROMBINGPIBALPHA PEPTIDE 2 COMPLEX"
4CH8_B_A_3_3.pdb,4CH8,24316004,1.75,P00734,PF00089,2.40.10.10,B,249,A,26,--D------CGLRPLFEKKSLEDKTERELLESYI-------,--T------TTTTTTTGGGCCCCCHHHHHHHHHC-------,--3------1000000022422021021012124-------,3,3,17,--d------dCCCCCEEEEEEEEEEEEEEEEEEE-------,5,19,C:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,A:1;D:5;E:4;F:1;G:2;I:1;K:5;N:3;P:3;Q:1;R:6;S:1;W:1;Y:1,A:10;C:6;D:9;E:9;F:7;G:15;H:4;I:14;K:10;L:20;M:6;N:4;P:8;Q:7;R:10;S:10;T:8;V:15;W:5;Y:6,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:4;E:2;G:3;H:10;T:16,B:7;C:30;E:73;G:13;H:14;T:46,3_3,C:1;D:1;E:0;F:0;G:1;H:1;I:1;K:0;M:1;N:2;P:2;R:2;S:2;V:1;W:2;Y:1,B:2;C:4;E:2;T:10,C:0;D:1;E:1;F:1;G:2;H:0;I:0;K:3;M:0;N:1;P:1;R:0;S:1;V:0;W:0;Y:2,B:0;C:1;E:7;T:5,--8------6566777889988777789899999-------,ARG_137_B_COREBINDING;ARG_211_B_COREBINDING;ASN_157_B_EXOSITE;ASN_209_B_COREBINDING;ASN_210_B_COREBINDING;ASP_113_B_COREBINDING;ASP_6_B_EXOSITE;CYS_119_B_COREBINDING;GLU_8_B_EXOSITE;GLY_10_B_COREBINDING;GLY_133_B_EXOSITE;GLY_136_B_EXOSITE;HIS_116_B_COREBINDING;ILE_9_B_COREBINDING;LYS_135_B_EXOSITE;LYS_189_B_EXOSITE;LYS_205_B_EXOSITE;MET_11_B_COREBINDING;PHE_208_B_EXOSITE;PRO_117_B_COREBINDING;PRO_13_B_COREBINDING;PRO_207_B_EXOSITE;SER_112_B_COREBINDING;SER_12_B_COREBINDING;SER_5_B_EXOSITE;TRP_14_B_COREBINDING;TRP_212_B_COREBINDING;TYR_114_B_COREBINDING;TYR_134_B_EXOSITE;TYR_183_B_EXOSITE;VAL_118_B_COREBINDING,TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR,0.722450962795237,0.569512994835514,0.291410363576865,--9------9999999999999999999999999-------,ASP_1_A_e;CYS_2_A_e;GLY_3_A_C;LEU_4_A_C;ARG_5_A_C;PRO_6_A_C;LEU_7_A_C;PHE_8_A_E;GLU_9_A_E;LYS_10_A_E;LYS_11_A_E;SER_12_A_E;LEU_13_A_E;GLU_14_A_E;ASP_15_A_E;LYS_16_A_E;THR_17_A_E;GLU_18_A_E;ARG_19_A_E;GLU_20_A_E;LEU_21_A_E;LEU_22_A_E;GLU_23_A_E;SER_24_A_E;TYR_25_A_E;ILE_26_A_E,"HIGHSALT CRYSTAL STRUCTURE OF A THROMBINGPIBALPHA PEPTIDE 2 COMPLEX"
4E05_H_I_3_7.pdb,4E05,23223529,2.30,P00734,PF00089,2.40.10.10,H,253,I,30,-E---DYAAIEASLSETFNTAADP----GRRLGEGSKP,-C---CTTTTTTTTTTTTCBCCCG----GGBCGGGCCC,-3---2403204301230200200----0000210215,3,7,3,-E---EEEEEDEEDEDDEEECCCC----DDDDDDDEDE,4,16,A:0;C:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:0;C:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:2;D:6;E:4;F:2;G:1;I:1;K:5;N:4;P:6;R:6;S:2,A:8;C:5;D:8;E:6;F:6;G:16;H:4;I:13;K:11;L:17;M:6;N:5;P:8;Q:6;R:7;S:10;T:7;V:15;W:5;Y:8,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:8;E:1;G:1;H:7;T:22,B:8;C:29;E:71;G:6;H:18;T:39,3_7,A:0;C:1;D:1;E:2;F:0;G:1;H:1;I:0;K:1;L:2;M:0;N:0;Q:0;R:0;S:1;T:0;V:0;W:1;Y:1,B:1;C:0;E:4;G:2;T:5,A:1;C:1;D:1;E:3;F:1;G:3;H:0;I:2;K:2;L:1;M:1;N:1;Q:2;R:5;S:1;T:2;V:1;W:2;Y:1,B:2;C:10;E:8;G:0;T:11,-9---9999999976565534433----4444444445,ALA_195_H_EXOSITE;ARG_173_H_EXOSITE;ARG_228_H_EXOSITE;ARG_62_H_EXOSITE;ARG_68_H_EXOSITE;ARG_70_H_EXOSITE;ASN_143_H_EXOSITE;ASP_194_H_EXOSITE;ASP_199_H_COREBINDING;CYS_196_H_COREBINDING;CYS_226_H_EXOSITE;GLN_151_H_EXOSITE;GLN_24_H_EXOSITE;GLU_146_H_EXOSITE;GLU_197_H_COREBINDING;GLU_224_H_EXOSITE;GLU_25_H_COREBINDING;GLU_94_H_EXOSITE;GLY_198_H_COREBINDING;GLY_223_H_EXOSITE;GLY_225_H_EXOSITE;GLY_233_H_EXOSITE;HIS_43_H_COREBINDING;ILE_174_H_EXOSITE;ILE_78_H_EXOSITE;LEU_26_H_COREBINDING;LEU_27_H_COREBINDING;LEU_96_H_EXOSITE;LYS_149_H_EXOSITE;LYS_231_H_EXOSITE;LYS_52_H_COREBINDING;MET_80_H_EXOSITE;PHE_19_H_EXOSITE;SER_200_H_COREBINDING;SER_221_H_EXOSITE;THR_147_H_EXOSITE;THR_69_H_EXOSITE;TRP_141_H_EXOSITE;TRP_222_H_EXOSITE;TRP_50_H_COREBINDING;TYR_47_H_COREBINDING;TYR_71_H_EXOSITE;VAL_220_H_EXOSITE,APQYAPGDEPSYDEDTDDSDKLVENDTSITDEDYAAIEASLSETFNTAADPGRRLGEGSKP,0.312252964426877,0.602231258926191,0.12372146135574,-9---9999999999999999999----9999999999,GLU_1_I_E;ASP_2_I_E;TYR_3_I_E;ALA_4_I_E;ALA_5_I_E;ILE_6_I_E;GLU_7_I_E;ALA_8_I_E;SER_9_I_E;LEU_10_I_E;SER_11_I_E;GLU_12_I_E;THR_13_I_E;PHE_14_I_E;ASN_15_I_E;THR_16_I_E;ALA_17_I_C;ALA_18_I_C;ASP_19_I_C;PRO_20_I_C;GLY_21_I_E;ARG_22_I_E;ARG_23_I_E;LEU_24_I_E;GLY_25_I_E;GLU_26_I_E;GLY_27_I_E;SER_28_I_E;LYS_29_I_E;PRO_30_I_E,"ANOPHELIN FROM THE MALARIA VECTOR INHIBITS THROMBIN THROUGH A NOVEL 2 REVERSEBINDING MECHANISM"
4GLY_A_B_3_5.pdb,4GLY,23560397,1.52,P00749,PF00089,2.40.10.10,A,245,B,13,-C--CLGRGCENHRC-L,-C--CCTTTTTTTCC-C,-2--02100000022-2,3,5,4,-D--DDDCCCCCCCC-d,8,4,A:0;C:0;D:0;F:0;G:0;H:0;K:0;L:0;P:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:0;C:0;D:0;F:0;G:0;H:0;K:0;L:0;P:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,E:3;F:2;G:3;H:1;K:5;L:1;M:1;N:2;P:4;Q:5;R:6;S:4;T:2;Y:2,A:10;C:6;D:7;E:9;F:4;G:14;H:6;I:17;K:7;L:16;M:4;N:4;P:7;Q:6;R:5;S:13;T:16;V:10;W:4;Y:8,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,B:1;C:8;E:5;G:2;H:3;T:22,B:10;C:24;E:74;G:11;H:10;T:44,3_5,A:1;C:4;D:4;F:1;G:4;H:2;K:1;L:0;P:1;Q:1;R:2;S:3;T:0;V:2;W:1;Y:2,B:2;C:4;E:8;G:2;T:13,A:0;C:0;D:0;F:0;G:0;H:0;K:0;L:1;P:0;Q:0;R:0;S:0;T:1;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:2,-9--66544544468-9,ALA_223_A_COREBINDING;ARG_20_A_COREBINDING;ARG_220_A_COREBINDING;ASP_192_A_COREBINDING;ASP_197_A_COREBINDING;ASP_50_A_COREBINDING;ASP_90_A_COREBINDING;CYS_194_A_COREBINDING;CYS_222_A_COREBINDING;CYS_31_A_COREBINDING;CYS_47_A_COREBINDING;GLN_195_A_COREBINDING;GLY_196_A_COREBINDING;GLY_219_A_COREBINDING;GLY_221_A_COREBINDING;GLY_229_A_COREBINDING;HIS_46_A_COREBINDING;HIS_94_A_COREBINDING;LEU_92_A_EXOSITE;LYS_227_A_COREBINDING;PHE_48_A_COREBINDING;PRO_228_A_COREBINDING;SER_193_A_COREBINDING;SER_198_A_COREBINDING;SER_217_A_COREBINDING;THR_91_A_EXOSITE;TRP_218_A_COREBINDING;TYR_51_A_COREBINDING;TYR_57_A_COREBINDING;VAL_230_A_COREBINDING;VAL_30_A_COREBINDING,CCLGRGCENHRCL,0.986427652262972,0.385517213237687,0.809040172055751,-9--99999999999-9,CYS_1_B_E;CYS_2_B_E;LEU_3_B_E;GLY_4_B_E;ARG_5_B_C;GLY_6_B_C;CYS_7_B_C;GLU_8_B_C;ASN_9_B_C;HIS_10_B_C;ARG_11_B_C;CYS_12_B_C;LEU_13_B_e,"HUMAN UROKINASETYPE PLASMINOGEN ACTIVATOR UPA IN COMPLEX WITH THE 2 TWODISULFIDE BRIDGE PEPTIDE UK504"
4GUX_C_F_3_1.pdb,4GUX,24169696,1.80,P00760,PF00089,2.40.10.10,C,223,F,34,---S------------GSD----------------------G------GV--------------------------CPKILK-KCRRDSDC-PGACICRGNGYCG----------------,---C------------CCC----------------------C------CC--------------------------EECCCC-BCCCGGGC-TTTTCEETTTEEC----------------,---0------------143----------------------1------00--------------------------000001-20322310-1210100411000----------------,3,1,29,---D------------EEE----------------------D------DD--------------------------CCCCCC-DEEEDEDD-DEDDDEEEEEEED----------------,6,21,C:0;D:0;F:0;G:0;H:0;K:0;L:0;N:0;Q:0;S:0;T:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;K:0;L:0;N:0;Q:0;S:0;T:0;V:0;W:0;Y:0,A:1;D:1;E:1;F:1;G:5;K:6;N:1;P:2;Q:1;S:13;T:1;V:1,A:13;C:9;D:3;E:3;F:1;G:15;H:1;I:15;K:7;L:13;M:2;N:14;P:6;Q:7;R:2;S:15;T:7;V:15;W:3;Y:7,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,B:1;C:3;E:2;H:9;T:19,B:5;C:27;E:66;G:4;H:9;T:47,3_1,C:3;D:2;F:1;G:3;H:2;K:1;L:1;N:0;Q:1;S:3;T:0;V:1;W:1;Y:3,B:1;C:2;E:8;G:2;T:9,C:0;D:0;F:0;G:2;H:0;K:0;L:0;N:1;Q:1;S:3;T:2;V:0;W:0;Y:0,B:0;C:1;E:0;G:0;T:8,---5------------999----------------------9------97--------------------------554347-76769887-6875645566644----------------,ASN_79_C_EXOSITE;ASP_171_C_COREBINDING;ASP_176_C_COREBINDING;CYS_173_C_COREBINDING;CYS_197_C_COREBINDING;CYS_41_C_COREBINDING;GLN_155_C_EXOSITE;GLN_174_C_COREBINDING;GLY_128_C_EXOSITE;GLY_175_C_COREBINDING;GLY_194_C_COREBINDING;GLY_196_C_EXOSITE;GLY_204_C_COREBINDING;HIS_23_C_COREBINDING;HIS_40_C_COREBINDING;LEU_81_C_COREBINDING;LYS_43_C_COREBINDING;PHE_24_C_COREBINDING;SER_126_C_EXOSITE;SER_127_C_EXOSITE;SER_172_C_COREBINDING;SER_177_C_COREBINDING;SER_192_C_COREBINDING;SER_195_C_EXOSITE;THR_129_C_EXOSITE;THR_80_C_EXOSITE;TRP_193_C_COREBINDING;TYR_131_C_COREBINDING;TYR_206_C_COREBINDING;TYR_22_C_COREBINDING;VAL_191_C_COREBINDING,SGSDGGVCPKILKKCRRDSDCPGACICRGNGYCG,0.67929830365252,0.359251826732301,0.432218694644274,---9------------999----------------------9------99--------------------------999999-99999599-9999999999999----------------,SER_1_F_E;GLY_2_F_E;SER_3_F_E;ASP_4_F_E;GLY_5_F_E;GLY_6_F_E;VAL_7_F_E;CYS_8_F_C;PRO_9_F_C;LYS_10_F_C;ILE_11_F_C;LEU_12_F_C;LYS_13_F_C;LYS_14_F_E;CYS_15_F_E;ARG_16_F_E;ARG_17_F_E;ASP_18_F_E;SER_19_F_E;ASP_20_F_E;CYS_21_F_E;PRO_22_F_E;GLY_23_F_E;ALA_24_F_E;CYS_25_F_E;ILE_26_F_E;CYS_27_F_E;ARG_28_F_E;GLY_29_F_E;ASN_30_F_E;GLY_31_F_E;TYR_32_F_E;CYS_33_F_E;GLY_34_F_E,"CRYSTAL STRUCTURE OF TRYPSINMCOTIII COMPLEX"
4K1E_A_B_3_1.pdb,4K1E,,1.30,Q9Y5K2,PF00089,2.40.10.10,A,223,B,14,G------------------------------------------------F--------------------------CQRSIP---------PI--C---------FP--D-----------,C------------------------------------------------E--------------------------EECTTT---------TE--E---------EC--C-----------,1------------------------------------------------0--------------------------000003---------11--2---------14--1-----------,3,1,29,d------------------------------------------------d--------------------------CCCCCC---------DD--D---------DD--D-----------,6,6,A:0;C:0;D:0;F:0;G:0;H:0;K:0;L:0;M:0;N:0;S:0;V:0;Y:0,A:0;C:0;D:1;F:0;G:0;H:0;K:0;L:1;M:0;N:0;S:0;V:0;Y:1,A:2;D:3;E:8;G:3;K:3;L:1;M:2;N:3;P:6;Q:4;R:2;S:5;T:1,A:10;C:9;D:2;E:5;F:3;G:16;H:5;I:9;K:2;L:17;M:2;N:7;P:7;Q:9;R:2;S:16;T:6;V:18;W:4;Y:4,B:0;C:0;E:0;G:0;H:0;T:0,B:0;C:0;E:0;G:0;H:2;T:1,C:8;E:5;G:1;H:6;T:23,B:4;C:23;E:68;G:4;H:10;T:44,3_1,A:1;C:3;D:3;F:2;G:2;H:1;K:1;L:2;M:1;N:1;S:3;V:1;Y:1,B:1;C:2;E:8;G:1;H:0;T:10,A:0;C:0;D:0;F:0;G:0;H:0;K:0;L:2;M:0;N:0;S:0;V:0;Y:0,B:0;C:0;E:0;G:0;H:0;T:2,7------------------------------------------------5--------------------------444466---------55--6---------79--9-----------,ALA_196_A_COREBINDING;ASN_174_A_COREBINDING;ASP_153_A_exosite;ASP_171_A_COREBINDING;ASP_176_A_COREBINDING;ASP_86_A_COREBINDING;CYS_173_A_COREBINDING;CYS_198_A_COREBINDING;CYS_26_A_COREBINDING;GLY_175_A_COREBINDING;GLY_194_A_COREBINDING;HIS_41_A_COREBINDING;LEU_151_A_exosite;LEU_155_A_EXOSITE;LEU_24_A_COREBINDING;LEU_82_A_EXOSITE;LEU_83_A_COREBINDING;LYS_195_A_COREBINDING;MET_131_A_COREBINDING;PHE_193_A_COREBINDING;PHE_25_A_COREBINDING;SER_172_A_COREBINDING;SER_177_A_COREBINDING;SER_192_A_COREBINDING;TYR_152_A_exosite;TYR_78_A_COREBINDING;VAL_191_A_COREBINDING,GFCQRSIPPICFPD,0.38958171121726,0.313084378804658,0.200362172078464,9------------------------------------------------9--------------------------999999---------99--9---------99--9-----------,GLY_1_B_e;PHE_2_B_e;CYS_3_B_C;GLN_4_B_C;ARG_5_B_C;SER_6_B_C;ILE_7_B_C;PRO_8_B_C;PRO_9_B_E;ILE_10_B_E;CYS_11_B_E;PHE_12_B_E;PRO_13_B_E;ASP_14_B_E,"ATOMIC RESOLUTION CRYSTAL STRUCTURES OF KALLIKREINRELATED PEPTIDASE 4 2 COMPLEXED WITH A MODIFIED SFTI INHIBITOR FCQR"
4KEL_A_B_3_1.pdb,4KEL,,1.15,Q9Y5K2,PF00089,2.40.10.10,A,223,B,14,G------------------------------------------------F--------------------------CQRSIP---------PI--C---------FP--N-----------,C------------------------------------------------E--------------------------EECTTT---------TE--E---------CC--C-----------,1------------------------------------------------0--------------------------000003---------11--2---------14--1-----------,3,1,29,d------------------------------------------------d--------------------------CCCCCC---------DD--D---------DD--D-----------,6,6,A:0;C:0;D:0;F:0;G:0;H:0;K:0;L:0;N:0;S:0;V:0;Y:0,A:0;C:0;D:1;F:0;G:0;H:0;K:0;L:1;N:0;S:0;V:0;Y:1,A:2;D:3;E:8;G:3;K:3;L:1;M:2;N:4;P:6;Q:4;R:3;S:5;T:1,A:10;C:9;D:2;E:5;F:3;G:16;H:5;I:9;K:2;L:18;M:3;N:6;P:7;Q:9;R:1;S:16;T:6;V:18;W:4;Y:4,B:0;C:0;E:0;G:0;H:0;T:0,B:0;C:0;E:0;G:0;H:2;T:1,C:9;E:5;G:1;H:6;T:24,B:4;C:26;E:65;G:4;H:10;T:44,3_1,A:1;C:3;D:3;F:2;G:2;H:1;K:1;L:2;N:1;S:3;V:1;Y:1,B:1;C:1;E:8;G:1;H:0;T:10,A:0;C:0;D:0;F:0;G:0;H:0;K:0;L:1;N:0;S:0;V:0;Y:0,B:0;C:0;E:0;G:0;H:0;T:1,8------------------------------------------------5--------------------------444455---------55--6---------69--8-----------,ALA_196_A_COREBINDING;ASN_174_A_COREBINDING;ASP_153_A_exosite;ASP_171_A_COREBINDING;ASP_176_A_COREBINDING;ASP_86_A_COREBINDING;CYS_173_A_COREBINDING;CYS_198_A_COREBINDING;CYS_26_A_COREBINDING;GLY_175_A_COREBINDING;GLY_194_A_COREBINDING;HIS_41_A_COREBINDING;LEU_151_A_exosite;LEU_155_A_EXOSITE;LEU_24_A_COREBINDING;LEU_83_A_COREBINDING;LYS_195_A_COREBINDING;PHE_193_A_COREBINDING;PHE_25_A_COREBINDING;SER_172_A_COREBINDING;SER_177_A_COREBINDING;SER_192_A_COREBINDING;TYR_152_A_exosite;TYR_78_A_COREBINDING;VAL_191_A_COREBINDING,GFCQRSIPPICFPN,0.389731143375061,0.312944307510886,0.261950376980068,9------------------------------------------------9--------------------------999999---------99--9---------99--9-----------,GLY_1_B_e;PHE_2_B_e;CYS_3_B_C;GLN_4_B_C;ARG_5_B_C;SER_6_B_C;ILE_7_B_C;PRO_8_B_C;PRO_9_B_E;ILE_10_B_E;CYS_11_B_E;PHE_12_B_E;PRO_13_B_E;ASN_14_B_E,"ATOMIC RESOLUTION CRYSTAL STRUCTURE OF KALLIKREINRELATED PEPTIDASE 4 2 COMPLEXED WITH A MODIFIED SFTI INHIBITOR FCQRN"
4KTS_A_B_3_1.pdb,4KTS,24591244,1.30,P00760,PF00089,2.40.10.10,A,223,B,13,--I-------------------------------------------------------------------------STRKYP---------SD------------------------WEEW,--C-------------------------------------------------------------------------CBCTTT---------TC------------------------GGGC,--3-------------------------------------------------------------------------100011---------01------------------------2215,3,1,29,--d-------------------------------------------------------------------------CCCCCC---------DD------------------------DEDD,6,6,C:0;D:0;F:0;G:0;H:0;K:0;L:0;Q:0;S:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;K:0;L:0;Q:0;S:0;V:0;W:0;Y:0,A:1;D:1;E:1;G:5;K:5;N:2;P:2;Q:1;S:13;T:2;V:1,A:13;C:8;D:4;E:3;F:2;G:17;H:1;I:15;K:8;L:13;M:2;N:14;P:6;Q:8;R:2;S:18;T:8;V:15;W:3;Y:7,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,C:4;E:1;H:9;T:20,B:5;C:28;E:66;G:4;H:9;T:55,3_1,C:4;D:1;F:1;G:3;H:2;K:1;L:1;Q:1;S:3;V:1;W:1;Y:3,B:1;C:3;E:5;G:2;T:11,C:0;D:0;F:0;G:0;H:0;K:0;L:0;Q:0;S:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,--8-------------------------------------------------------------------------534334---------44------------------------7769,ASP_180_A_COREBINDING;CYS_177_A_COREBINDING;CYS_201_A_COREBINDING;CYS_25_A_COREBINDING;CYS_41_A_COREBINDING;GLN_178_A_COREBINDING;GLY_179_A_COREBINDING;GLY_198_A_COREBINDING;GLY_200_A_COREBINDING;HIS_23_A_COREBINDING;HIS_40_A_COREBINDING;LEU_81_A_COREBINDING;LYS_43_A_COREBINDING;PHE_24_A_COREBINDING;SER_176_A_COREBINDING;SER_181_A_COREBINDING;SER_196_A_COREBINDING;TRP_197_A_COREBINDING;TYR_131_A_COREBINDING;TYR_22_A_COREBINDING;TYR_42_A_COREBINDING;VAL_195_A_COREBINDING,ISTRKYPSDWEEW,0.679670466565714,0.361329209808902,0.684932843423353,--9-------------------------------------------------------------------------999999---------99------------------------9999,ILE_1_B_e;SER_2_B_C;THR_3_B_C;ARG_4_B_C;LYS_5_B_C;TYR_6_B_C;PRO_7_B_C;SER_8_B_E;ASP_9_B_E;TRP_10_B_E;GLU_11_B_E;GLU_12_B_E;TRP_13_B_E,"BOVINE TRYPSIN IN COMPLEX WITH MICROVIRIDIN J AT PH 85"
4MNY_B_D_3_10.pdb,4MNY,24453110,1.70,P00749,PF00089,2.40.10.10,B,245,D,13,GCQVNYCPPVPCL,CTTTTTTTCCCCC,4231000121324,3,10,1,CCCCCCCCCCCCC,13,0,C:0;D:0;G:0;H:0;I:0;L:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,C:0;D:0;G:0;H:0;I:0;L:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,D:1;E:4;F:2;G:3;H:1;K:5;L:1;N:2;P:2;Q:5;R:6;S:4;Y:2,A:11;C:8;D:8;E:8;F:5;G:15;H:6;I:16;K:8;L:16;M:5;N:4;P:10;Q:6;R:6;S:12;T:17;V:10;W:4;Y:9,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:0,B:1;C:8;E:4;G:1;H:3;T:21,B:9;C:26;E:81;G:10;H:10;T:48,3_10,C:2;D:2;G:3;H:2;I:1;L:1;Q:1;R:1;S:4;T:2;V:2;W:1;Y:1,B:1;C:4;E:6;G:1;T:11,C:0;D:0;G:0;H:0;I:0;L:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,9996444444445,ARG_220_B_COREBINDING;ASP_192_B_COREBINDING;ASP_50_B_COREBINDING;CYS_194_B_COREBINDING;CYS_222_B_COREBINDING;GLN_195_B_COREBINDING;GLY_219_B_COREBINDING;GLY_221_B_COREBINDING;GLY_229_B_COREBINDING;HIS_46_B_COREBINDING;HIS_94_B_COREBINDING;ILE_49_B_COREBINDING;LEU_92_B_COREBINDING;SER_145_B_COREBINDING;SER_193_B_COREBINDING;SER_198_B_COREBINDING;SER_217_B_COREBINDING;THR_146_B_COREBINDING;THR_91_B_COREBINDING;TRP_218_B_COREBINDING;TYR_148_B_COREBINDING;VAL_216_B_COREBINDING;VAL_230_B_COREBINDING,GCQVNYCPPVPCL,-1,0.406537483639613,,9999999999999,GLY_1_D_C;CYS_2_D_C;GLN_3_D_C;VAL_4_D_C;ASN_5_D_C;TYR_6_D_C;CYS_7_D_C;PRO_8_D_C;PRO_9_D_C;VAL_10_D_C;PRO_11_D_C;CYS_12_D_C;LEU_13_D_C,"CRYSTAL STRUCTURE OF UROKINASETYPE PLASMINOGEN ACTIVATOR UPA 2 COMPLEXED WITH BICYCLIC PEPTIDE UK903"
4X1Q_U_P_3_1.pdb,4X1Q,25545505,2.28,P00749,PF00089,2.40.10.10,U,247,P,10,-C--------------------------------P-------------A---------------------------YSRYLD---------C-----------------------------,-C--------------------------------T-------------T---------------------------TBCCCC---------C-----------------------------,-3--------------------------------0-------------3---------------------------000002---------2-----------------------------,3,1,29,-d--------------------------------e-------------d---------------------------CCCCCC---------d-----------------------------,6,3,A:0;C:0;D:0;G:0;H:0;L:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:2;C:0;D:1;G:0;H:0;L:0;Q:0;R:0;S:0;T:1;V:0;W:0;Y:0,D:2;E:4;F:2;G:2;H:1;K:6;L:1;N:2;P:2;Q:5;R:7;S:2;T:2;Y:3,A:9;C:6;D:6;E:9;F:5;G:15;H:6;I:17;K:8;L:16;M:5;N:4;P:10;Q:6;R:4;S:15;T:16;V:10;W:4;Y:6,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:1;G:0;T:3,C:7;E:4;H:3;T:27,B:8;C:27;E:77;G:7;H:12;T:46,3_1,A:0;C:4;D:2;G:4;H:1;L:1;Q:1;R:2;S:3;T:0;V:2;W:1;Y:4,B:2;C:4;E:8;G:2;T:9,A:0;C:0;D:0;G:0;H:0;L:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,-8--------------------------------8-------------8---------------------------877778---------8-----------------------------,ALA_89_U_exosite;ALA_93_U_exosite;ARG_20_U_COREBINDING;ARG_220_U_COREBINDING;ASP_192_U_COREBINDING;ASP_197_U_COREBINDING;ASP_90_U_exosite;CYS_194_U_COREBINDING;CYS_222_U_COREBINDING;CYS_31_U_COREBINDING;CYS_47_U_COREBINDING;GLN_195_U_COREBINDING;GLY_196_U_COREBINDING;GLY_219_U_COREBINDING;GLY_221_U_COREBINDING;GLY_229_U_COREBINDING;HIS_46_U_COREBINDING;LEU_92_U_COREBINDING;SER_193_U_COREBINDING;SER_198_U_COREBINDING;SER_217_U_COREBINDING;THR_91_U_exosite;TRP_218_U_COREBINDING;TYR_150_U_COREBINDING;TYR_173_U_COREBINDING;TYR_29_U_COREBINDING;TYR_94_U_COREBINDING;VAL_216_U_COREBINDING;VAL_30_U_COREBINDING,CPAYSRYLDC,0.371891266628109,0.421642902076132,2.00333172490229,-9--------------------------------9-------------9---------------------------999999---------9-----------------------------,CYS_1_P_e;PRO_2_P_e;ALA_3_P_e;TYR_4_P_C;SER_5_P_C;ARG_6_P_C;TYR_7_P_C;LEU_8_P_C;ASP_9_P_C;CYS_10_P_e,"THE CRYSTAL STRUCTURE OF MUPAIN1 IN COMPLEX WITH MURINISED HUMAN UPA 2 AT PH74"
4X1S_U_P_3_1.pdb,4X1S,25545505,1.90,P00749,PF00089,2.40.10.10,U,246,P,10,-C--------------------------------P-------------A---------------------------YSAYLA---------C-----------------------------,-C--------------------------------T-------------T---------------------------TBCCCC---------C-----------------------------,-3--------------------------------0-------------3---------------------------000002---------1-----------------------------,3,1,29,-d--------------------------------e-------------d---------------------------CCCCCC---------d-----------------------------,6,3,A:0;C:0;D:0;G:0;H:0;K:0;L:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:2;C:0;D:1;G:0;H:0;K:0;L:0;Q:0;R:0;S:0;T:1;V:0;W:0;Y:0,D:2;E:4;F:2;G:4;H:2;K:6;L:1;N:2;P:3;Q:5;R:5;S:2;T:2;Y:2,A:9;C:7;D:7;E:8;F:5;G:15;H:5;I:17;K:7;L:16;M:5;N:4;P:9;Q:6;R:7;S:16;T:16;V:11;W:4;Y:7,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:1;G:0;T:3,B:1;C:7;E:3;G:2;H:3;T:26,B:9;C:25;E:81;G:8;H:11;T:47,3_1,A:0;C:3;D:1;G:2;H:1;K:1;L:1;Q:1;R:1;S:2;T:0;V:1;W:1;Y:4,B:2;C:3;E:5;G:2;T:7,A:0;C:0;D:0;G:0;H:0;K:0;L:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,-9--------------------------------7-------------6---------------------------989679---------9-----------------------------,ALA_89_U_exosite;ALA_93_U_exosite;ARG_220_U_COREBINDING;ASP_197_U_COREBINDING;ASP_90_U_exosite;CYS_194_U_COREBINDING;CYS_31_U_COREBINDING;CYS_47_U_COREBINDING;GLN_195_U_COREBINDING;GLY_196_U_COREBINDING;GLY_219_U_COREBINDING;HIS_46_U_COREBINDING;LEU_92_U_COREBINDING;LYS_227_U_COREBINDING;SER_198_U_COREBINDING;SER_217_U_COREBINDING;THR_91_U_exosite;TRP_218_U_COREBINDING;TYR_150_U_COREBINDING;TYR_173_U_COREBINDING;TYR_29_U_COREBINDING;TYR_94_U_COREBINDING;VAL_30_U_COREBINDING,CPAYSAYLAC,0.372968655221544,0.422096784533682,1.89200792810178,-9--------------------------------9-------------9---------------------------999999---------9-----------------------------,CYS_1_P_e;PRO_2_P_e;ALA_3_P_e;TYR_4_P_C;SER_5_P_C;ALA_6_P_C;TYR_7_P_C;LEU_8_P_C;ALA_9_P_C;CYS_10_P_e,"THE CRYSTAL STRUCTURE OF MUPAIN116D9A IN COMPLEX WITH MURINISED 2 HUMAN UPA AT PH74"
4X6N_A_H_3_13.pdb,4X6N,25728130,2.10,P03951,PF00089,2.40.10.10,A,238,H,7,CTTKIKP,TTTTCCC,2303034,3,13,1,CCCCCCC,7,0,C:0;G:0;I:0;L:0;N:0;P:0;Q:0;S:0;T:0;V:0;W:0,C:0;G:0;I:0;L:0;N:0;P:0;Q:0;S:0;T:0;V:0;W:0,A:1;D:3;E:8;G:4;H:1;I:1;K:9;N:2;P:1;R:4;S:2;T:3;V:2;Y:1,A:9;C:8;D:7;E:7;F:3;G:21;H:7;I:16;K:7;L:13;M:2;N:4;P:6;Q:11;R:8;S:10;T:13;V:14;W:7;Y:10,B:0;C:0;E:0;H:0;T:0,B:0;C:0;E:0;H:0;T:0,C:9;E:1;G:1;H:3;T:28,B:6;C:26;E:73;G:12;H:9;T:57,3_13,C:1;G:1;I:2;L:2;N:1;P:1;Q:1;S:1;T:1;V:1;W:1,B:1;C:2;E:3;H:5;T:2,C:0;G:0;I:0;L:0;N:0;P:0;Q:0;S:0;T:0;V:0;W:0,B:0;C:0;E:0;H:0;T:0,7999999,ASN_36_A_COREBINDING;CYS_113_A_COREBINDING;GLN_236_A_COREBINDING;GLY_35_A_COREBINDING;ILE_231_A_COREBINDING;ILE_34_A_COREBINDING;LEU_114_A_COREBINDING;LEU_232_A_COREBINDING;PRO_115_A_COREBINDING;SER_116_A_COREBINDING;THR_235_A_COREBINDING;TRP_38_A_COREBINDING;VAL_228_A_COREBINDING,MDDDDKMDNECTTKIKPR,-1,0.34984370796342,,9999999,CYS_1_H_C;THR_2_H_C;THR_3_H_C;LYS_4_H_C;ILE_5_H_C;LYS_6_H_C;PRO_7_H_C,"FACTOR XIA IN COMPLEX WITH THE INHIBITOR 11S143AMINO1H 2 INDAZOL6YL5CHLORO1HIMIDAZOL2YL2PHENYLETHYL35CHLORO 3 21HTETRAZOL1YLBENZYLUREA"
4XOJ_A_B_3_1.pdb,4XOJ,26212347,0.91,P00760,PF00089,2.40.10.10,A,223,B,13,G------------------------------------------------R--------------------------CTKSIP---------PI--C---------FP--------------,C------------------------------------------------E--------------------------EECTTT---------TE--E---------CC--------------,3------------------------------------------------0--------------------------000002---------11--2---------05--------------,3,1,29,d------------------------------------------------d--------------------------CCCCCC---------DD--D---------DD--------------,6,5,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:0;S:0;T:0;V:0;W:0;Y:0,C:0;D:0;F:0;G:0;H:0;L:0;N:0;Q:1;S:1;T:1;V:0;W:0;Y:0,A:1;E:1;G:5;K:5;N:1;P:2;Q:1;S:12;T:2;V:1,A:13;C:9;D:4;E:3;F:2;G:17;H:1;I:15;K:9;L:13;M:2;N:14;P:6;Q:7;R:2;S:17;T:7;V:15;W:3;Y:8,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:1;G:0;T:2,C:3;E:1;H:8;T:19,B:3;C:32;E:68;G:5;H:10;T:49,3_1,C:3;D:2;F:1;G:3;H:2;L:1;N:0;Q:1;S:3;T:0;V:1;W:1;Y:2,B:1;C:2;E:7;G:1;T:9,C:0;D:0;F:0;G:0;H:0;L:0;N:1;Q:0;S:1;T:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:2,9------------------------------------------------5--------------------------544445---------55--5---------69--------------,ASN_79_A_EXOSITE;ASP_171_A_COREBINDING;ASP_176_A_COREBINDING;CYS_173_A_COREBINDING;CYS_197_A_COREBINDING;CYS_25_A_COREBINDING;GLN_155_A_exosite;GLN_174_A_COREBINDING;GLY_175_A_COREBINDING;GLY_194_A_COREBINDING;GLY_196_A_COREBINDING;HIS_23_A_COREBINDING;HIS_40_A_COREBINDING;LEU_81_A_COREBINDING;PHE_24_A_COREBINDING;SER_172_A_COREBINDING;SER_177_A_COREBINDING;SER_192_A_COREBINDING;SER_195_A_exosite;SER_78_A_EXOSITE;THR_80_A_exosite;TRP_193_A_COREBINDING;TYR_131_A_COREBINDING;TYR_22_A_COREBINDING;VAL_191_A_COREBINDING,GRCTKSIPPICFP,0.679143696355056,0.358893584546087,0.185725604050706,9------------------------------------------------9--------------------------999969---------99--9---------99--------------,GLY_1_B_e;ARG_2_B_e;CYS_3_B_C;THR_4_B_C;LYS_5_B_C;SER_6_B_C;ILE_7_B_C;PRO_8_B_C;PRO_9_B_E;ILE_10_B_E;CYS_11_B_E;PHE_12_B_E;PRO_13_B_E,"STRUCTURE OF BOVINE TRYPSIN IN COMPLEX WITH ANALOGUES OF SUNFLOWER 2 INHIBITOR 1 SFTI1"
4YES_B_A_3_3.pdb,4YES,26005532,1.50,P00734,PF00089,2.40.10.10,B,252,A,29,GE---A--DCGLRPLFEKKSLEDKTERELLESYI-------,TT---T--TTTTTTTTGGGCCCCCHHHHHHHHCC-------,13---3--10000010023322020021013004-------,3,3,17,EE---E--DDCCCCCEEEEEEEEEEEEEEEEEEE-------,5,19,C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,A:2;D:6;E:4;F:2;G:2;K:4;N:3;P:4;Q:2;R:7;S:2;T:2;W:1;Y:1,A:9;C:6;D:7;E:10;F:7;G:16;H:4;I:15;K:11;L:19;M:5;N:5;P:7;Q:6;R:9;S:9;T:7;V:15;W:5;Y:6,B:0;C:0;E:0;H:0;T:0,B:0;C:0;E:0;H:0;T:0,C:8;E:1;G:3;H:8;T:22,B:7;C:28;E:73;G:10;H:15;T:45,3_3,C:1;D:1;E:0;G:1;H:1;I:1;K:0;L:0;M:1;N:1;P:2;R:2;S:1;V:1;W:2;Y:1,B:2;C:4;E:2;H:0;T:8,C:0;D:2;E:1;G:2;H:0;I:0;K:3;L:1;M:1;N:1;P:1;R:0;S:2;V:0;W:0;Y:2,B:0;C:2;E:9;H:1;T:4,99---7--54333343444444444444444448-------,ARG_137_B_COREBINDING;ARG_212_B_COREBINDING;ASN_158_B_EXOSITE;ASN_211_B_COREBINDING;ASP_113_B_COREBINDING;ASP_35_B_EXOSITE;ASP_6_B_EXOSITE;CYS_119_B_COREBINDING;GLU_8_B_EXOSITE;GLY_10_B_COREBINDING;GLY_133_B_EXOSITE;GLY_136_B_EXOSITE;HIS_116_B_COREBINDING;ILE_9_B_COREBINDING;LEU_129_B_EXOSITE;LYS_135_B_EXOSITE;LYS_190_B_EXOSITE;LYS_206_B_EXOSITE;MET_11_B_COREBINDING;MET_205_B_EXOSITE;PRO_117_B_COREBINDING;PRO_13_B_COREBINDING;PRO_208_B_EXOSITE;SER_112_B_COREBINDING;SER_34_B_EXOSITE;SER_5_B_EXOSITE;TRP_14_B_COREBINDING;TRP_213_B_COREBINDING;TYR_114_B_COREBINDING;TYR_134_B_EXOSITE;TYR_184_B_EXOSITE;VAL_118_B_COREBINDING,TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR,0.721982959850607,0.568625041654324,0.149228013455921,99---9--99999999999999999999999999-------,GLY_1_A_E;GLU_2_A_E;ALA_3_A_E;ASP_4_A_E;CYS_5_A_E;GLY_6_A_C;LEU_7_A_C;ARG_8_A_C;PRO_9_A_C;LEU_10_A_C;PHE_11_A_E;GLU_12_A_E;LYS_13_A_E;LYS_14_A_E;SER_15_A_E;LEU_16_A_E;GLU_17_A_E;ASP_18_A_E;LYS_19_A_E;THR_20_A_E;GLU_21_A_E;ARG_22_A_E;GLU_23_A_E;LEU_24_A_E;LEU_25_A_E;GLU_26_A_E;SER_27_A_E;TYR_28_A_E;ILE_29_A_E,"THROMBIN IN COMPLEX WITH S4CHLORO215METHYL1HPYRROLE2 2 CARBONYLPYRROLIDINE2CARBOXAMIDOMETHYLPHENYLMETHANAMINIUM"
4ZHL_U_P_3_1.pdb,4ZHL,26281711,2.06,P00749,PF00089,2.40.10.10,U,247,P,10,-C--------------------------------P-------------A---------------------------YSRYIG---------C-----------------------------,-C--------------------------------T-------------T---------------------------TBCCCC---------C-----------------------------,-3--------------------------------0-------------2---------------------------000012---------2-----------------------------,3,1,29,-e--------------------------------e-------------d---------------------------CCCCCC---------d-----------------------------,6,3,A:0;C:0;D:0;G:0;H:0;L:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:2;C:0;D:1;G:0;H:0;L:0;Q:0;R:0;S:0;T:1;V:0;W:0;Y:0,D:2;E:4;F:1;G:2;K:6;L:1;N:3;P:2;Q:5;R:7;S:4;T:2;Y:3,A:9;C:6;D:6;E:9;F:6;G:15;H:7;I:17;K:8;L:16;M:5;N:3;P:10;Q:6;R:4;S:13;T:16;V:10;W:4;Y:8,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:1;G:0;T:3,C:10;E:4;G:2;H:3;T:23,B:8;C:23;E:78;G:8;H:11;T:50,3_1,A:0;C:4;D:2;G:4;H:1;L:1;Q:1;R:2;S:3;T:0;V:2;W:1;Y:2,B:2;C:2;E:7;G:2;T:10,A:0;C:0;D:0;G:0;H:0;L:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,-6--------------------------------6-------------6---------------------------554455---------5-----------------------------,ALA_89_U_exosite;ALA_93_U_exosite;ARG_20_U_COREBINDING;ARG_220_U_COREBINDING;ASP_192_U_COREBINDING;ASP_197_U_COREBINDING;ASP_90_U_exosite;CYS_194_U_COREBINDING;CYS_222_U_COREBINDING;CYS_31_U_COREBINDING;CYS_47_U_COREBINDING;GLN_195_U_COREBINDING;GLY_196_U_COREBINDING;GLY_219_U_COREBINDING;GLY_221_U_COREBINDING;GLY_229_U_COREBINDING;HIS_46_U_COREBINDING;LEU_92_U_COREBINDING;SER_193_U_COREBINDING;SER_198_U_COREBINDING;SER_217_U_COREBINDING;THR_91_U_exosite;TRP_218_U_COREBINDING;TYR_150_U_COREBINDING;TYR_29_U_COREBINDING;VAL_216_U_COREBINDING;VAL_30_U_COREBINDING,CPAYSRYIGC,0.371891266628109,0.421642902076132,2.19126150881176,-9--------------------------------9-------------9---------------------------999999---------9-----------------------------,CYS_1_P_e;PRO_2_P_e;ALA_3_P_e;TYR_4_P_C;SER_5_P_C;ARG_6_P_C;TYR_7_P_C;ILE_8_P_C;GLY_9_P_C;CYS_10_P_e,"THE CRYSTAL STRUCTURE OF MUPAIN1IG IN COMPLEX WITH MURINISED HUMAN 2 UPA AT PH74"
4ZJ4_A_B_3_1.pdb,4ZJ4,26536069,1.50,,,2.40.10.10,A,239,B,10,-C--------------------------------P-------------A---------------------------RFAALF----------C----------------------------,-C--------------------------------T-------------T---------------------------TBCCCC----------C----------------------------,-1--------------------------------1-------------3---------------------------000013----------0----------------------------,3,1,29,-e--------------------------------e-------------d---------------------------CCCCCC----------d----------------------------,6,3,C:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:1;E:0;F:0;G:0;H:0;I:0;K:0;L:0;R:0;S:1;V:0;W:0;Y:0,A:1;D:3;E:8;G:3;K:8;L:2;M:1;N:2;P:2;Q:4;R:1;S:3;T:6,A:8;C:7;D:5;E:7;F:3;G:18;H:4;I:18;K:9;L:15;M:2;N:5;P:7;Q:12;R:5;S:10;T:9;V:13;W:9;Y:6,B:0;E:0;G:0;T:0,B:0;E:0;G:0;T:2,C:7;E:3;G:1;H:5;T:28,B:8;C:26;E:69;G:9;H:13;T:47,3_1,C:1;D:2;E:1;F:1;G:3;H:2;I:1;K:1;L:1;R:1;S:2;V:1;W:1;Y:3,B:3;E:4;G:1;T:13,C:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;R:0;S:0;V:0;W:0;Y:0,B:0;E:0;G:0;T:0,-6--------------------------------6-------------5---------------------------544566----------6----------------------------,ARG_26_A_COREBINDING;ASP_164_A_COREBINDING;ASP_47_A_exosite;ASP_93_A_COREBINDING;CYS_184_A_COREBINDING;GLU_210_A_COREBINDING;GLY_186_A_COREBINDING;GLY_209_A_COREBINDING;GLY_90_A_COREBINDING;HIS_27_A_COREBINDING;HIS_44_A_COREBINDING;ILE_141_A_COREBINDING;LEU_28_A_COREBINDING;LYS_185_A_COREBINDING;PHE_134_A_COREBINDING;SER_188_A_COREBINDING;SER_207_A_COREBINDING;SER_88_A_exosite;TRP_208_A_COREBINDING;TYR_162_A_COREBINDING;TYR_165_A_COREBINDING;TYR_85_A_COREBINDING;VAL_87_A_COREBINDING,CPARFAALFC,0.398181484067848,0.362642776777726,1.42419099842683,-9--------------------------------9-------------9---------------------------999999----------5----------------------------,CYS_1_B_e;PRO_2_B_e;ALA_3_B_e;ARG_4_B_C;PHE_5_B_C;ALA_6_B_C;ALA_7_B_C;LEU_8_B_C;PHE_9_B_C;CYS_10_B_e,"THE CRYSTAL STRUCTURE OF HUMAN PLASMA KALLIKREIN IN COMPLEX WITH ITS 2 PEPTIDE INHIBITOR PKALIN1"
4ZJ5_A_P_3_1.pdb,4ZJ5,26536069,1.75,,,2.40.10.10,A,239,P,10,-C--------------------------------P-------------K---------------------------RFAALF----------C----------------------------,-C--------------------------------T-------------T---------------------------TBCCCC----------C----------------------------,-1--------------------------------1-------------3---------------------------000013----------0----------------------------,3,1,29,-e--------------------------------e-------------d---------------------------CCCCCC----------d----------------------------,6,3,C:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;R:0;S:0;V:0;W:0;Y:0,C:0;D:1;E:0;F:0;G:0;H:0;I:0;K:0;L:0;R:0;S:0;V:0;W:0;Y:0,A:1;D:5;E:7;G:3;K:8;L:1;M:1;N:2;P:2;Q:4;R:1;S:1;T:5,A:8;C:7;D:4;E:8;F:3;G:18;H:4;I:18;K:9;L:16;M:2;N:5;P:7;Q:12;R:5;S:12;T:10;V:13;W:9;Y:7,B:0;E:0;G:0;T:0,B:0;E:0;G:0;T:1,C:6;E:3;H:6;T:26,B:8;C:27;E:69;G:10;H:12;T:51,3_1,C:1;D:1;E:1;F:1;G:3;H:2;I:1;K:1;L:1;R:1;S:3;V:1;W:1;Y:2,B:3;E:4;G:1;T:12,C:0;D:0;E:0;F:0;G:0;H:0;I:0;K:0;L:0;R:0;S:0;V:0;W:0;Y:0,B:0;E:0;G:0;T:0,-7--------------------------------6-------------6---------------------------555667----------7----------------------------,ARG_26_A_COREBINDING;ASP_47_A_exosite;ASP_93_A_COREBINDING;CYS_184_A_COREBINDING;GLU_89_A_COREBINDING;GLY_186_A_COREBINDING;GLY_209_A_COREBINDING;GLY_90_A_COREBINDING;HIS_27_A_COREBINDING;HIS_44_A_COREBINDING;ILE_141_A_COREBINDING;LEU_28_A_COREBINDING;LYS_185_A_COREBINDING;PHE_134_A_COREBINDING;SER_188_A_COREBINDING;SER_207_A_COREBINDING;SER_88_A_COREBINDING;TRP_208_A_COREBINDING;TYR_165_A_COREBINDING;TYR_85_A_COREBINDING;VAL_87_A_COREBINDING,CPKRFAALFC,0.398779212699049,0.360621511424281,1.57943122673955,-9--------------------------------9-------------9---------------------------999999----------9----------------------------,CYS_1_P_e;PRO_2_P_e;LYS_3_P_e;ARG_4_P_C;PHE_5_P_C;ALA_6_P_C;ALA_7_P_C;LEU_8_P_C;PHE_9_P_C;CYS_10_P_e,"THE CRYSTAL STRUCTURE OF HUMAN PLASMA KALLIKREIN IN COMPLEX WITH ITS 2 PEPTIDE INHIBITOR PKALIN2"
4ZJ6_A_B_3_1.pdb,4ZJ6,26536069,1.55,,,2.40.10.10,A,239,B,10,-C--------------------------------P-------------A---------------------------RFAALW----------C----------------------------,-C--------------------------------T-------------T---------------------------TTCCCC----------C----------------------------,-1--------------------------------1-------------3---------------------------000013----------0----------------------------,3,1,29,-e--------------------------------e-------------d---------------------------CCCCCC----------d----------------------------,6,3,C:0;D:0;E:0;G:0;H:0;K:0;L:0;S:0;V:0;W:0;Y:0,C:0;D:1;E:0;G:0;H:0;K:0;L:0;S:0;V:0;W:0;Y:0,D:4;E:7;G:2;K:10;L:2;M:1;N:2;P:2;Q:4;R:2;S:3;T:6,A:9;C:7;D:5;E:8;F:4;G:19;H:4;I:19;K:7;L:15;M:2;N:5;P:7;Q:12;R:5;S:10;T:9;V:13;W:9;Y:7,E:0;G:0;T:0,E:0;G:0;T:1,C:8;E:4;G:2;H:5;T:26,B:10;C:26;E:69;G:11;H:13;T:47,3_1,C:1;D:1;E:1;G:3;H:2;K:1;L:1;S:3;V:1;W:1;Y:2,E:4;G:1;T:12,C:0;D:0;E:0;G:0;H:0;K:0;L:0;S:0;V:0;W:0;Y:0,E:0;G:0;T:0,-6--------------------------------5-------------5---------------------------544555----------5----------------------------,ASP_47_A_exosite;ASP_93_A_COREBINDING;CYS_184_A_COREBINDING;GLU_89_A_COREBINDING;GLY_186_A_COREBINDING;GLY_209_A_COREBINDING;GLY_90_A_COREBINDING;HIS_27_A_COREBINDING;HIS_44_A_COREBINDING;LEU_28_A_COREBINDING;LYS_185_A_COREBINDING;SER_188_A_COREBINDING;SER_207_A_COREBINDING;SER_88_A_COREBINDING;TRP_208_A_COREBINDING;TYR_165_A_COREBINDING;TYR_85_A_COREBINDING;VAL_87_A_COREBINDING,CPARFAALWC,0.398032051910047,0.360693119014686,1.36110984126925,-9--------------------------------9-------------9---------------------------999999----------9----------------------------,CYS_1_B_e;PRO_2_B_e;ALA_3_B_e;ARG_4_B_C;PHE_5_B_C;ALA_6_B_C;ALA_7_B_C;LEU_8_B_C;TRP_9_B_C;CYS_10_B_e,"THE CRYSTAL STRUCTURE OF HUMAN PLASMA KALLIKREIN IN COMPLEX WITH ITS 2 PEPTIDE INHIBITOR PKALIN3"
4ZKS_U_P_3_5.pdb,4ZKS,,1.85,P00749,PF00089,2.40.10.10,U,246,P,12,C-SA---RGLENHAAC-,C-CT---TTTTTTCCC-,3-10---001000242-,3,5,4,d-dd---CCCCCCCCd-,8,3,A:0;C:0;D:0;F:0;G:0;H:0;K:0;P:0;Q:0;R:0;S:0;V:0;W:0;Y:0,A:0;C:0;D:0;F:0;G:0;H:0;K:1;P:0;Q:0;R:0;S:1;V:0;W:0;Y:0,D:1;E:2;F:2;G:3;H:1;K:6;L:1;M:2;N:2;P:4;Q:5;R:6;S:3;T:3;Y:2,A:11;C:7;D:7;E:10;F:4;G:14;H:6;I:17;K:7;L:17;M:3;N:4;P:7;Q:6;R:6;S:13;T:16;V:10;W:4;Y:8,B:0;C:0;E:0;G:0;T:0,B:0;C:0;E:0;G:0;T:2,C:9;E:4;G:1;H:3;T:26,B:7;C:25;E:79;G:9;H:11;T:46,3_5,A:1;C:3;D:3;F:1;G:4;H:2;K:0;P:1;Q:1;R:1;S:2;V:2;W:1;Y:2,B:1;C:3;E:8;G:2;T:10,A:0;C:0;D:0;F:0;G:0;H:0;K:0;P:0;Q:0;R:0;S:0;V:0;W:0;Y:0,B:0;C:0;E:0;G:0;T:0,9-97---655556899-,ALA_198_U_COREBINDING;ARG_20_U_COREBINDING;ASP_192_U_COREBINDING;ASP_197_U_COREBINDING;ASP_50_U_COREBINDING;CYS_194_U_COREBINDING;CYS_222_U_COREBINDING;CYS_47_U_COREBINDING;GLN_195_U_COREBINDING;GLY_196_U_COREBINDING;GLY_219_U_COREBINDING;GLY_221_U_COREBINDING;GLY_229_U_COREBINDING;HIS_46_U_COREBINDING;HIS_94_U_COREBINDING;LYS_142_U_exosite;PHE_48_U_COREBINDING;PRO_228_U_COREBINDING;SER_145_U_exosite;SER_193_U_COREBINDING;SER_217_U_COREBINDING;TRP_218_U_COREBINDING;TYR_51_U_COREBINDING;TYR_57_U_COREBINDING;VAL_216_U_COREBINDING;VAL_30_U_COREBINDING,CSARGLENHAAC,0.985105822718146,0.381294353047912,0.639653030947246,9-99---999999999-,CYS_1_P_e;SER_2_P_e;ALA_3_P_e;ARG_4_P_C;GLY_5_P_C;LEU_6_P_C;GLU_7_P_C;ASN_8_P_C;HIS_9_P_C;ALA_10_P_C;ALA_11_P_C;CYS_12_P_e,"THE CRYSTAL STRUCTURE OF UPAIN1W3A IN COMPLEX WITH INACTIVE UPA 2 UPAS195A AT PH74"
